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The Claisen rearrangement, a [3,3] sigmatropic rearrangement, remains an important method for 
the construction of C-C bonds nearly a century after its discovery.  However, methods to affect a 
catalytic and asymmetric variant of this reaction are rare.   A transition metal/Lewis acid co-
catalyst system (Ru(II)-B(III)) has been successfully employed to affect an enantioselective, and 
diastereoselective Claisen rearrangement of simple, achiral, allyl vinyl ethers without the need 
for auxiliary functionality to assist in substrate-catalyst association. In addition, we have 
developed a complementary ruthenium catalyzed enolate allylic alkylation reaction that forms 
Claisen-like products, without the need to synthesize allyl vinyl ethers.  
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 1 
1.0  INTRODUCTION TO CATALYZED CLAISEN REARRANGEMENTS 
1.1 THE CLAISEN REARRANGEMENT 
 
The Claisen rearrangement, the [3,3] sigmatropic rearrangement of an allyl vinyl ether 1 to a 
- unsaturated aldehyde 3 was discovered in 1912 by Ludwig Claisen.1  Since then, this 
rearrangement has become a popular method for carbon-carbon bond formation in organic 
synthesis.
2
  Its utility stems from the fact that the rearrangement proceeds through a highly 
ordered chair-type transition state 2 providing both a reliable and predictable method for 
establishing vicinal stereocenters (Figure 1). The popularity of this stereoselective process has 
resulted in the development of a number of related transformations that include the Carroll 
(1940),
3
 Eschenmoser (1964),
4
 Johnson (1970),
5
 Ireland (1972),
6
 and Reformansky (1973) 
variants of the Claisen rearrangement.
7 
 
 
Figure 1. General Claisen Rearrangement 
 
The development of a catalytic asymmetric Claisen rearrangement remains a challenging 
undertaking.   Efforts have been made to accomplish this formidable task by utilizing Lewis 
 2 
acids and transition metals as two distinct modes of catalysis (Figure 2).  Unfortunately, due to 
the structure of the allyl vinyl ether and its carbonyl containing product, little success has been 
made.  Catalysis by Lewis acids generally requires stoichiometric amounts of reagents due to the 
greater Lewis basicity of the carbonyl containing product versus the starting allyl vinyl ether.
8,9 
 
In addition, catalysis by transition metals is met with its own problems, specifically the fact that 
late transition metals generally prefer to bind to the more electron rich vinyl olefin, resulting in 
strict substrate requirements.
10
   As a result of this complication, few catalytic asymmetric 
variants of the Claisen rearrangement exist today, and they will be discussed herein.   
 
 
Figure 2. Modes of Catalysis for the Claisen Rearrangement 
 
1.2 MODES OF CATALYSIS FOR THE CLAISEN REARRANGMENT 
1.2.1 Lewis Acid Catalysis 
1.2.1.1 Origins of Lewis Acid Catalysis 
The Claisen rearrangement of simple, aliphatic allyl vinyl ethers is a thermal process that 
generally requires temperatures of around 200 °C.  As a consequence of this thermal restriction, 
a number of attempts have been made to accelerate these reactions. The earliest endeavors utilize 
 3 
Lewis acids to coordinate to the oxygen atom of the allyl vinyl ether (Figure 3).
8,9,11, 12
  The 
binding helps to weaken the breaking C-O bond and stabilize the developing negative charge on 
the oxygen atom of the enolate-like moiety, thus aiding to accelerate the reaction.
13
  
 
 
Figure 3. Lewis Acid Catalysis 
 
The earliest examples of Lewis acid-catalyzed Claisen rearrangements utilized BF3,
11
 
BCl3
14
 and alumina.
15
  Although enhancements to the rate of the reaction were observed, yields 
were poor and a large amount of side reactions were produced. This is thought to be the result of 
complete ionization of the allyl vinyl ether.  The first synthetically useful variant was developed 
by Yamamoto utilizing a chiral Al(III) complex (eq 1).
8
  Unfortunately, multiple equivalents of 
the Lewis acid were necessary to promote the Claisen reaction due to the increased Lewis 
basicity of the carbonyl containing product over the allyl vinyl ether. Although the reaction was 
not catalytic, it demonstrated that Lewis acids in combination with chiral ligands were suitable 
candidates to enhance the rate of the reaction. This provided a basis for further development of 
catalytic asymmetric reactions. 
 4 
 
1.2.1.2 Examples of Lewis Acid Catalyzed Claisen Rearrangements 
Trost was the first to report a catalytic Claisen rearrangement.
16  
He was able to demonstrate that 
lanthanide(III) cations in combination with 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-
octanedionate (FOD) ligands were suitable catalysts for the Claisen rearrangement of cyclic 
aliphatic allyl vinyl ethers.  The correct choice of lanthanide metal proved to be critical to ensure 
a concerted process. 
The Lewis acidity of many of the lanthanide(III) complexes proved to be problematic as 
they caused the rearrangement to proceed with dissociation and racemization of the starting allyl 
vinyl ethers.  Ultimately, it was determined that (FOD) complexes of Eu and Ho provided the 
best results overall, with Ho(FOD)3 proving to be the most effective catalyst.  Under the 
optimized conditions, the rearrangement proceeded with up to 98% chirality transfer and yielded 
a single diastereomer.  Trost demonstrated that this catalyst system operated for a variety of allyl 
vinyl ethers, including acyclic and cyclic substrates, albeit with varying yields and chirality 
transfers (eq 2 and 3).
16
   
 
 5 
 
 
Following Trosts discovery that Lewis acids were viable catalysts for mediating Claisen 
rearrangements, Hiersmann looked to expand this work and develop an improved catalytic, 
enantioselective Claisen rearrangement utilizing a chiral Lewis acid catalyst.
12,17,18
   In doing so, 
he decided to use 2-alkoxycarbonyl-substituted allyl vinyl ethers such as 13 (Figure 4), due to 
their ease of synthesis, stability, and inherent reactivity. 
 
 
Figure 4. 2-Alkoxycarbonyl Substituted Allyl Vinyl Ethers 
  
After performing a Lewis acid screen, he discovered that a variety of metal triflates 
including Cu(II), Lanthanide(III), and Sc(III), were effective catalysts for mediating the Claisen 
rearrangement.
12
  He determined that Cu(OTf)2 in combination with molecular sieves provided 
 6 
optimal reactivity, a 99% yield of the Claisen product, and good diastereoselectivity (93:7 
syn:anti).  Encouraged by the results, he wanted to further extend his work to produce an 
enantioselective rearrangement.   The observation that Cu(OTf)2 was an efficient catalyst 
directed his search for a chiral catalyst towards the well known chiral Cu(II) bisoxazoline 
complexes 14 and 15 (Figure 5).
17, 18 
 
 
Figure 5. Copper Bisoxazoline Complexes 14 and 15 
 
Hiersmann  utilized copper complexes of the type 14a in which the bisoxazoline ligand 
contained a phenyl group or a t-butyl group. He demonstrated that these Lewis acids facilitated 
the rearrangement via bidentate chelation to the substrate 17 (Figure 6), causing an inductive 
effect that would effectively polarize the transition state.  This allowed the reaction to proceed 
through a lower activation energy than the thermal rearrangement to afford the Claisen product 
18.
18 
 
 7 
 
Figure 6. Lewis Acid Mediated Claisen Rearrangement 
 
The use of the Cu(II)bisoxazoline complex 15b was able to mediate an enantioselective 
(72-91% ee) and highly diastereoselective rearrangement.  Interestingly, the diastereoselectivities 
were shown to be highly dependent on the configuration of the allyl bond of the starting allyl 
vinyl ethers.  The Z configuration provided products with high diastereoselectivities (3:97, 
syn:anti) and enantioselectivities of up to 91%.  The E configuration provided 
enantioselectivities of up to 72%, but inferior diastereoselectivities (28:72, syn:anti).
17
   
Although both excellent diastereoselectivities and enantioselectivities were observed in 
the reaction with these copper(II) catalysts, there were severe substrate restrictions.  The 
alkoxycarbonyl moiety at the 2-position of the vinyl ether was absolutely necessary 
mechanistically for bidentate activation by the copper(II) bisoxazoline Lewis acid.  Also, the 
diastereoselectivity of the reaction was dependent on the allyl ether geometry with the Z isomer 
providing superior results.  The limited utility of this methodology showcased the need for 
catalysts that worked for a wider range of substrates.  
1.2.1.3 Hydrogen Bonding Catalysis 
Most recently, Jacobsen has developed a catalytic and enantioselective Claisen rearrangement 
(Scheme 1).
19,20
 Rather than using Lewis acid catalysis like Hiersmann, he utilized hydrogen 
bond donor catalysts to affect the Claisen rearrangement.   
 8 
Simple unactivated allyl vinyl ethers were the desired target substrate for Jacobsen.  
However, utilizing chiral guanidinium ion catalysts as bidentate hydrogen bond donors failed to 
provide sufficient product formation.  As a result, the substrate was modified to include an 
alkoxycarbonyl moiety to aid in substrate activation. With this added modification, Jacobsen was 
able to affect a catalytic, asymmetric Claisen rearrangement with yields of up to 92% (Scheme 
1).  More specifically catalyst 20 was able to afford Claisen products of substrates containing 
methyl and ethyl groups at the R1 position with high enantioselectivities (up to 92%).  In 
addition, disubstituted ethers provided products of type 22 in high enantioselectivity and 
diastereoselectivity.  This demonstrated that the reaction proceeded though a six-membered chair 
like transition state 21 that was stabilized from hydrogen bond interactions between the catalyst 
and both the ether and carbonyl oxygen of the substrate.  This showcased the ability of chiral 
hydrogen bond donors to act as catalysts affecting the Claisen rearrangement, but added 
functionality on the substrate was still required to aid in the reactions success.  
 
Scheme 1. Hydrogen Bond-Donor Catalysis of the Claisen Rearrangement 
 
 
 
 9 
1.2.2 Transition Metal Catalysis of Claisen Rearrangements 
1.2.2.1  Mechanism of Catalysis 
In sharp contrast to Lewis acid-catalyzed Claisen rearrangements is transition metal-catalysis.  
The late transition metals are better able to coordinate to the soft C-C multiple bonds of the allyl 
vinyl ether than the lone pairs of the oxygen atom. This interaction activates the C-C bond 
towards nucleophilic attack.
21
  Capitalizing on this metal-olefin interaction, catalytic Claisen 
rearrangements have been developed that utilize transition metals such as Pd,
10,21
 Hg,
22
 and Pt,
23
 
with Pd(II) catalysis being the most prevalent.   
Catalysis by Pd(II) exclusively provides the formal [3,3] Claisen product, suggesting that 
the mechanism resembles the thermal concerted rearrangement.  In order to rationalize this 
selectivity, it has been proposed that that the reaction proceeds through a “cyclization-induced” 
rearrangement mechanism in which the Pd(II) coordinates to the allyl olefin of the allyl vinyl 
ether activating it towards attack by the nucleophilic vinyl olefin (Scheme 2).
10,24
 This promotes 
the formation of a 6-membered cyclic carbonium ion intermediate 24 which rapidly rearranges to 
the product 25 and regenerates the catalyst. 
   
Scheme 2. Cyclization-induced Rearrangement  
 
 
 10 
There is an inherent problem that is associated with transition metal catalysis.  The 
electrophilic metal catalyst can irreversibly bind to the strongly nucleophilic vinyl ether moiety 
instead if the allylic double bond.
25
  As a result, catalysis is often inhibited unless the vinyl ether 
moiety is blocked.   
1.2.2.2 Examples of Transition Metal Catalyzed Claisen Reactions 
Van der Baan and Bickelhaupt developed the first known example of a catalytic Claisen 
rearrangement utilizing a Pd(II) complex.
10
  Taking advantage of the “cyclization induced” 
rearrangement, they subjected a variety of allyl 1-cyclohexenyl ethers such as compound 26, to 
PdCl2(CH3CN)3 (eq 4).  The reaction did produce the desired Claisen product albeit with a few 
minor side products 28 from double bond isomerization.  They were also able to demonstrate that 
the rearrangement worked efficiently with a variety of other cyclic ethers, except those with 
trisubstituted allylic ether double bonds.  They reasoned that this was most likely attributed to 
sterics, and prevented the Pd(II) catalyst from binding to the allylic double bond in these 
congested systems.
10 
 
 
 
Next, Van der Baan and Bickelhaupt attempted to expand their substrate scope to include 
acyclic allyl vinyl ethers 30 (Table 1).  Unfortunately, these systems were not as compliant as 
their cyclic counterparts. The allyl vinyl ethers with a highly substituted vinyl group worked well 
in the rearrangement, providing products with yields greater than 90% on average (Table 1, entry 
 11 
c).  However, when ethers void of substituent’s on the vinyl groups were utilized, the reactions 
yielded large quantities of the corresponding allylic alcohol 32, with only traces of the desired 
Claisen product ( Table 1, entries a and b).  They reasoned that the Pd(II) catalyst preferred to 
associate with the more electron rich vinyl ether -system when it was not shielded by alkyl 
groups, preventing the formation of the desired Claisen product 31.
10
  Although Van der Baan 
and Bickelhaupt discovered the first catalytic Claisen rearrangement, they realized it would have 
limited synthetic utility since it was restricted to compounds containing substituted vinyl groups. 
 
Table 1. Van der Baan and Bickelhaupt Substrate Scope Exploration 
 
 
  Nakai and co-workers were the next group to investigate the Pd(II) catalyzed Claisen 
rearrangement.
26-28
 They were ultimately responsible for elucidating and defining the 
stereochemical outcome of Van der Baan and Bickelhaupt’s work.  They observed that the allyl 
vinyl ether 33, in the absence of a palladium catalyst would form the thermal product 35 
(Scheme 3).  However, in the presence of the palladium catalyst the kinetic product 34 was 
formed.  It was suggested that the kinetic selectivity was due to a Pd(II) bound boat like 
 12 
transition state
 
whereas the thermal selectivity of the product was due to a chair-like transition 
state.   
 
Scheme 3. Stereochemical Outcome of Thermal vs. Pd(II) Catalyzed Rearrangements 
 
 
Although Nakai and co-workers were able to determine the stereochemical outcome of 
the palladium catalyzed Claisen rearrangements, they were unable to solve the problem of 
substrate scope.   Ultimately, the strict requirements that Van der Baan and Bickehaupt 
discovered still prevented this transformation from taking place in a truly catalytic asymmetric 
manner. 
In 1997, Overman discovered the first catalytic asymmetric Pd(II)- catalyzed 
rearrangement that proceeded without rigid substrate requirements.
29
  He discovered that achiral 
allylic imidates could be converted to enantioenriched allylic amides via a Pd(II)- catalyzed 
Claisen-like rearrangement.  Utilizing palladium(II) complex 37 with allylic imidates of type 36, 
provided the allylic amides 38 in high yields (93-99%) and enantioselectivities (93-99% ) (eq  
5).
30
  In addition, he also demonstrated that substitution of the allyl bond (R2) was tolerated for 
unbranched substituent’s.  However, when t-butyl or cyclohexyl groups were used the reaction 
proceeded at a much slower rate.  Additionally, it was discovered that (E)-allylic 
trichloroacetimidates were the only viable starting materials as the (Z) isomer failed to react in 
high yields and enantioselectivities.  Although the rearrangement of the acetimidates provided 
 13 
rearrangement products with high enantioselectivities, and good substrate scope, the 
methodology could not be translated to allyl vinyl ethers. 
 
 
1.3 LIMITATIONS OF PREVIOUS CATALYTIC CLAISEN REARRANGEMENTS 
Lewis acid, hydrogen bond donor and transition metal catalysis has provided an excellent 
starting point towards the discovery of truly catalytic Claisen rearrangements.  They have 
provided a great deal of insight into the multitude of mechanistic pathways in which these 
catalyzed reactions are able to operate, however they each have their own respective limitations.  
Lewis acids and hydrogen bond donors have been shown to be efficient catalysts for 
facilitating the Claisen rearrangement, and provide almost complete chirality transfer.  
Unfortunately, the substrate scopes for these copper(II) bisoxazoline and hydrogen bond donor 
catalyzed reactions are not that large due to the fact that the alkoxylcarbonyl moiety is necessary 
for the reaction to take place.  In addition, the Pd(II) catalyzed rearrangements provided reactions 
that are highly diastereoselective, but their substrate scope for allyl vinyl ethers is poor.  These 
reactions are only enantioselective for acetimidates and attempts at enantioselective 
 14 
transformations of simple allyl vinyl ethers have been met with little success.  In order for a more 
synthetically useful catalytic asymmetric Claisen rearrangement, there is a need for reaction 
conditions that utilize simple allyl vinyl ethers and provide highly enantioselective, and 
diastereoselective products.   
 15 
2.0   DEVELOPMENT OF A CATALYTIC ASYMMETRIC CLAISEN 
REARRANGEMENT OF STRUCTURALLY SIMPLE, UNACTIVATED ALLYL VINYL 
ETHERS  
2.1 TRANSITION METAL ACTIVATION OF ALLYL VINYL ETHERS 
Catalytic asymmetric Claisen rearrangements have been plagued by strict substrate requirements 
necessary for substrate-catalyst association.  As a result, we sought to develop a catalytic 
asymmetric Claisen rearrangement on structurally simple, unactivated allyl vinyl ethers of type 
39.  We envisioned that this could be accomplished utilizing the strategy of olefin activation with 
late transition metals to produce structurally complex aldehyde products of type 40, with control 
of both relative and absolute stereochemistry (eq 6).  
 
 
 
Transition metal-catalyzed Claisen rearrangements have generally been restricted to 
rearrangements of allyl imidates rather than simple allyl vinyl ethers.
10,21,29,30
   In addition, focus 
has been placed on rearrangements involving “cyclization induced” mechanisms.  However, a 
report by Bosnich, on the rearrangement of allylic imidates, demonstrated that an alternate 
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mechanism could be utilized to affect the Claisen rearrangement (Scheme 4).
31
  In his report, 
transition metals such as Ir(I) and Rh(I) were able to oxidatively add to the allylic imidate 41 
forming a -allyl metal complex and amide anion 42. Upon nucleophilic addition to the -allyl 
metal complex, the product 44 of a formal [3,3] rearrangement was formed. 
 
Scheme 4. Late Transition Metal-Mediated Rearrangement of Allyl Imidates 
 
 
Transition metal -allyl chemistry is typically seen in allylic alkylation reactions with the 
most popular being the Tsuji-Trost allylation (Scheme 5).
32
  The reaction uses Pd(0) complexes 
to form the key intermediate metal allyl systems of type 45. However, palladium is not the 
only metal known to produce these allyl systems.  Other metals that participate in this type of 
reaction include iridium,
33
 ruthenium,
34 
 molybdenum,
35
 tungsten,
36
 and rhodium.
37
  Depending 
on the metal employed, the regiochemical bias of the reaction can be influenced.  Generally, 
Pd(0) complexes prefer to form linear addition products 46,
32
 whereas complexes of Ir(I) and 
Ru(II) provide a preference for the branched substitution products 47.
33,34
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Scheme 5. Tsuji-Trost Allylation 
 
2.2 REACTION DESIGN 
Bosnich’s research suggested that the archetypical Claisen rearrangement could be catalyzed by 
transition metals utilizing a π-allyl mechanism (Scheme 6). The late transition metal could 
oxidatively add across the C-O -bond of the allyl vinyl ether 39 with concomitant formation of 
a metal-bound enolate and allyl cation complex 49.  The metal bound enolate could function as a 
nucleophile and add to the π-allyl system forming the desired Claisen product 40.   
 
Scheme 6. Desired Late Transition Metal-Catalyzed Asymmetric Claisen Rearrangement 
 
 
 The archetypal Claisen rearrangement proceeds exclusively through a concerted process 
providing the [3,3] product where as our proposed rearrangement would proceed via an 
asynchronous mechanism.  This could be problematic due to the formation of an asymmetric 
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metal π-allyl complex 49, allowing the formation of both the formal [3,3] and [1,3] products 40 
and 50.  As a result, our catalyst design needed to be focused on transition metals that were able 
to labilize allylic C-O -bonds and enforce nucleophilic attack at the branched position of the 
metal-allyl complex.  
Complexes of Ir(I) and Ru(II) have been utilized to enforce the formation of the branched 
substitution products in allylic alkylation reactions.
33,34
  More specifically, [Cp*Ru(2,2’-
bipyridine)]
+ 
52 and [CpRu(2,2’-bipyridine)]+ complexes have been shown to exhibit a strong 
regiochemical bias for producing the desired branched products (eq 7).
34a,38,39
 In addition, 
reactions utilizing these Ru(II) complexes have proven to be enantioselective when using chiral 
(N,N)-bidentate ligands of type 55 (eq 8).
39c,d
  As a consequence, Ru(II)- complexes were chosen 
as a starting point for catalyst design. 
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2.3 PRELIMINARY REACTION DEVELOPMENT 
Reaction development commenced with the use of simple allyl vinyl ether 39a, as a standard test 
substrate.  Utilizing 39a with 5-10 mol % of CpRu(II) complex 58, obtained by addition of 
[CpRu(CH3CN)3]PF6 to pyridine oxazoline ligand 55, in THF at room temperature, provided 
unreacted starting materials (Figure 7A).  This was not surprising as transition metal-based 
catalysts are expected to have a greater preference to associate with more electron rich 
olefins.
25,40 
 In the case of allyl vinyl ethers, the metal would prefer to associate with the vinyl 
olefin 59 (Figure 7B).  As a result of this preference, there exists an unproductive equilibrium as 
indicated by 48 to 59, preventing labilization of the C-O -bond necessary for the rearrangement 
to take place.   
 
 
Figure 7. A. Initial Experiment B. Possible Limitations of Simple Allyl Vinyl Ethers 
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At this juncture, an additional strategy for activating the substrate seemed necessary. The 
potential of a co-catalyst to assist in allyl vinyl ether activation appeared to be an easily 
implemented solution to reaction design.  In addition, Lewis acids have been shown to assist in 
the labilization of C-O -bonds of allyl vinyl ethers though Lewis acid-base association with the 
ether oxygen.
8-18  
As a result, we wanted to determine if a weak Lewis acid could be used as a co-
catalyst in our system, weakening the C-O -bond and increasing the potential for oxidative 
insertion of the ruthenium complex (Scheme 7).  However, the choice of Lewis acid would be 
critical as we would need to ensure that it did not catalyze the Claisen rearrangement 
independent of the enantioenriched CpRu(II) complex or degrade the catalyst in anyway.  
 
Scheme 7. General Lewis Acid Activation of Allyl Vinyl Ethers 
 
 
As a standard test reaction, we used allyl vinyl ether 39a, 5 mol % CpRu(II) 58, and a 
myriad of Lewis acids that are known to be compatible with transition metals (Table 2).  Weak 
Lewis acids that included ZnCl2, CuCl, NiCl2, and Ti(i-OPr)4 provided no reaction.  Conversely, 
stronger Lewis acids that included Cu(OTf)2, Sn(OTf)2, AgPF6, and Al(OTf)3 completely 
converted the starting material 39a into an inseparable mixture of both Claisen products 40a and 
50a, and many other unidentified side products.  The moderately Lewis acidic B(OMe)3, 
afforded about 5% of the desired Claisen product 40a.  
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Table 2. Lewis Acid Activation of Allyl Vinyl Ether 39a 
 
 
With B(OMe)3 providing the first positive result, we reasoned that by fine tuning the 
Lewis acidity of the borate through the alteration of its ligands, we could increase the efficiency 
of the reaction.  The use of more electron withdrawing ligands would increase the borates Lewis 
acidity and therefore possibly aid in the labilization of the C-O -bond. Utilizing 5 mol % of 
B(OCH2CF3)3 afforded a modest increase in reaction conversion of the test reaction to about 
10% (Table 3).  Employing 5 mol % of B(OPh)3 led to a more dramatic increase in reaction 
conversion to 63%, with enantioselectivity of the formal [3,3] product approaching synthetically 
useful levels (81% ee).  Although regioselectivity (40a:50a= 5:1) and diastereoselectivity 
(40aanti:40asyn= 2:1) remained poor, the borate proved to be an effective co-catalyst providing 
useful levels of conversion to the formal [3,3] product while exhibiting no tendency to mediate 
the background rearrangement independent of the Ru(II) catalyst. 
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Table 3. Effect of Boron Lewis Acids on Reaction Conversion 
 
 
2.4 LIGAND SCREEN FOR REACTION OPTIMIZATON 
Having found an appropriate co-catalyst for our system, attempts were made to optimize the 
regio-, diastereo-, and enantioselectivity of the reaction.  Capitalizing on the observation that 
pyridine oxazoline ligands were proficient in Ru-catalyzed reactions,
39c,d
 we wanted to determine 
how modifying the sterics and electronics of the ligand affected the reaction.  The steric 
environment of pyridine oxazoline backbone was first modification made to determine the effect 
of ligand structure on reaction selectivity (Table 4).  Utilizing allyl vinyl ether 39a, 5 mol % 
B(OPh)3, and 5 mol % CpRu(II) with pyridine oxazoline ligands 60b-d, in THF for 24 h 
provided negligible improvements in reaction selectivity in comparison to the original indanyl 
ligand 55.  The phenyl substituted ligand 60b provided an improvement in reaction conversion to 
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78%, but regioselectivity (40a:50a= 4.5:1) and diastereoselectivity (40aanti:40asyn= 2:1) remained 
unchanged from the indanyl ligand, and enantioselectivity decreased dramatically to 53%.  The 
benzyl substituted ligand 60c provided a small increase in regioselectivity up to about 7:1 
(40a:50a), however the diastereoselectivity (40aanti:40asyn = 1.6:1) and enantioselectivity (71%) 
proved to be inferior.  In addition, isopropyl ligand 60c, offered no improvements in selectivity 
compared to indanyl ligand 55 and the sterically hindered tert-butyl ligand 60d failed to provide 
any reaction.   
 
Table 4. Pyridine Oxazoline Ligand Screen for Reaction Optimization 
 
 
With the indanyl substituted pyridine oxazoline ligand 55 providing the best results in 
terms of diastereo- and enantioselectivity (40a:50a= 5:1, 40aanti:40asyn= 2:1, 81% ee), we sought 
to change the electronics of the ligand to improve the reaction regioselectivity.  Electron 
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donation to the metal center is known to increase the activity of the incipient metal complex 
towards oxidative insertion into adjacent C-O -bonds, in systems similar to ours.38a,39b  Also, it 
has been shown that increasing the electron density of the metal complex will also help improve 
regioselectivity in allylic alkylation type reactions due to the asymmetric bonding of the Ru 
catalyst to the allyl system (Figure 8).41,42 
 
 
Figure 8. Asymmetric Binding of Ru -allyl complex 
 
With this knowledge, we decided to synthesize a set of pyridine oxazoline ligands 61a-c 
with electron donating groups on the 4-position of the pyridine moiety (Table 5).  Utilizing 
ligand 61a, containing a methyl group on pyridine, under the standard reaction conditions (5 mol 
% B(OPh)3, 5 mol % CpRu(II), THF, 24 h) provided a modest increase in regioselectivity to 
6.5:1 (40a:50a), favoring the branched product 40a.  Further increasing the electron density of 
the ligand by adding a methoxy group to the pyridine ring, ligand 61b, afforded an even greater 
preference for the formation of the branched product (40a:50a= 9:1).  In addition, utilization of 
the highly electron donating dimethylamino group in 61c provided the best regioselectivity of 
12:1 (40a:50a). These observations demonstrated that modulating the electronics of the ligand 
provided a viable strategy for influencing regioselectivity.  
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Table 5. Electronic Effects of Ligands 61a, b, and c on Product Regioselectivity 
 
 
At this point, changing the electronics and the sterics of the pyridine oxazoline ligand 
provided no vast improvement in the reaction besides an increase in regioselectivity.  It was 
apparent that we needed to reevaluate ligand design in order to further optimize the reaction 
selectivity.  As a result, the mechanism of the reaction needed to be examined.  It was necessary 
to determine if the reaction was proceeding though an intermolecular mechanism in which the 
substrate became fragmented into separate nucleophilic and electrophilic species 62 or through 
an intramolecular mechanism 63 (Figure 9A).  For this purpose a double crossover experiment 
was developed using equimolar amounts of compound 39b and 39c in the presence of 5 mol % 
CpRu(II) complex 58, 5 mol % B(OPh)3 and THF (Figure 9B). The experiment produced an 
equimolar amount of four different products 40a, 40b, 40bʹ, and 40c, suggesting an 
intermolecular mechanism.  More specifically the reaction showcased that upon oxidative 
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insertion of the Ru(II) catalyst to the substrate, a Ru-bound -allyl system was formed with the 
dissociation of the enolate fragment from the coordination sphere of the metal allowing enolate 
crossover between substrates 39b and 39c.
38c
  We hypothesized that if the reaction could be 
forced to operate via an intramolecular mechanism 63 (Figure 9A) in which the enolate would 
not dissociate from the coordination sphere of the metal, a highly ordered transition state could 
be invoked and the Claisen products would be formed with better diastereoselectivity. 
 
 
Figure 9. A. Inner vs. Outer-sphere Mechanism B. Crossover Experiment 
 
Work reported by Kitamura and co-workers on the Ru(II)-catalyzed hydrolysis of allyl 
ethers provided valuable insight on the design of catalysts that would enforce an intramolecular 
mechanism.
43
 Kitamura proposed that their reaction proceeded via hydrogen bonding 
interactions between quinaldic acid and the allyl ether (Figure 10A).  We speculated that similar 
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hydrogen bonding interactions could possibly prevent dissociation of the enolate involved in our 
Claisen rearrangement, and provide a more ordered transition state that would invoke an 
intramolecular mechanism. Additionally, enantioenriched equivalents of quinaldic acid were 
conveniently available via hydrolysis of the pyridine oxazoline ligands, forming amides capable 
of hydrogen bonding (Figure 10B). 
 
 
Figure 10. A. Ru(II)-Catalyzed Hydrolysis of Ethers; B. Picolinamide Ligands 
 
To this end, a variety of enantioenriched picolinamide amide ligands of the type 65 were 
synthesized with relative ease (Scheme 8).  They were prepared by Lewis acid-catalyzed 
condensation of 4-chloropicolinitrile and various amino alcohols to generate the 
pyridyloxazolines of type 64.
44
  Heating 64 with aqueous dimethylamine effected nucleophilic 
aromatic substitution
45
 and oxazoline hydrolysis to afford the desired picolinamide ligand 65 in 
moderate to good yields.  
 
Scheme 8. General Synthesis of Picolinamide Ligands 
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Having secured an adequate synthesis of our desired ligands, we needed to determine 
whether they would facilitate an improvement in reaction selectivity via hydrogen bonding 
interactions with the allyl vinyl ether substrate. When subjected to the standard reaction 
conditions (5 mol % CpRu(II)-65, 5 mol % B(OPh)3, THF), the diastereoselectivity of the 
reaction increased substantially from 2:1 to over 10:1 (40aanti:40asyn) depending on the R groups 
present on the ligand (Table 6).  Ligands 65a-c provided products with diastereoselectivities of 
up to 7:1(40aanti:40asyn) and enantioselectivities of up to76%.  The indanyl substituted ligand 65d 
provided the best results in terms of product selectivity that were near synthetically useful levels 
(40a:50a= 4:1, 40aanti:40asyn= 10:1, 89% ee) albeit for substrate conversion at a modest 63%.   
  
Table 6. Picolinamide Ligand Screen for Optimization of Reaction Diastereoselectivity 
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2.5 REACTION OPTIMIZATION  
Having secured adequate enantio- and diastereocontrol in the desired reaction with the use of the 
picolinamide ligand 65d, optimization of reaction conversion to levels above 60% was crucial.  
Catalyst lifetime was thought to be contributing to incomplete substrate conversion.  As a result, 
we sought to avoid catalyst degradation by eliminating the possibility of trace amounts of water 
with the use of molecular sieves.  With the addition of a 1:1 weight/weight ratio of 4Å molecular 
sieves to substrate 39a utilizing our standard reaction conditions (5 mol % CpRu(II)-65d, 5 mol 
% B(OPh)3, THF), it was discovered that reaction conversion did increase dramatically to 93% 
over 24 hours (Table 7, entry a).  Surprisingly, there was also an improvement in both diastereo- 
and regioselectivity (40aanti:40asyn= 16:1, 40a:50a= 4.6:1 from 40aanti:40asyn= 10:1, 40a:50a= 4:1 
without 4Å MS).  It remains unclear if these improvements are the result of more rigorous water 
exclusion or are suggestive of a more complex role for the molecular sieves.
46 
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Table 7. Evaluation of Additives on Reaction Conversion
 
 
 
Another possible source of incomplete reaction conversion can be attributed to product 
inhibition as the resulting aldehyde product 40a is more Lewis basic than the allyl vinyl ether 
39a. To determine if this was a problem, we needed to introduce an excess of the Lewis basic 
aldehyde to our reaction to observe if reaction conversion decreased.  Addition of a full 
equivalent of aldehyde 40a to our standard reaction conditions (5 mol % CpRu(II)-65d, 5 mol % 
B(OPh)3, 100 wt % 4Å MS, THF) provided a decrease in reaction conversion, however the 
reaction was not completely inhibited (Table 7, entry b).  This showcased that we needed an 
additional mechanism to help expel the Lewis basic product from the coordination sphere of the 
metal allowing the active catalyst to be regenerated. 
 To accelerate catalyst turnover, we envisioned that added amounts of a polar, 
coordinating solvent could act as a labile ligand to aid in the expulsion of the product from the 
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coordination sphere of the metal by disrupting the Ru(II)-pentenal chelate 66 formed under the 
reaction conditions (Scheme 9).   Addition of 20 mol % of polar solvents that included DMF, 
acetonitrile, and acetone under the standard reaction conditions (5 mol % CpRu(II)-65d, 5 mol % 
B(OPh)3, 100 wt % 4Å MS, THF), provided an increase in reaction efficiency (Table 7, entry e).  
Acetonitrile proved to be the optimal additive, and provided complete conversion to the Claisen 
product after 24 hours along with small enhancements in enantio-, diastereo-, and regiochemistry 
(93% ee, 40aanti:40asyn = 20:1, 40a:50a= 5.3:1).  
 
Scheme 9. Product Inhibition and Role of Additives in Catalyst Turnover 
 
2.6 REACTION SCOPE 
Through the use of additives, including 4Å MS and a substoichiometric amount of acetonitrile, 
we demonstrated that a catalytic, diastereoselective and enantioselective Claisen rearrangement 
was possible for simple vinyl ether 39a.  Expansion of substrate scope beyond the phenyl 
substituted allyl vinyl ether 39a was critical for synthetic utility. To test the substrate scope, a 
diverse set of C1-alkyl, C6-aryl and heteroaryl allyl vinyl ethers were synthesized (Table 8).  
Under the fully optimized conditions (5 mol % CpRu(II)-65d, 5 mol % B(OPh)3, 100 wt % 4Å 
MS, 20 mol % MeCN, THF), all allyl vinyl ethers afforded the rearranged Claisen products with 
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high enantioselectivity and anti-diastereoselectivity.  The steric and electronic differences in the 
substrate did not affect enantioselectivity, and provided products with greater than 90% ee except 
for 40f and 40k (Table 8, entry f and k). In addition, diastereoselectivity did not seem to be 
affected by the steric and electronic differences of the C6-aryl or heteroaryl groups on the 
substrate, providing products with high anti-diastereoselectivity of greater than 10:1 for all E,E-
allyl vinyl ether substrates.  The lower diastereoselectivity for compound 40b (40banti:40bsyn= 
6.3:1, entry b) can be attributed to a mixture of olefin isomers about the vinyl ether moiety.  
Regioselectivity on the other hand, varied greatly with the electronics of the C6-aryl group on the 
substrate.   Aromatic groups that had an electron-donating group on the 4-position of the ring 
(entry d) provided products with high regioselectivity (40d:50d= 14:1) compared to aromatic 
groups with electron withdrawing groups at the 4-position of the ring (entry e) (40e:50e= 4.7:1).  
This is not too surprising as the electronics of the phenyl ring will influence the stability of the 
branched position of the -allyl system.  The electron donating groups will support the partial 
positive charge on the branched position while electronegative groups will destabilize it resulting 
in different ratios of the branched and linear products.  Additionally, substitution at the 2-
position of the aromatic ring also greatly influenced regioselectivity.  The regioselectivities were 
lower when the 2-position of the ring was substituted (entries f and j) compared to the 4-position 
(entries c-e).  Additionally all reaction conversions and yields were excellent, averaging above 
80% in most cases. 
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Table 8. Investigation of Substrate Scope with Optimized Claisen Conditions 
 
 
In addition to sterics and electronics of the substrate influencing the reaction, olefin 
geometry within the allyl vinyl ether had a significant impact on regio- and diastereoselectivity 
(eq 9).  Inverting the geometry of either the vinyl ether or the allyl olefin of the substrate (Z-vinyl 
ether 67, or Z-allyl ether 68) caused the diastereoselectivity of the formal [3,3] product to invert 
from anti to syn, complementary to that of the thermal Claisen rearrangement.  The 
enantioselectivities of the products remained high (93%) which is consistent with the 
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rearrangement of the E,E-allyl vinyl ethers, however both the regioselectivities and 
diastereoselectivities were eroded.  The Z,E-vinyl ether provided a 1:1 mixture of the formal 
[3,3] to [1,3] products, where the E,Z- vinyl ether provided a 4:1 mixture.  The 
diastereoselectivities in both cases were low at 3:1 with a preference for the syn diastereomer.  
 
 
 
Finally, to examine whether aromatic substrates are required, a non-aromatic substrate 70 
was synthesized and subjected to the optimized reaction conditions (5 mol % CpRu(II)-65d, 5 
mol % B(OPh)3, 100 wt % 4Å MS, 20 mol % MeCN, THF) (Table 9, entry a).  Substrate 70 
proved to be considerably less reactive, and required higher catalyst loadings (10% CpRu(II)-
65d) and a more Lewis acidic borate (10 mol % B(O
p
C6H4F)3) in order to achieve some 
reactivity (Table 9, entry b).  Even with the use of the higher catalyst loading, this substrate only 
provided the linear product 72 rather than the desired branched product 71, in a modest 44% 
yield with low enantioselectivity (26%). This may be attributed both to the sterics and electronics 
of the substrate.  The cyclohexane ring is more sterically demanding than the phenyl ring system, 
possibly preventing nucleophilic attack at the branched position of the -allyl system.   
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Table 9. Optimization of Reaction Conditions for Aliphatic Substrate 70 
 
 
Additionally, computational studies by the group of Bruneau and co-workers revealed that the 
binding of Ru to -allyl systems of aliphatic substrates is much more symmetric than that of 
aromatic substrates (Figure 11).
34a  
Therefore, the branched position of the allyl system becomes 
less distinct relative to the terminal position providing poor regioselectivities in the allylic 
alkylation chemistry of alkyl allylic substrates.   
 
 
Figure 11. Symmetric Bonding of Ruthenium with Aliphatic Substrates 
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2.7 CROSSOVER EXPERIMENT AND ELUCIDATION OF THE REACTION 
MECHANISM 
Efforts to elucidate the mechanism of the reaction focused on obtaining a crystal structure of the 
Ru(II)-65d complex.  We wanted to determine how the picolinamide ligand 65d bound to the 
Ru(II)-complex in order to determine the origin of diastereoselectivity.  However, these efforts 
failed due to the instability of the complex.  As an alternative, we decided to develop a crossover 
experiment to determine whether or not oxidative addition of the Ru(II)-complex was occurring 
with the release of the enolate fragment, or if it stayed within the coordination sphere of the 
metal.    
Utilizing an equimolar amount of substrates 39b and 39c under the optimized reaction 
conditions (5 mol % CpRu(II)-65d, 5 mol % B(OPh)3, 100 wt % 4Å MS, 20 mol % MeCN, THF) 
provided no crossover products and gave diastereoselectivities identical to those obtained for 
single-substrate reactions (Scheme 10).  In order to determine if this was indeed the result of the 
hydroxyl moiety on the ligand, we needed to run the exact same crossover experiment utilizing 
ligand 73, in which a methyl ether replaces the free alcohol.  Utilizing the protected ligand 73 in 
the crossover experiment of substrates 39b and 39c provided an equimolar mixture of four 
products with poor diastereoselectivity consistent with the rearrangement occurring with 
dissociation of the enolate moiety from the coordination sphere of the metal.  Therefore, we can 
conclude that the alcohol residue on the ligand both helps to enforce an intramolecular 
mechanism as well as secure a highly ordered transition state required for stereoselective C-C 
bond formation. 
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Scheme 10. Crossover Experiments Utilizing Ligands 65d, and 73 
 
 
From these results, along with previously established models pertaining to CpRu(allyl) 
complexes,
34a,38f,41
 we were able to provide a potential reaction mechanism (Figure 12).  The 
B(OPh)3 activated allyl vinyl ether 74 could enter the coordination sphere of the metal by 
replacing the solvent molecule forming complex 75.  Oxidative addition of the ether C-O -bond 
would then be able to occur with the assistance of the Lewis acid, providing an endo-
(allyl)Ru(IV) complex 76.  An exo conformation is possible, but not likely due to possible 
steric interactions occurring between the central C-H bond of the allyl system and the Cp ring.  
The resulting boron enolate stays within the coordination sphere of the metal via interaction with 
the hydroxyl moiety of the ligand, allowing intramolecular delivery of the enolate to the more 
substituted end of the allyl ligand affording the Ru-pentenal chelate 66 with anti-
diastereoselectivity.  The product is then released from the coordination sphere of the metal via 
 38 
disruption of the pentenal chelate via added acetonitrile, affording the desired product 40 and 
regenerating the active catalyst 77. 
 
 
Figure 12. Potential Mechanism for Ru(II)-Catalyzed Claisen Rearrangement 
2.8 EXPANSION OF SUBSTRATE SCOPE 
In an attempt to expand the substrate scope of the catalytic asymmetric Claisen rearrangement, it 
became apparent that the synthesis of a more diverse class of allyl vinyl ethers of type 79 was no 
longer trivial or facile.  The use of the Ir(PCy)3
+
 isomerization catalyst on diallyl ethers 78 with 
C1-alkyl (when R= H or methyl), provided allyl vinyl ethers with high E selectivity (eq 10).
48
  
However, when the alkyl chain is elongated to an ethyl or a propyl group, a mixture of olefin 
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isomers formed and the product was isolated in low yields.  In addition, when a halogen was 
present the reaction shut down, and only diallyl ether starting material was recovered.  Since a 
mixture of olefin geometries would erode the diastereoselectivity of the final Claisen product we 
needed to develop an alternative solution to either the synthesis of allyl vinyl ethers or propose a 
different method to form the Claisen products. 
 
 
2.9 CONCLUSIONS 
In conclusion, we have developed a transition metal-catalyzed asymmetric Claisen 
rearrangement for simple allyl vinyl ethers that does not require any additional functionality for 
substrate-catalyst association and reaction completion.  The reaction proceeds under mild 
conditions with low catalyst loadings and in general, easily accessible starting materials. All 
reactions proceed with high yields (80%) and good diastereoselectivities (10:1 anti:syn) with 
some as high as 25:1.   Enantioselectivities that have been determined are excellent averaging 
above 90%. Despite the rearrangement being limited to C6-aryl substrates, it provides easy 
access to - unsaturated carbonyl compounds in a highly asymmetric manner. 
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3.0  RUTHENIUM-CATALYZED ENOLATE ALLYLIC ALKYLATIONS 
PROVIDING CLAISEN-LIKE PRODUCTS 
3.1 A CLAISEN ALTERNATIVE 
Due to the substrate scope limitations encountered utilizing the catalytic asymmetric Claisen 
rearrangement we wanted to develop a complementary reaction utilizing easily accessible 
starting materials that would provide the same C-C bond connections and high diastereo- and 
enantioselectivity as the Claisen rearrangement.  Based on the mechanistic studies performed 
utilizing the asymmetric Claisen conditions, we speculated that the reaction proceeded via 
oxidative addition to the C-O -bond of the allyl vinyl ether with subsequent Ru-bound enolate-
allyl cation recombination (Scheme 11A).  Due to the intramolecular nature of the reaction, the 
products of type 40 were formed with vicinal stereocenters in high diastereo- and 
enantioselectivity.  Developing an intermolecular variant of the rearrangement utilizing easily 
prepared pyrrole silyl enol ethers
 
as the enolate 81, and allylic acetates 80 as the pro-electrophile, 
would provide a complimentary strategy to access similar Claisen products of type 82, but with a 
larger substrate scope that was inaccessible from our catalytic asymmetric Claisen rearrangement 
(Scheme 11B).  
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Scheme 11. A. Catalytic Asymmetric Claisen Reaction; B. A Claisen Alternative using Silyl 
Enol Ethers as Nucleophiles 
 
3.2 INTRODUCTION TO ENOLATE ALLYLIC ALKYLATIONS 
Transition metal-catalyzed allylic alkylation reactions provide highly versatile C-C bond 
constructions in a variety of synthetic reactions.
49
  In general, the nucleophilic partner in these 
reactions are stabilized carbon nucleophiles that include malonic esters, ketoesters, 1,3 
diketones or nitro compounds.  While enolates are an important class of nucleophiles; their use in 
allylic alkylation chemistry has not been fully developed.  Trost pioneered the use of enolates in 
allylic alkylation chemistry in the 1980’s.50  He utilized the lithium enolate of acetophenone as a 
nucleophile in the palladium catalyzed allylic alkylation of allyl acetate (Scheme 12, eq 11).  
However, the reaction was plagued by the formation of the double alkylated product 84.  This 
remained a challenge, especially when the enolate precursor contained more than one acidic 
proton.  Due to these discouraging results, chemists turned to “softer” tin or boron enolates, 
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which react more efficiently with the “soft” Pd- -allyl system.51  Indeed, this did solve the 
problem of double alkylation and produced the mono-alkylated product in up to 90% yield in 
some instances (Scheme 12, eq 12).  
 
Scheme 12. Early Developments in Enolate Allylic Alkylation Chemistry 
 
 
An asymmetric variant of the reaction took much longer to develop due to the 
intermolecular nature of the reaction.  In order for chiral ligands to influence stereochemistry in 
the reaction, they need to be a part of the bond making and bond breaking process occurring 
outside of the coordination sphere of the metal.  In 1999, Trost developed a Pd-catalyzed 
asymmetric allylic alkylation utilizing allyl acetate, and the tin enolate of 2-methyl-1-tetralone 
85 (Scheme 13, eq 13).
52
 This provided the allylated product 86 with a quaternary center in high 
yield and good enantioselectivity.  In addition, a diastereoselective reaction was developed 
utilizing simple lithium enolates (Scheme 13, eq 14).
53
  The choice of metal salt influenced the 
regioselectivity of the reaction, providing products 87 and 88 with high enantioselectivity, and 
diastereoselectivities that ranged from 5 to 20:1. 
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Scheme 13. Initial Examples of Asymmetric Enolate Allylic Alkylations 
 
 
The use of nonstabilized silyl enol ethers as nucleophiles in allylic alkylation reactions 
has remained underdeveloped due to their lack of reactivity.  Hartwig and co-workers developed 
the first iridium-catalyzed, enantioselective reaction with silyl enol ethers (Scheme 14, eq 15).
54
 
However, they discovered that the reaction required an activator for the silyl enol ether 89. With 
the addition of catalytic amounts of metal fluorides, such as CsF and ZnF2, the reaction was able 
to proceed with good yields enantioselectivities of up to 96%.   However, the development of a 
regio-, diastereo- and enantioselective allylic alkylation utilizing silyl enol ethers as a 
nucleophile remains elusive to this day.  There are a few diastereoselective examples, but the 
selectivities are generally poor or the yields are low (Scheme 14, eq 16 and 17).
55,56 
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Scheme 14. Silyl Enol Ethers as Nucleophiles in Enolate Allylic Alkylations 
 
3.3 INITIAL STUDIES TOWARDS THE RUTHENIUM CATALYZED ENOLATE 
ALLYLIC ALKYLATION 
Reaction design commenced with the choice of appropriate substrates.  Mono-substituted allylic 
acetates 80 were chosen as the electrophilic substrate based on their rich history in allylic 
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alkylation chemistry, including Ru- based methodologies,  as well as their ability to readily form 
Ru(IV)(-allyl) complexes capable of providing branched addition products.34,38,39  In addition, 
they are easily synthesized from either commercially available or easily prepared allylic 
alcohols. The N-acyl pyrrole derived silyl enol ether 81a was selected based on its ability to act 
as an ester or amide enolate that can be prepared in high yields with almost exclusive Z-
configuration.
57
   Additionally, it has proven to be synthetically useful in a variety of reaction 
methodologies.  For example, it was shown to be a good nucleophile in Lewis base catalyzed 
Mukaiyama aldol additions developed in the Nelson lab (Scheme 15, eq 18).
58 
 Also it served as 
a nucleophile in the Mukaiyama-Michael additions developed by Evans providing products with 
high diastereoselectivities and yields (Scheme 15, eq 19).
59
 Although these pyrrole silyl enol 
ethers have never been used to capture metal -allyl complexes, their increased nucleophilicity 
relative to ketone derived silyl enol ethers, and ability to induce high diastereoselectivity, makes 
them an attractive nucleophile for our system.  
 
Scheme 15. Examples of Pyrrole Silyl Enol Ethers as Nucleophiles 
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After the selection of potential reaction partners, the viability of the reaction was probed 
utilizing our previously developed Claisen conditions as a starting point.  Initial exposure of 
cinnamyl acetate 80a and pyrrole silyl enol ether  81a to our established Claisen conditions, 5 
mol % of the Ru(II) complex generated in situ through the reaction of [CpRu(CH3CN)3]PF6 with 
ligand 65d, gave no reaction after 24 hours (eq 20).  With the addition of 5 mol % Lewis acid co-
catalyst B(OPh)3 to activate the allylic acetate, the reaction afforded the desired branched acyl 
pyrrole product 82a.  However, consistent with the preliminary Claisen experiments, it was 
formed in low yield, and with poor selectivity (82a:83a= 3.3:1, 82aanti:82asyn= 1.3:1, 40% ee, 
52% yield). 
 
 
 
Due to the poor reaction yields and incomplete consumption of starting materials, it 
appeared that either the allylic acetate was not sufficiently activated enough to undergo oxidative 
addition by the Ru(II)-catalyst or the pyrrole silyl enol ether 81a was not a strong enough 
nucleophile to add to the  -allyl system.  If oxidative addition to the allylic acetate was indeed 
problematic, the leaving group could be easily altered or a stronger Lewis acid could be used to 
further activate the allylic substrate.  To this end, we decided to probe the impact of leaving 
group structure on reaction efficiency as better leaving groups should increase the rate of 
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oxidative addition.
60
  As a result we replaced the acetate leaving group with p-NO2 
phenylcarbonate. Utilizing substrate 90 under the Claisen conditions, (5 mol % CpRu(II) salt, 5 
mol % 65d, 5 mol % B(OPh)3, THF, 24 h) the desired product was formed in 86% yield, but 
with negligible selectivity (82a:83a= 3.4:1, 82aanti:82asyn= 1:1, 0% ee 82a)(Table 10).   
Having achieved an improvement in reaction yield to 86% with the use of a better leaving 
group, we turned our attention to reaction selectivity, more specifically regioselectivity. Our 
previous research demonstrated that regioselectivity was affected by ligand electronics.  As a 
result, we wanted to employ a more electron donating ligand, such as the pyridine oxazoline 
ligand 55.  This ligand did lead to a dramatic increase in both regioselectivity and 
enantioselectivity, yet diastereoselectivity remained poor at 1:1 (82aanti:82asyn) (Table 10).  Next, 
we chose to investigate the imidazoline ligand 91 due to its structural similarity to the oxazoline 
ligand.  The imidazoline moiety contains a nitrogen atom in place of the oxygen which allows 
for an increase in basicity over the oxazoline moiety.
61
 Utilizing imidazoline ligand 91 under the 
same reaction conditions as above, regioselectivity remained unchanged despite the increase in 
electron density; surprisingly, diastereoselectivity increased to 3:1 (82aanti:82asyn). 
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Table 10. Ligand Screen Utilizing Allylic p- NO2-phenyl Carbonates as a Substrate 
 
  
Having secured selectivities nearing synthetically useful levels with the use of 
imidazoline ligand 91 it became apparent that the p-NO2 phenyl carbonate was not a desirable 
leaving group from a synthetic point of view.  As a result, we wanted to determine if we could 
achieve similar selectivities and reactivity with alternative leaving groups.  Additionally, we 
thought that a less activated leaving group could result in better reaction selectivity. As a result 
the p-NO2 phenyl carbonate was replaced with phenyl carbonate (eq 21).  However, utilizing 
substrate 92 under optimized reaction conditions (5 mol % CpRu(II) salt, 5 mol % 91, 5 mol % 
B(OPh)3, THF, 24 h), lead primarily to the formation of aryl ether 93, from nucleophilic addition 
of the phenoxide leaving group to the -allyl complex.  In order to prevent nucleophilic addition 
of the phenoxide from occurring, we decided to utilize the stronger Lewis acid, B(O
p
C6H4F)3, as 
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a means to both activate the substrate, and help to sequester the phenoxide.  However, in order to 
prevent the aryl ether from forming, up to 30 mol % of the borate was needed.   Ultimately, the 
use of the phenyl carbonate leaving group did substantially improve the diastereoselectivity of 
the reaction to 6:1 (82aanti:82asyn) from 3:1; however the difficulty associated with this substrate 
required us to re-evaluate the leaving group once again. 
 
 
 
Having found that the increased Lewis acidity of B(O
p
C6H4F)3 provided better activation 
of the allylic carbonate substrate 92 compared to B(OPh)3, it became apparent that B(O
p
C6H4F)3 
could be used to increase the reactivity of the original allylic acetate substrate 80a.   Utilizing 15 
mol % B(O
p
C6H4F)3 under the optimized Ru(II)-imidazoline catalyst conditions (5 mol % Ru(II) 
salt, 5 mol % 91, THF, 24 h) provided a marked improvement in reaction efficiency (86% yield) 
along with an increase in regio-, diastereo-, and enantioselectivity (82a:83a= 13:1, 
82aanti:82asyn= 7:1, 92% ee) (Table 11).  However, utilization of stronger Lewis acids including 
B(O
p
C6H4CF3)3 and B(O
p
C6H4NO2)3, proved to be detrimental to diastereoselectivity.  We can 
conclude that not only does ligand structure affect reaction selectivity but leaving group ability 
seems to have a profound effect on diastereoselectivity. 
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Table 11. Effect of Lewis Acid on Product Diastereoselectivity 
 
3.4 LIGAND MODIFICATIONS  
Having secured reaction conditions that provided our desired Claisen-like products with good 
selectivities (82a:83a= 13:1, 82aanti:82asyn= 7:1, 92% ee), we decided to further probe the 
imidazoline ligand structure to determine if greater product selectivites could be achieved. This 
was easily done as the ligand could be synthesized via a condensation reaction between an 
aldehyde of type 94, and diamine 95 to form the imidazoline moiety in 96, followed by 
protection of the resulting free amine (eq 22).
62
  This left three distinct ways to modify the 
ligand: 1) protecting group manipulations on the free amine, 2) steric and electronic adjustments 
of the pyridine ring, and 3) alteration of the sterics of the diamine backbone (Table 12).  The 
structural modifications could be used to systematically alter the binding of the -allyl complex 
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and therefore probe the origins of regioselectivity and enantioselectivity in the reaction in order 
to elucidate the optimal ligand for reaction success. 
 
 
 
Table 12. Structural Modifications on the Imidazoline Ligand and their Anticipated Effects 
 
 
Ligand modifications began with the protecting group on the amine.   We reasoned that 
the electronic nature of the imidazoline ligand could be altered through the manipulation of the 
the protecting group. Three ligands were synthesized with different protecting groups: methyl 
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protected 91, benzyl protected 97, and non-protected 98 (Table 13).  In comparing the results of 
the standard reaction (5 mol % Ru(II) salt, 5 mol % ligand, 15 mol % B(O
p
C6H4F)3, THF, 24 h), 
we found that the methyl protected ligand 91 provided the best selectivity (82a:83a= 13:1, 
82aanti:82asyn= 7:1, 92% ee, 86% yield).  The benzyl protected ligand 97 provided slightly 
diminished selectivies compared to the methyl protected version (82a:83a= 11:1, 82aanti:82asyn= 
5:1, 88% ee). We believe this may be due to the increased steric nature of the benzyl group 
causing less efficient electron donation to the imine moiety of the ligand.
61,63,64
  The free amine 
ligand 98 also provided inferior results with a dramatic decrease in regioselectivity and yield 
(82a:83a= 6:1, 82aanti:82asyn= 5:1, 81% ee, and 50% yield).  The decrease in yield implies that 
oxidative addition to the allylic acetate is not as facile, suggesting that the free amine moiety in 
ligand 98 may be sequestering the borate Lewis acid.  Since the methyl group proved to be the 
optimal protecting group, we chose to utilize it for the remainder of the ligand modifications. 
 
Table 13. Modifications to the Amine Protecting Group on the Imidazoline Ligand 
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The next set of alterations to the ligand began with the sterics and electronics of the 
pyridine moiety.  We hoped to gain insight on how the -allyl complex bound to the Ru(II) 
complex and therefore optimize enantioselectivity.  Investigations of the sterics were focused on 
the 5- and 6-position of the pyridine ring, as they offered the greatest potential of increasing 
selectivity.  Attachment of a methyl group to the 6-position of the pyridine ring in ligand 99 
proved detrimental to reaction conversion, providing the desired product 82a in only 20% yield 
(Table 14).  However, diastereoselectivity, regioselectivity and enantioselectivity remained 
consistent at (82a:83a= 13:1, and 82aanti:82asyn= 5:1, 88% ee).  Utilization of a quinoline moiety, 
to add sterics to both the 5-, and 6-position on the pyridine ring in ligand 100, also proved 
detrimental to the reaction outcome, causing diastereoselectivity, enantioselectivity and yield to 
decrease dramatically (82aanti:82asyn=2.5:1, 75% ee, 50 % yield). This led us to believe that steric 
constraints on the pyridine ring prevented the -allyl complex from efficiently binding to the 
catalyst, providing low yields and poor selectivities of the desired product. 
 Given that increasing the sterics of the pyridine moiety offered no improvements to the 
reaction selectivity, the electronics of the ring were probed.  We hoped that increasing the 
electronics of the pyridine ring would increase its -basicity, therefore possibly influencing the 
asymmetric nature of the -allyl complex and increasing regioselectivity of the rearrangement.42   
Placement of a methoxy group at the 4-position of the pyridine ring in ligand 101, provided the 
desired product with about the same regio-, diastereo- and enantioselectivity as the parent 
imidazoline ligand 91 (82a:83a= 13:1, 82aanti:82asyn= 7:1, 90% ee, 82% yield). However, by 
further increasing the electron density of the pyridine ring, by replacing the methoxy group with 
the pyrrolidine moiety in 102, a modest improvement in both regioselectivity (82a:83a= 18:1 
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from 82a:83a= 13:1) and diastereoselectivity (82aanti:82asyn= 9:1 from 82aanti:82asyn= 7:1) was 
observed.   
 
Table 14. Ligand Screen for Reaction Optimization: Alteration of the Sterics and Electronics of 
the Pyridine Ring 
 
 
Following alterations to the pyridine ring of the ligand, the diamine backbone of the 
imidazoline ring was examined to try and optimize enantioselectivity.  We wondered if both 
phenyl groups were necessary for reaction selectivity, as molecular models showed that the 
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phenyl group adjacent to the amine moiety pointed away from the coordination sphere of the 
catalyst.  Surprisingly, utilizing ligand 103, where the phenyl group adjacent to the methyl amine 
was replaced with a hydrogen, the regio-, diastereo-, and enantioselectivity of the reaction 
decreased dramatically (82a:83a= 3:1, 82aanti:82asyn= 1.5:1, 53% ee) (Table 15).  Since this 
observation suggested that both rings were necessary for increased reaction selectivity, 
increasing the steric environment was probed.  The phenyl groups were replaced with the bulkier 
cyclohexane rings in ligand 104.  This modification provided the product with increased regio- 
and enantioselectivity (82a:83a= 20:1, 97% ee), albeit a small decrease in diastereoselectivity 
(82aanti:82asyn= 5.4:1 from 82aanti:82asyn= 7:1). Upon discovering that the dicyclohexyl backbone 
provided an increase in regioselectivity and enantioselectivity, we wondered if placing the 
electron-donating pyrrolidine ring on the pyridine moiety would further enhance its selectivity as 
it had with the diphenyl substituted ligand 102 (Table 14).  Indeed, using ligand 105 the 
regioselectivity of the reaction increased dramatically to 42:1, but diastereoselectivity dropped to 
4.5:1(82aanti:82asyn) and enantioselectivity remained constant (95% ee).  
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Table 15. Steric Alterations of the Imidazoline Ring 
 
 
In order to further investigate the effect of increased sterics and electronics on the system, 
[Cp*Ru(CH3CN)3]PF6 salt was used as the precatalyst (Table 16).  In general, the Cp*Ru(II) 
complexes are largely preferred over the CpRu(II) complexes because they are more electron 
rich and catalytically more active, providing products with greater regioselectivities in favor of 
the branched substitution product.
34,38
 Surprisingly, the reaction provided products with opposite 
diastereo-and enantioselectivity compared with the CpRu(II)-imidazoline catalyst with ligands 
91 and 104 (82aanti:82asyn= 1:3 compared to 82aanti:82asyn=  7:1).  In addition, the products were 
formed with substantially decreased regio- and diastereoselectivity.  Moreover, utilization of the 
ligands 102 and 105 with substitution at the 4-position of the pyridine, failed to produce any 
reaction turnover.   This may be attributed to an increase in the steric environment due to the 
bulkier Cp* ring system, preventing efficient binding of the substrate to the catalyst. 
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Table 16. Reaction Results using Cp*Ru(II) Complex 
 
3.5 REACTION SCOPE 
Although, the Cp*Ru(II) complex provided interesting results, the diastereoselectivities and 
regioselectivities could not be improved further.  The CpRu(II) complexes with ligands 102 and 
104 ultimately provided superior results.  At this juncture, with ligand 102 providing higher 
diastereoselectivities and ligand 104 providing better regioselectivities and enantioselectivities, 
we needed to determine how they performed on a larger substrate scope. 
Various aryl and heteroaryl allylic acetates along with a variety of silyl pyrrole enol 
ethers were synthesized and subjected to the optimized reaction conditions (5 mol % CpRu(II) 
salt, 5 mol % 102 or 104, 15 mol % B(O
p
C6H4F)3, THF, 16 h).  The substrates afforded the 
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Claisen-type products with generally high yields of up to 99% with a few exceptions (Table 17 
and 18).  The use of additional borate was required to increase the yield of the n-propyl silyl enol 
ether to useful levels for unknown reasons (Table 17 and 18, entry c). The borate is thought to 
only aid in the activation of the allylic acetate, however this demonstrates that it may also play a 
role in the activation of the silyl enol ether.  In addition, the Cl-substituted enolate only provided 
the desired product in about 38% yield (Table 17, entry f).  Increasing the catalytic loading of the 
borate proved ineffective possibly due to the decreased nucleophilicity of this enolate. The Cl-
substituted product was also susceptible to substitution by the acetate leaving group of the 
substrate.  Although this contributed to a lower yield in the reaction, it showcased that the 
product could be easily derivitized at R1. Also it is important to note that the bulky isopropyl 
group of silyl enol ether 81d (Table 17 and 18, entry d) provided no reaction, showing that the 
enolate is sensitive to substitution at the -position.  
Despite the range of yields being dependent upon enolate sterics and electronics, the 
products of all of the reactions were formed with consistently high regioselectivities [82a:83a 
>19:1 for ligand 104 (Table 17) and > 8:1 with ligand 102 (Table 18)]. The only exception being 
for the highly electron deficient p-NO2-phenyl allylic acetate which gave moderate 
regioselectivity (82a:83a= 5:1 ) (Table 17, entry j). This is likely due to the fact that the benzylic 
position is destabilized relative to the rest allylic acetates.  
Enantioselectivities utilizing ligand 104 (Table 17), were consistently above 93% for all 
enolates and allylic acetates. In general, the major anti diastereomer was formed in higher ee 
than the syn diastereomer, however the variation was not that substantial (>93% ee anti, >85% ee 
syn).  There was more variation in enantioselectivity when ligand 102 was used (Table 18).  The 
ee was highly dependent on the enolate with a high of R1=Me (95% ee) and a low of R1=Cl (34% 
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ee) for the anti diastereomer. In addition, the syn diastereomer was formed with substantially 
lower enantioselectivities independent of enolate substitution. 
Diastereoselectivity showed some dependence on both the substitution of the aryl allylic 
acetate and the pyrrole silyl enol ether.  For example, the more sterically hindered o-
methoxyphenyl allylic acetate (entry g) provided decreased diastereoselectivity (82aanti:82asyn= 
3.3:1) when compared to the other substrates providing up to 9:1 (82aanti:82asyn) 
diastereoselectivity.  Pyrrole silyl enol ether substitution had a greater impact on 
diastereoselectivity providing a range marked with a high of R1 = methyl (82aanti:82asyn= 9:1) 
(Table 18, entry a) and a low of R1 = Cl (82aanti:82asyn= 1.3:1) (Table 17, entry f).  This may be 
attributed to the fact that the Cl atom is quite small in comparison to the rest of the substituents.  
In addition, the diphenyl substituted ligand 102, provided consistently higher 
diastereoselectivities in comparison to ligand 104 for reasons that are unclear at this time.   
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Table 17. Enolate Allylic Alkylation Reaction Scope Using Ligand 104  
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Table 18.  Enolate Allylic Alkylation Reaction Scope Utilizing Ligand 102 
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The optimized catalyst system for the aryl and heteroaryl allylic acetates (5 mol % 
CpRu(II) salt, 5 mol % 102 or 104, 15 mol % B(O
p
C6H4F)3, THF, 16 h) did not translate to the 
corresponding alkyl allylic acetates (Table 19).  The catalyzed rearrangement of crotyl acetate 
provided the desired products 106 and 107 in very low yields using both ligands 104 ( 37 % 
yield) and 102 (36 % yield), with low regioselectivities especially in the case of ligand 104 
(106:107 1.4:1).  The reaction required the more electron rich ligand 105 to provide the product 
with a synthetically useful regioselectivity of 6:1 favoring the branched product 106.   
 
Table 19. Optimization of Reaction Conditions for Aliphatic Substrates 
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3.6 PROPOSED REACTION MECHANISM 
The reaction mechanism is postulated to commence with association of the activated allylic 
acetate 108 to the CpRu(II)-imidazoline active catalyst 112, forming complex 109 (Figure 13A).  
The reaction can then proceed via oxidative addition of the CpRu(II)-imidazoline across the 
allylic acetate C-O -bond with assistance from the Lewis acidic B(OpC6H4F)3 to form a Ru(IV) 
allyl complex 110.  Following oxidative addition, the resulting acetate leaving group could 
function to activate the latent enolate nucleophile 81a through Lewis acid-base interaction with 
the silicon residue.
58,65
 The resulting highly reactive enolate could then easily add to the -allyl 
intermediate with a bias for attack at the more substituted carbon, forming the chelated product 
complex 111 with a preference for the anti- diastereomer. With the addition of acetonitrile, the 
Claisen-like product 82 gets expelled from the coordination sphere of the Ru-complex 
regenerating the active catalyst 112.  
 Ruthenium-catalyzed allylic alkylation chemistry is generally known to proceed through 
-allyl intermediates which should provide the anti and syn diastereomers (82syn and 82anti) with 
the same enantioselectivity.  However, since the enantioselectivities of the anti and syn 
diastereomers were quite different, especially when utilizing the diphenyl substituted ligand 102 
(95% ee 82aanti, 79% ee 82asyn) (See Table 18), we could not fully discount the possibility that 
the reaction proceeds through a metal-mediated SN2
’ 
reaction mechanism.
66
  In this case, the 
Ru(II)-complex would oxidatively add to the allylic acetate and form a Ru(II) -bonded enyl 
complex 114 or 115 (Figure 13B). To further elucidate the exact nature of the mechanism we 
utilized the branched allylic acetate 113 under the optimized reaction conditions to determine if 
the opposite regioisomer was formed due to the formation of enyl complex 115.  However, the 
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substrate 113 provided the same branched substitution product 82a as the linear allylic acetate 
80a (Figure 13B). This showcased that both the branched and linear substrates most likely 
proceed through the same Ru(IV)--allyl intermediate.   
 65 
 
Figure 13. A. Proposed Reaction Mechanism; B. Evidence for a -allyl Mechanism  
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The major product in our enolate allylic alkylation reaction is formed with a preference 
for the anti-diastereomer.  Since the reaction proceeds through an intermolecular mechanism, 
there is no intrinsic mechanism for enforcing a highly ordered transition state.  However, upon 
inspection of both possible antiperiplanar 116 and synclinal 117 transition states (Figure 14) 
there appears to be a lower energy conformer that could explain the observed anti-diastereomer.  
Both the antiperiplanar and synclinal transition states suffer from destabilizing gauche 
interactions, however, the antiperiplanar transition state 116 appears to be a lower energy 
conformer due to the presence of only two gauche interactions to the three observed in the 
synclinal transition state.  As a result, this may be the reason the anti-diastereomer is formed in 
preference to the syn-diastereomer albeit without a high degree of selectivity.  However, these 
transition states do not take into account the Ru(II) catalyst, therefore it is unclear if there are 
other steric and electronic interactions in play that affect the formation of the anti diastereomer. 
 
 
Figure 14. Antiperiplanar and Synclinal Transition States 
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3.7 CONCLUSIONS 
A highly regioselective, diastereoselective, and enantioselective ruthenium-catalyzed enolate 
allylic alkylation reaction that tolerates a variety of aromatic allylic acetates and pyrrole silyl 
enol ether nucleophiles has been developed.  This reaction methodology provides a superior way 
to access a variety of Claisen-like products that were recently inaccessible due to trouble 
accessing allyl vinyl ethers.  In addition, just about any aryl allylic acetate can be paired with a 
pyrrole silyl enol ether to provide an even greater substrate scope than listed in the above table.  
In addition, the resulting acyl pyrrole products can be easily derivatized to methyl esters, 
carboxylic acids and alcohols in a highly efficient manner, providing the potential for the 
products to be used in the construction of natural products. 
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4.0  EXPERIMENTAL 
4.1 RUTHENIUM CATALYZED CLAISEN REARRANGEMENT 
General Information: Unless otherwise stated, all reactions were performed in dry glassware 
under an atmosphere of oxygen-free nitrogen using standard inert atmosphere techniques for the 
manipulation of both solvents and reagents. Anhydrous solvents were obtained by passage 
through successive alumina- and Q5-packed columns on a solvent purification system.  Acetone 
was distilled from Drierite and stored under nitrogen over 4 Å MS. Sodium hydride (60% 
dispersion in mineral oil) was purchased from Sigma-Aldrich and used as is.  Crotyl and allyl 
bromide were purchased from Sigma-Aldrich and purified by distillation over CaH2.  
[Ir(COE)Cl]2, and PCy3 were purchased from Strem, [CpRu(CH3CN)3]PF6 from Sigma-Aldrich; 
these reagents were stored and weighed out in a nitrogen-filled glove box.  NMR spectra were 
recorded on a Bruker Avance-300 (300 MHz) spectrometer with chemical shifts reported relative 
to residual CHCl3 (7.26 ppm) for 
1
H and CDCl3 (77.00 ppm) for 
13
C NMR spectra.  High 
resolution mass spectra were obtained on a VG-7070 or Fisons Autospec high-resolution 
magnetic sector mass spectrometer. Analytical thin layer chromatography (TLC) was performed 
on EM Reagent 0.25 mm silica gel 60-F plates.  Flash chromatography was performed over EM 
silica gel 60 (230-240 mesh).  Analytical gas chromatography (GC) was performed using a 
Varian 3900 gas chromatograph with a flame ionization detector and split mode capillary 
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injection system using Varian Chirasil-Dex CB WCOT Fused Silica 25M x 0.25MM column (CP 
7502).  
 
 
 
 
General Procedure for the Synthesis of di(allyl) ethers (General Procedure A): Sodium 
hydride (2.5 eq, 60% suspension in mineral oil) was added to a 0 °C solution of alcohol A (1.0 
equiv) in THF (0.5 M) and the reaction was stirred 30 min. Allylic bromide B (1.4 equiv) was 
added and the resulting suspension was warmed to ambient temperature and stirred for 3 h.  A 
saturated solution of NH4Cl (equal in volume to the reaction mixture) was added slowly at 0 C 
to quench the reaction and the resulting mixture extracted with Et2O (3x the initial volume of the 
reaction mixture). The combined organic extracts were dried over anhydrous MgSO4, solvent 
removed in vacuo, and the residue purified as indicated in the text. 
 
(E)-[3-(Allyloxy)prop-1-en-1-yl]benzene: This compounds 
characterization materials match the data provided in the following publication: 
Kerrigan, N. J.; Bungard, C. J.; Nelson, S. G. Tetrahedron 2008 (64) 6863-6869.  
 
  (E)-1-[3-(Allyloxy)prop-1-enyl]-4-methoxybenzene: General 
procedure A was followed employing (E)-3-(4-methoxyphenyl)prop-2-en-1-
ol (1.0 g, 6.1 mmol) and allyl bromide (0.79 mL, 8.5 mmol) in THF.  The crude product was 
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purified by flash chromatography over silica gel (1:1 Et2O/hexanes) to yield 0.85 g (68%) of the 
title compound as a colorless oil. 
1
H NMR (300 MHz, CDCl3):  7.33 (d, J = 8.7, 2H), 6.85 (d, J 
= 6.6 Hz, 2H), 6.55 (d, J = 15.9 Hz, 1H), 6.17 (dt, J = 15.9, 6.3 Hz, 1H), 5.95 (app ddt, J = 15.9, 
10.5, 5.7 Hz, 1H), 5.31 (dq, J = 17.1, 1.5 Hz, 1H), 5.23-5.18 (m, 1H) 4.13 (dd, 6.0, 1.2 Hz, 2H), 
4.03 (dt, J = 5.4, 1.5 Hz, 1H), 3.80 (s, 3H); 
13
C NMR (75 MHz, CDCl3):  159.1, 134.6, 132.0, 
129.3, 127.5, 123.6, 116.9, 113.8, 70.89, 70.80, 55.1; IR max
neat 
cm
-1
: 3075, 2934, 2839, 1723, 
1603, 1513, 1251, 1174, 1110, 833; HRMS (EI) m/z calcd for C13H16O2 (M)
+
: 204.1150; found: 
204.1145. 
 
(E)-1-[3-(Allyloxy)prop-1-en-1-yl]-4-methylbenzene: This 
compounds characterization materials match the data provided in the 
following publication: Nishina, N. and Yamamoto, Y. Tetrahedron Letters 2008 (49) 4908-4911.  
 
 (E)-1-[3-(Allyloxy)prop-1-enyl]-4-bromobenzene: General procedure A was 
followed employing (E)-3-(4-bromophenyl)prop-2-en-1-ol (1.0 g, 4.7 mmol) 
and allyl bromide (0.49 mL, 5.7 mmol) in THF.  The crude product was purified by flash 
chromatography over silica gel (1:1 Et2O/hexanes) to yield 1.1 g (92%) of the title compound as 
a yellow oil. 
1
H NMR (300 MHz, CDCl3):  7.34 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 8.1 Hz, 2H), 
6.56 (d, J = 15.9 Hz, 1H), 6.29 (dt, J = 15.9, 5.7 Hz, 1H), 5.95 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H), 
5.32 (dd, J = 15.6, 1.5 Hz, 1H), 5.22 (dd, J = 10.2, 1.5 Hz, 1H), 4.14 (dd, J = 6.0, 1.2 Hz, 2H), 
4.04 (dt, J = 5.7, 1.2 Hz, 2H); 
13
C NMR (75 MHz, CDCl3):  135.7, 134.6, 131.6, 130.9, 127.9, 
126.9, 121.3, 117.1, 71.2, 70.4; IR max
neat 
cm
-1
: 2924, 2853, 1723, 1587, 1487, 1401, 1020, 819, 
757; HRMS (EI) m/z calcd for C12H13BrO (M)
+
: 252.0149; found: 252.0151. 
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 (E)-1-[3-(Allyloxy)prop-1-enyl]-2-methoxybenzene: General procedure A was 
followed employing (E)-3-(2-methoxyphenyl)prop-2-en-1-ol (3.0 g, 18 mmol) 
and allyl bromide (1.9 mL, 22 mmol) in THF.  The crude product was purified by flash 
chromatography over silica gel (1:1 Et2O/hexanes) to yield 3.5 g (94%) of the title compound as 
a colorless oil. 
1
H NMR (300 MHz, CDCl3):  7.46 (dd, J = 7.5, 1.2 Hz, 1H), 7.24 (t, J = 7.2 Hz, 
1H), 6.97-6.86 (m, 3H), 6.32 (dt, J = 16.2, 6.3 Hz, 1H), 5.56 (ddt, J = 16.2, 10.8, 5.7 Hz, 1H), 
5.32 (dd, J = 17.4, 1.5 Hz, 1H), 5.21 (dd, J = 10.2, 1.0 Hz, 1H), 4.18 (d, J = 6.0 Hz, 2H), 4.05 (d, 
J = 5.7 Hz, 2H), 3.85 (s, 3H); 
13
C NMR (75 MHz, CDCl3):  156.6, 134.8, 128.6, 127.5, 126.9, 
126.6, 125.6, 120.5, 117.0, 110.7, 71.2, 70.9, 55.3; IR max
neat 
cm
-1
: 3005, 2837, 1647, 1597, 
1489, 1483, 1463, 1387.3, 1243, 975, 926, 752; HRMS (EI) m/z calcd for C13H16O2 (M)
+
: 
204.1150; found: 204.1146.  
 
 (E)-1-[3-(Allyloxy)prop-1-enyl]-3-methoxybenzene: General procedure A was 
followed employing (E)-3-(3-methoxyphenyl)prop-2-en-1-ol (1.9 g, 11 mmol) 
and allyl bromide (1.4 mL, 16 mmol) in THF.  The crude product was purified by 
flash chromatography over silica gel (1:1 Et2O/hexanes) to yield 2.1 g (91%) of the title 
compound as a colorless oil. 
1
H NMR (300 MHz, CDCl3):  7.23 (t, J = 15.6, 1H), 6.99 (d, J = 
7.8 Hz, 1H), 6.93 (s, 1H), 6.81 (dd, J = 8.1, 2.5 Hz, 1H), 6.61 (d, J = 16.0 Hz, 1H), 6.34-6.25 (m, 
2H), 4.88 (s, J = 6.6 Hz, 1H), 4.34 (dd, J = 6.0, 1.0 Hz, 2H), 3.81 (s, 3H), 1.58 (dd, J = 7.0, 1.5 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  159.6, 138.1, 134.6, 132.1, 129.4, 126.3, 119.8, 117.0, 
113.2, 111.6, 71.0, 70.5, 55.1; IR max
neat 
cm
-1
: 3002, 2836, 1599, 1582, 1269, 1156, 1112, 1047, 
969, 775, 689; HRMS (EI) m/z calcd for C13H16O2 (M)
+
: 204.1150; found: 204.1144. 
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 (E)-1-[3-(Allyloxy)prop-1-enyl]-3-chlorobenzene: General procedure A was 
followed employing (E)-3-(3-chlorophenyl)prop-2-en-1-ol (2.6 g, 15 mmol) and 
allyl bromide (2.0 mL, 21 mmol) in THF.  The crude product was purified by 
flash chromatography over silica gel (1:1 Et2O/hexanes) to yield 2.8 g (88%) of the title 
compound as a pale orange oil. 
1
H NMR (300 MHz, CDCl3):  7.37 (s, 1H), 7.27-7.19 (m, 3H), 
6.56 (d, J = 17.1 Hz, 1H), 6.31 (dt, J = 15.9, 6.0 Hz, 1H), 6.02-5.89 (m, 1H), 5.32 (dq, J = 17.1, 
1.5 Hz, 1H), 5.22 (dq, J = 10.5, 1.5 Hz, 1H), 4.16 (dd, J = 5.7, 1.2 Hz, 2H), 4.05 (dt, J = 5.4, 1.5 
Hz, 2H); 
13
C NMR (75 MHz, CDCl3):  138.5, 134.5, 134.4, 130.6, 129.7, 127.6, 127.4, 126.3, 
124.5, 117.1, 71.2, 70.3; IR max
neat 
cm
-1
: 3078, 2849, 1739, 1593, 1565, 1473, 1425, 1356, 1077, 
965, 772, 682; HRMS (EI) m/z calcd for C12H13ClO (M)
+
: 208.0653; found: 208.0654. 
 
 (E)-2-[3-(Allyloxy)prop-1-enyl]furan: General procedure A was followed 
employing (E)-3-(Furan-2-yl)prop-2-en-1-ol (2.0 g, 16 mmol) and allyl bromide 
(2.1 mL, 23 mmol) in THF.  The crude product was purified by flash chromatography over silica 
gel (1:1 Et2O/hexanes) to yield 2.5 g (93%) of the title compound as a pale yellow oil. 
1
H NMR 
(300 MHz, CDCl3):  7.34 (d, J = 1.2 Hz, 1H), 6.44 (d, J = 15.9 Hz, 1H), 6.35 (dd, J = 3.3, 1.8 
Hz, 1H), 6.26-6.17 (m, 2H), 6.00-5.87 (m, 1H), 5.30 (dq, 17.1, 1.5 Hz, 1H), 5.22-5.18 (m, 1H);
 
13
C NMR (75 MHz, CDCl3):  152.3, 141.9, 134.6, 124.6, 120.3, 116.9, 111.1, 107.8, 71.0, 70.0; 
IR max
neat 
cm
-1
: 2848, 1489, 1354, 1255, 1111, 1075, 1013, 961, 926, 735, 594; HRMS (EI) m/z 
calcd for C16H16O (M)
+
: 164.0837; found: 164.0835. 
 
 (E)-1-[3-(Allyloxy)prop-1-enyl]naphthalene: General procedure A was 
followed employing (E)-3-(Naphthalen-1-yl)prop-2-en-1-ol (0.50 g, 2.7 mmol) 
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and allyl bromide (0.28 mL, 3.3 mmol) in THF.  The crude product was purified by flash 
chromatography over silica gel (1:1 Et2O/hexanes) to yield 376 mg (62%) of the title compound 
as a pale yellow oil. 
1
H NMR (300 MHz, CDCl3):  8.14-8.11 (m, 1H), 7.87-7.82 (m, 1H), 7.78 
(d, J = 8.1 Hz, 1H), 7.62 (d, J = 7.2 Hz, 1H), 7.54-7.42 (m, 3H), 7.39 (d, J = 19.8 Hz, 1H), 6.34 
(dt, J = 15.6, 5.7, 1H), 6.00 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H), 5.36 (dq, J = 17.4, 1.8 Hz, 1H), 
5.25 (dq, J = 10.2, 1.2 Hz, 1H), 4.28 (dd, J = 6.0, 1.5 Hz, 2H), 4.12 (dt, J = 5.4, 1.2 Hz, 2H); 
13
C 
NMR (75 MHz, CDCl3):  134.7, 134.5, 133.6, 131.1, 129.4, 129.3, 128.5, 127.9, 126.0, 125.7, 
125.6, 123.9, 123.7, 117.1, 71.2, 70.8; IR max
neat 
cm
-1
: 3051, 2920, 1723, 1687, 1510, 1108, 778; 
HRMS (EI) m/z calcd for C16H16O (M)
+
: 224.1201; found: 224.1200. 
 
 (E)-2-[3-(Allyloxy)prop-1-enyl]naphthalene: General procedure A 
was followed employing (E)-3-(Naphthalen-2-yl)prop-2-en-1-ol (798 mg, 
4.33 mmol) and allyl bromide (0.56 mL, 6.1 mmol) in THF.  The crude product was purified by 
flash chromatography over silica gel (1:1 Et2O/hexanes) to yield 800 mg (82%) of the title 
compound as a white semisolid. 
1
H NMR (300 MHz, CDCl3):  7.80 (t, J = 4.5 Hz, 2H), 7.75 (d, 
J = 10.2 Hz, 2H), 7.61 (dd, J = 8.7, 1.2 Hz, 1H), 7.48-7.41 (m, 2H), 6.78 (d, J = 15.9 Hz, 1H), 
6.43 (dt, J = 15.9, 6.0 Hz, 1H), 5.98 (ddd, J = 22.8, 11.1, 5.7 Hz, 1H), 5.34 (d, J = 17.1 Hz, 1H), 
5.23 (d, J = 10.5 Hz, 1H), 4.21 (d, J = 6.0 Hz, 2H), 4.08 (d, J = 5.4 Hz, 2H); 
13
C NMR (75 MHz, 
CDCl3):  134.6, 134.1, 133.4, 132.9, 132.4, 128.1, 127.9, 127.6, 126.4, 126.3, 126.1, 125.8, 
123.5, 117.1, 71.1, 70.7; IR max
neat 
cm
-1
:2923, 2849, 1664, 1623, 1122, 967, 859, 747; HRMS 
(EI) m/z calcd for C16H16O (M)
+
: 224.1201; found: 224.1198. 
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{(E)-3-[(E)-But-2-enyloxy]prop-1-enyl}benzene: General procedure A was 
followed employing cinnamyl alcohol (3.0 g, 22 mmol) and (E)-1-bromobut-2-
ene (2.8 mL, 29 mmol) in THF.  The crude product was purified by flash chromatography over 
silica gel (1:1 Et2O/hexanes) to yield 3.3 g (79%) of the title compound as a pale yellow oil. 
1
H 
NMR (300 MHz, CDCl3):  7.44-7.24 (m, 5H), 6.64 (d, J = 15.9 Hz, 1H), 6.39-6.29 (m, 1H), 
5.84-5.62 (m, 2H), 4.16 (app dq, J = 6.6, 1.5 Hz, 2H), 3.99 (dt, J = 6.0, 1.0 Hz, 2H), 3.53 (dd, J = 
6.0, 1.0 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  136.6, 132.3, 132.2, 129.7, 128.4, 127.9, 127.5, 
127.4, 126.7, 126.3, 126.1, 65.3, 17.7; IR max
neat 
cm
-1
: 3025, 2916, 2849, 1671, 1599, 1494, 
1448, 1358, 1103, 1051, 966, 739, 692; HRMS (EI) m/z calcd for C13H16O (M)
+
: 188.1201; 
found: 188.1193. 
 
(E)-[3-(Allyloxy)prop-1-enyl]cyclohexane:  General Procedure C was followed 
employing (E)-3-Cyclohexylprop-2-en-1-ol (2.6 g, 17 mmol) and allyl bromide 
(1.7 mL, 20 mmol) in THF.  The crude product was purified by flash chromatography over silica 
gel (1:1 Et2O/hexanes) to yield 3.0 g (99%) of the title compound as a pale orange oil. 
1
H NMR 
(300 MHz, CDCl3):  5.92 (ddt, J = 16.2, 10.8, 5.7 Hz, 1H), 5.65 (dd, J = 15.6, 6.3 Hz, 1H), 5.50 
(dt, J = 15.3, 6.0 Hz, 1H), 5.27 (dd, J = 17.4, 1.5 Hz, 1H), 5.17 (d, J = 10.5 Hz, 1H), 3.96 (d, J = 
5.7 Hz, 2H), 3.93 (d, J = 6.0 Hz, 2H), 1.97-1.91 (m, 1H), 1.74-1.62 (m, 5H), 1.33-1.01 (m, 4H), 
0.88-0.83 (m, 1H); 
13
C NMR (75 MHz, CDCl3):  140.5, 134.9, 123.5, 116.9, 71.1, 70.8, 40.3, 
32.7, 26.1, 26.0; IR max
neat 
cm
-1
: 2925, 2851, 1667, 1647, 1448, 1351, 1098, 970, 921; HRMS 
(EI) m/z calcd for C12H20O (M)
+
: 180.1514; found 180.1517.  
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General Procedure B.  Synthesis of Allyl Vinyl Ethers 39a-k,67,68,70: [Ir(cC8H14)2Cl]2 (0.5 
mol %), PCy3 (3 mol %)  and NaBPh4 (3 mol %) were combined in a flame dried flask in a 
nitrogen-filled glovebox.  The flask was removed from the glovebox and a mixture of 
CH2Cl2/acetone (25:1, 0.67 M final concentration of the diallyl ether substrate) was added.  The 
resulting yellow-orange solution was stirred for 5 min at ambient temperature.  The diallyl ether 
(1.0 equiv) was added to the catalyst solution in a minimal amount of CH2Cl2 (≤5% of the total 
solvent volume) and the reaction was stirred for 10-60 min (until complete consumption of the 
starting material as monitored by TLC.  The reaction mixture was concentrated under a stream of 
N2 then pentanes (4x the reaction volume) were added and the resulting heterogeneous mixture 
was filtered through a Florisil
®
 plug eluting with additional pentanes.  The eluent was 
concentrated to afford the allyl vinyl ethers that were used in the subsequent reaction without 
further purification.  
 
{(E)-3-[(E)-Prop-1-en-1-yloxy]prop-1-en-1-yl}benzene (39a):  This 
compound’s  characterization materials match the data provided in the following 
publication: Kerrigan, N. J.; Bungard, C. J.; Nelson, S. G. Tetrahedron 2008, 64, 6863-6869.  
 
{(E)-3-[(E)-But-1-enyloxy]prop-1-enyl}benzene (39b): General procedure B 
was followed employing 1.0 g of ((E)-3-((E)-but-2-enyloxy)prop-1-enyl)benzene 
(5.3 mmol), 24 mg [Ir(cC8H14)2Cl]2 (0.02 mmol), 45 mg of PCy3 (0.16 mmol), and 36 mg of 
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NaBPh4 (0.11 mmol).  After 2 h the reaction mixture was filtered through a plug of Florisil
®
 and 
purified further over silica gel (99:1 hexanes/Et2O) to yield 0.38 g (38%) of the compound as a 
pale yellow oil. 
1
H NMR (300 MHz, CDCl3):  7.42-7.23 (m, 5H), 6.65 (d, J = 15.9 Hz, 1H), 
6.36-6.28 (m, 2H), 4.91 (dt, J = 14.1, 7.2 Hz), 4.35 (dd, J = 6.0, 1.5 Hz, 2H), 1.96 (app dquin, J = 
7.5, 1.5 Hz, 2H), 0.99 (t, J = 7.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  145.0, 143.7, 136.5, 
132.6, 128.5, 127.7, 126.5, 124.8, 109.3, 106.9, 72.2, 69.7, 21.0, 15.2; IR max
neat 
cm
-1
: 3027, 
2961, 2927, 2869, 2852, 1651, 1494, 1450, 1376, 1172, 1066, 965, 929, 739, 692; HRMS (EI) 
m/z calcd for C13H16O (M)
+
: 188.1201; found: 188.1193. 
 
1-Methyl-4-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39c): 
General procedure B was followed employing 2.1 g of (E)-1-(3-
(allyloxy)prop-1-enyl)-4-methylbenzene (11 mmol), 50 mg [Ir(cC8H14)2Cl]2 (0.060 mmol), 92 
mg of PCy3 (0.33 mmol), and 75 mg of NaBPh4 (0.22 mmol).  After 30 min the reaction mixture 
was filtered through a plug of Florisil
®
 to yield 1.7 g (81%) of the compound as a pale yellow 
waxy solid. 
1
H NMR (300 MHz, CDCl3):  7.30 (d, J = 8.1 Hz, 2H), 7.14 (d, J = 8.1 Hz, 2H), 
6.61 (d, J = 15.9 Hz, 1H) 6.31-6.22 (m, 2H), 4.88 (dq, J = 13.2, 6.6 Hz, 1H), 4.34 (dd, J = 6.0, 
1.2 Hz, 2H), 2.34 (s, 3H), 1.58 (dd, J = 6.9, 1.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  146.0, 
137.6, 133.6, 132.7, 129.2, 129.0, 126.4, 123.8, 99.4, 69.9, 21.1, 12.5; IR max
neat 
cm
-1
: 2930, 
2900, 2855, 1654, 1512, 1457, 1377, 1186, 967, 939, 796; HRMS (EI) m/z calcd for C13H16O 
(M)
+
: 188.1201; found: 188.1196. 
 
1-Methoxy-4-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39d): 
General procedure B was followed employing 450 mg of (E)-1-[3-
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(allyloxy)prop-1-enyl]-4-methoxybenzene (2.2 mmol), 20 mg [Ir(cC8H14)2Cl]2 (0.020 mmol), 37 
mg of PCy3 (0.13 mmol), and 16 mg of NaBPh4 (0.04 mmol).  After 30 min the reaction mixture 
was filtered through a plug of Florisil
®
 to yield 400 mg (89%) of the title compound as a flaky 
white solid. 
1
H NMR (300 MHz, CDCl3):  7.32 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 
6.57 (d, J = 15.9 Hz, 1H), 6.26 (dd, J = 17.6, 1.5 Hz, 1H), 6.16 (dt, J = 15.9, 6.3 Hz, 1H), 4.86 (s, 
J = 6.6 Hz, 1H), 4.31 (dd, J = 6.0, 1.2 Hz, 2H), 3.80 (s, 3H), 1.56 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C 
NMR (75 MHz, CDCl3):  159.2, 145.9, 132.3, 129.1, 127.6, 122.5, 113.8, 99.2, 69.9, 55.1, 12.5; 
IR max
neat 
cm
-1
: 3053, 2958, 2899, 2855, 1654, 1607, 1512, 1251, 1180, 966, 755; HRMS (EI) 
m/z calcd for C13H16O2 (M)
+
: 204.1150; found: 204.1146. 
 
1-Bromo-4-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39e): General 
procedure B was followed employing 2.7 g of (E)-1-[3-(Allyloxy)prop-1-
enyl]-4-bromobenzene (11 mmol), 47 mg [Ir(cC8H14)2Cl]2 (0.05 mmol), 88 mg of PCy3 (0.31 
mmol), and 72 mg of NaBPh4 (0.21 mmol).  After 30 min the reaction mixture was filtered 
through a plug of Florisil
®
 to yield 2.0 g (75%) of the compound as a white waxy solid. 
1
H NMR 
(300 MHz, CDCl3):  7.44 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 6.9 Hz, 2H), 6.57 (d, J = 16.2, 1H), 
6.34-6.23 (m, 2H), 4.87 (dq, J = 13.5, 6.6 Hz, 1H), 4.33 (dd, J = 5.7, 1.2 Hz, 2H), 1.57 (dd, J = 
6.6, 1.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  145.9, 135.4, 131.6, 131.2, 127.9, 125.7, 121.5, 
99.5, 69.5, 12.5; IR max
neat 
cm
-1
: 2901, 2856, 1654, 1486, 1371, 1178, 969, 853, 799; HRMS 
(EI) m/z calcd for C12H13BrO (M)
+
: 252.0149; found: 252.0138. 
 
1-Methoxy-2-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39f): General 
procedure B was followed employing 2.0 g of (E)-1-[3-(allyloxy)prop-1-enyl]-2-
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methoxybenzene (9.8 mmol), 44 mg [Ir(cC8H14)2Cl]2 (0.05 mmol), 82 mg of PCy3 (0.29 mmol), 
and 67 mg of NaBPh4 (0.19 mmol).  After 30 min the reaction mixture was filtered through a 
plug of Florisil
®
 to yield 1.1 g (56%) of the compound as a colorless oil. 
1
H NMR (300 MHz, 
CDCl3):  7.45 (dd, J = 7.5, 1.2 Hz, 1H), 7.26-7.21 (m, 1H), 6.98-6.86 (m, 3H), 6.38-6.26 (m, 
2H), 4.87 (dq, J = 13.5, 6.9 Hz, 1H), 4.36 (d, J = 6.9 Hz, 2H) 3.86 (s, 3H), 1.58 (dd, J = 6.6, 1.5 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  156.7, 146.0, 128.8, 127.8, 127.0, 125.5, 125.4, 120.5, 
110.7, 99.2, 70.3, 55.3, 12.6; IR max
neat 
cm
-1
: 3031, 2934, 2052, 1897, 1784, 1656, 1597, 1490, 
1244, 1174, 1028, 973, 927, 751; HRMS (EI) m/z calcd for C12H16O2 (M)
+
: 204.1150; found: 
204.1145. 
 
1-Methoxy-3-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39g):  General 
procedure B was followed employing 1.0 g of (E)-1-[3-(Allyloxy)prop-1-enyl]-3-
methoxybenzene (4.9 mmol), 44 mg [Ir(cC8H14)2Cl]2 (0.04 mmol), 82 mg of 
PCy3 (0.29 mmol), and 36 mg of NaBPh4 (0.09 mmol).  After 30 min the reaction mixture was 
filtered through a plug of Florisil
®
 to yield 0.80 g (80%) of the compound as a waxy colorless 
solid. 
1
H NMR (300 MHz, CDCl3):  7.26-7.21 (m, 1H), 6.95 (d, J = 7.8 Hz, 1H), 6.93 (s, 1H), 
6.81 (dd, J = 8.1, 2.4 Hz, 1H), 6.61 (d, J = 16.0 Hz, 1H), 6.34-6.25 (m, 2H), 4.88 (sextet, J = 6.6 
Hz, 1H), 4.34 (dd, J = 6.0, 1.0 Hz, 2H), 3.81 (s, 3H), 1.58 (dd, J = 7.0, 1.5 Hz, 3H); 
13
C NMR 
(75 MHz, CDCl3):  159.7, 145.9, 137.9, 132.4, 129.4, 125.2, 119.1, 113.4, 111.7, 99.4, 69.7, 
55.1, 12.5; IR max
neat 
cm
-1
: 2935, 1656, 1599, 1581, 1489, 1455, 1263, 1172, 1047, 968, 927, 
772, 688; HRMS (EI) m/z calcd for C13H16O2 (M)
+
: 243.0787; found: 243.0783. 
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1-Chloro-3-{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39h): General 
procedure B was followed employing 1.0 g of (E)-1-[3-(Allyloxy)prop-1-enyl]-3-
chlorobenzene (4.8 mmol), 43 mg [Ir(cC8H14)2Cl]2 (0.04 mmol), 81 mg of PCy3 
(0.29 mmol), and 36 mg of NaBPh4 (0.09 mmol).  After 30 min the reaction mixture was filtered 
through a plug of Florisil
®
 to yield 0.91 g (91%) of the compound as a colorless liquid. 
1
H NMR 
(300 MHz, CDCl3):  7.25-7.20 (m, 4H), 6.59 (dt, J = 16.2, 1.2 Hz, 1H), 6.36-6.24 (m, 2H), 4.88 
(sextet, J = 6.6 Hz, 1H), 4.35 (dd, J = 5.7, 1.5 Hz, 2H), 1.59 (dd, J = 10.2, 3.3 Hz, 3H); 
13
C NMR 
(75 MHz, CDCl3):  145.9, 134.6, 133.1, 129.6, 128.76, 128.74, 127.8, 126.9, 126.8, 99.5, 69.6, 
12.5; IR max
neat 
cm
-1
: 3060, 2923, 2858, 1656, 1593, 1565, 1397, 1176, 965, 927, 771, 682; 
HRMS (EI) m/z calcd for C12H13ClO (M)
+
: 208.0654; found: 208.0650. 
 
2-{(E)-3-[(E)-Prop-1-enyloxy]prop-1-enyl}furan (39i): General procedure B 
was followed employing 500 mg of (E)-2-[3-(Allyloxy)prop-1-enyl]furan (3.0 
mmol), 27 mg [Ir(cC8H14)2Cl]2 (0.04 mmol), 51 mg of PCy3 (0.18 mmol), and 22 mg of NaBPh4 
(0.06 mmol).  After 30 min the reaction mixture was filtered through a plug of Florisil
®
 to yield 
400 mg (80%) of the compound as an orange oil. 
1
H NMR (300 MHz, CDCl3):  7.34 (d, J = 1.5 
Hz, 1H), 6.44, (d, J = 15.9 Hz, 1H), 6.36 (dd, J = 3.3, 1.8 Hz, 1H), 6.26-6.17 (m, 2H), 4.85 
(sextet, J = 6.6 Hz, 1H), 4.31 (dd, J = 6.0, 1.2 Hz, 2H), 1.56 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C NMR 
(75 MHz, CDCl3):  146.0, 142.1, 123.5, 120.6, 111.2, 108.2, 99.5, 59.3, 12.5; IR max
neat 
cm
-1
: 
3059, 2925, 2858, 1657, 1489, 1457, 1377, 1175, 960, 926, 735; HRMS (EI) m/z calcd for 
C10H12O2 (M)
+
: 164.0837; found: 164.0833. 
 
 80 
1-{(E)-3-[(E)-Prop-1-enyloxy]prop-1-enyl}naphthalene (39j): General 
procedure B was followed employing 854 mg of (E)-1-[3-(Allyloxy)prop-1-
enyl]naphthalene (3.8 mmol), 17 mg [Ir(cC8H14)2Cl]2 (0.02 mmol), 32 mg of PCy3 (0.11 mmol), 
and 26 mg of NaBPh4 (0.07 mmol).  After 30 min the reaction mixture was filtered through a 
plug of Florisil
®
 to yield 720 mg (85%) of the compound as a pale white waxy solid. 
1
H NMR 
(300 MHz, CDCl3):  8.13-8.09 (m, 1H), 7.87-7.84 (m, 1H), 7.79 (d, J = 8.1 Hz, 1H), 7.61 (d, J 
= 7.2 Hz, 1H), 7.55-7.45 (m, 3H), 7.40 (d, J = 15.9 Hz, 1H), 6.33 (app dq, J = 15.6, 5.7 Hz, 2H), 
4.93 (dq, J = 13.2, 6.6 Hz, 1H), 4.46 (dd, J = 5.7, 1.2 Hz, 2H), 1.60 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C 
NMR (75 MHz, CDCl3):  146.0, 134.3, 133.5, 131.1, 129.7, 128.4, 128.1, 128.0, 126.0, 125.7, 
125.5, 123.9, 123.7, 99.5, 69.8, 12.5; IR max
neat 
cm
-1
: 3058, 2922, 2886, 2857, 1655, 1508, 1454, 
1381, 1173, 965, 926, 776; HRMS (EI) m/z calcd for C16H16O (M)
+
: 224.1201; found: 224.1206. 
 
2-{(E)-3-[(E)-Prop-1-enyloxy]prop-1-enyl} naphthalene (39k): General 
procedure B was followed employing 760 mg of (E)-2-[3-(Allyloxy)prop-1-
enyl]naphthalene (3.4 mmol), 30 mg [Ir(cC8H14)2Cl]2 (0.03 mmol), 56 mg of PCy3 (0.20 mmol), 
and 25 mg of NaBPh4 (0.06 mmol).  After 30 min the reaction mixture was filtered through a 
plug of Florisil
®
 to yield 700 mg (93%) of the compound as a waxy colorless solid. 
1
H NMR 
(300 MHz, CDCl3):  7.82-7.75 (m, 4H), 7.61 (dd, J = 8.4, 1.5 Hz, 1H), 7.50-7.42 (m, 2H), 6.80 
(d, J = 15.9 Hz, 1H), 6.43 (dt, J = 15.9, 6.0 Hz, 1H), 6.33-6.28 (m, 1H), 4.91 (sextet, 6.6 Hz, 
1H), 4.40 (dd, J = 5.7, 1.2 Hz, 2H), 1.60 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  
146.0, 133.9, 133.4, 133.0, 132.6, 128.1, 127.9, 127.6, 126.5, 126.2, 125.9, 125.2, 123.4, 99.4, 
69.8, 12.5; IR max
neat 
cm
-1
: 3044, 2950, 2888, 1654, 1175, 966, 814, 740; HRMS (EI) m/z calcd 
for C16H16O (M)
+
: 224.1201; found: 224.1209. 
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 {(E)-3-[(E)-Prop-1-enyloxy]prop-1-enyl}cyclohexane (70): General procedure 
B was followed employing 1.0 g of (E)-[3-(Allyloxy)prop-1-en-1-yl]cyclohexane 
(5.5 mmol), 25 mg [Ir(cC8H14)2Cl]2 (0.02 mmol), 46 mg of PCy3 (0.16 mmol), and 38 mg of 
NaBPh4 (0.11 mmol).  After 2 min the reaction mixture was filtered through a plug of Florisil® 
and purified further over silica gel (99:1 hexanes/Et2O) to yield 0.21 g (21%) of the compound as 
a pale yellow oil. 
1
H NMR (300 MHz, CDCl3):  6.21 (dd, J = 9.6, 1.5 Hz, 1H), 5.65 (dd, 15.6, 
6.6 Hz, 1H), 5.52 (dtd, J = 21.6, 6.0, 1.2 Hz, 1H), 4.80 (dq, J = 13.5, 6.6 Hz, 1H), 1.99-1.93 (m, 
1H), 1.74-1.58 (m, 5H), 1.55 (dd, J = 6.6, 1.5 Hz, 3H), 1.33-1.01 (m, 4H), 0.90-0.86 (m, 1H); 
13
C 
NMR (75 MHz, CDCl3):  146.0, 141.0, 122.5, 98.9, 70.2, 40.3, 33.1, 32.5, 26.1, 25.9, 12.5; IR 
max
neat 
cm
-1
: 2925, 2852, 1657, 1448, 1382, 1264, 1179, 970, 929, 777; HRMS (EI) m/z calcd for 
C12H20O (M)
+
: 180.1514; found: 180.1517. 
 
{(Z)-3-[(E)-Prop-1-enyloxy]prop-1-enyl}benzene (68): General procedure B was 
followed employing 470 mg of (Z)-[3-(Allyloxy)prop-1-enyl]benzene (2.7 mmol), 
12 mg [Ir(cC8H14)2Cl]2 (0.02 mmol), 23 mg of PCy3 (0.08 mmol), and 19 mg of NaBPh4 (0.05 
mmol).  After 30 min, the reaction mixture was filtered through a plug of Florisil
®
 and further 
purified over silica gel (99:1 hexanes/Et2O) to yield 340 mg (72%) of the compound as a clear 
colorless oil.  
1
H NMR (300 MHz, CDCl3):  7.41-7.22 (m, 5H), 6.66 (d, J = 11.7 Hz, 1H), 6.26 
(dq, J = 12.6, 1.5 Hz, 1H), 5.89 (dt, J = 12.3, 6.3 Hz, 1H), 4.81 (app dq, J = 13.5, 6.6 Hz, 1H), 
4.48 (dd, J = 6.3, 1.8 Hz, 2H), 1.57 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  
145.9, 136.4, 131.9, 128.7, 128.3, 127.8, 127.3, 99.2, 65.8, 12.6; IR max
neat 
cm
-1
: 3026, 2924, 
1657, 1493, 1169, 982; HRMS (EI) m/z calcd for C12H14O (M)
+
: 174.1044; found: 174.1038. 
{(E)-3-[(Z)-Prop-1-en-1-yloxy]prop-1-en-1-yl}benzene (67): This 
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compound’s characterization materials match the data provided in the following publication: 
Wipf, P.; Waller, D. L.; Reeves, J. T. J. Org. Chem. 2005, 20, 8096-8102. 
 
    (3aR,8aS)-2-(4-Methylpyridin-2-yl)-8,8a-dihydro-3aH-
indeno[1,2-d]oxazole (61a): (1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol 
(0.95g, 4.2 mmol),  4-Methyl-2-cyanopyridine (0.50g, 4.2 mmol), ZnCl2 (0.03 
g, 0.21 mmol) and 8.5 mL of chlorobenzene were added to a round bottom 
flask fitted with a reflux condenser under an inert atmosphere of N2.  The reaction was heated to 
130 C for 24 h at which time the heat was removed and the mixture was allowed to slowly cool 
to ambient temperature.  The chlorobenzene was removed in vacuo and the crude material 
purified over silica gel (0-3% MeOH/CH2Cl2) to yield a gray solid.  This solid was triturated 
with cold Et2O and filtered to provide 0.15 g (14%) of the title compound as a white solid. []
19
D
 
+98.2 (c 1.11, CHCl3);  
1
H NMR (300 MHz, CDCl3):  8.51 (d, J = 5.1 Hz, 1H), 7.89 (d, J = 0.6 
Hz, 1H), 7.57-7.53 (m, 1H), 7.27-2.26 (m, 3H), 7.18 (dd, J = 5.1, 0.9 Hz, 1H), 6.89-6.78 (m, 
3H), 5.80 (d, J = 7.8 Hz, 1H), 5.74 (ddd, J = 8.4, 6.0, 2.4 Hz, 1H), 3.55-3.39 (m, 2H), 2.33 (s, 
3H); 
13
C NMR (75 MHz, CDCl3):  163.6, 149.1, 148.2, 141.2, 139.7, 128.6, 127.4, 126.6, 
125.3, 116.5, 115.7, 115.4, 84.0, 76.6, 39.5, 20.8;  IR max
neat 
cm
-1
: 3068, 2945, 2908, 1640, 
1510, 1458, 1354, 1196, 1098, 833, 749; HRMS (ES+) m/z calcd for C16H15N2O (M + H)
+
: 
251.1183; found: 251.1185. 
 
(3aR,8aS)-2-(4-Methoxypyridin-2-yl)-8,8a-dihydro-3aH-
indeno[1,2-d]oxazole (61b) : (1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol 
(0.33g, 2.2 mmol),  4-Methoxy-2-cyanopyridine (0.20g, 2.2 mmol), ZnCl2 
 83 
(0.01 g, 0.08 mmol) and 5.0 mL of chlorobenzene were added to a round bottom flask fitted with 
a reflux condenser under an inert atmosphere of N2.  The reaction was heated to 130 C for 24 h 
at which time the heat was removed and the mixture was allowed to slowly cool to ambient 
temperature.  The chlorobenzene was removed in vacuo and the crude material purified over 
silica gel (0-3% MeOH/CH2Cl2) to 0.16 g (40%) of a gray solid. []
19
D
 +129 (c 1.03, CHCl3);  
1
H 
NMR (300 MHz, CDCl3):  8.46 (d, J = 5.7 Hz, 1H), 7.57 (dd, J = 6.6, 3.0 Hz, 2H), 7.26 (d, J = 
2.4 Hz, 3H), 6.86 (dd, J = 5.7, 2.7 Hz, 1H), 5.79 (d, J = 7.8 Hz, 1H), 5.57 (ddd, J = 8.1, 5.7, 2.7 
Hz, 1H), 3.86 (s, 3H), 3.56-3.42 (m, 2H); 
13
C NMR (75 MHz, CDCl3):  165.9, 163.2, 150.7, 
148.4, 141.5, 139.8, 128.5, 127.4, 125.6, 125.3, 112.3, 109.4, 83.9, 55.4, 39.6;  IR max
neat 
cm
-1
: 
3060, 3015, 2925, 1642, 1529, 1484, 1360, 1305, 1216, 1078, 1038, 750; HRMS (ES+) m/z 
calcd for C16H15N2O2 (M + H)
+
: 267.1134; found: 267.1144.  
 
(3aR,8aS)-2-[4-(Pyrrolidin-1-yl)pyridin-2-yl]-8,8a-dihydro-3aH-    
indeno[1,2-d]oxazole (61c): (3aR,8aS)-2-(4-Chloropyridin-2-yl)-8,8a-
dihydro-3aH-indeno[1,2-d]oxazole (0.10 g, 0.37 mmol) was added to a 
medium pressure reaction vessel along with pyrrolidine (1.2 mL, 15 mmol).  
The vessel was sealed and heated at 110 C for 4 h.  At this time the reaction vessel was removed 
from the oil bath and allowed to slowly cool to ambient temperature. The reaction was quenched 
with an equal volume of saturated NH4Cl, and extracted (3 x equal volume of CH2Cl2), dried 
over anhydrous MgSO4, and concentrated.  The crude product was purified over silica gel (1-5% 
MeOH/CH2Cl2) to yield 0.63 g (56%) of the title compound as a foamy, tan solid. []
19
D
 +36 (c 
0.94, CHCl3);   
1
H NMR (400 MHz, CDCl3): ):  8.27(d, J = 6.0 Hz, 1H), 7.60–7.58 (m, 1H), 
7.29–7.27 (m, 4H), 6.51 (dd, J = 6.0, 2.8 Hz, 1H), 5.78 (d, J = 8.0 Hz, 1H), 5.58–5.54 (m, 1H), 
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3.50–3.49 (m, 2H), 3.02 (s, 6H);13C NMR (100 MHz, CDCl3):  164.3, 154.7, 149.8, 147.0, 
141.9, 140.1, 128.6, 127.5, 125.9, 125.5, 108.1, 107.0, 83.87,  77.2, 39.9, 39.4, 29.9; IR max
neat 
cm
-1
: 3031, 2922, 1601, 1511, 1378, 994; HRMS (ES+) m/z calcd for C17H17N3ONa (M)+: 
302.1269; found: 302.1265 
 
 
(S)-2-(4-Chloropyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole: 
Characterization materials match the data provided in the following publication: 
Chelucci, G.; Deiru, S. P.; Saba, A.; Valenti, R. Tetrahedron: Asymm. 1999, 10, 
1457-1464. 
 
(R)-2-(4-Chloropyridin-2-yl)-4-phenyl-4,5-dihydrooxazole: Characterization 
materials match the data provided in the following publication: Chelucci, G.; 
Deiru, S. P.; Saba, A.; Valenti, R. Tetrahedron: Asymm. 1999, 10, 1457-1464. 
 
(S)-4-Benzyl-2-(4-chloropyridin-2-yl)-4,5-dihydrooxazole: Characterization 
materials match the data provided in the following publication: Chelucci, G.; 
Deiru, S. P.; Saba, A.; Valenti, R. Tetrahedron: Asymm. 1999, 10, 1457-1464. 
 
 (8R,8aS)-8,8a-Dihydro-2-(4-chloropyridin-2-yl)-3aH-indeno[1,2-
d]oxazole: 1.6 g of (1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol (7.2 mmol), 
1.0 g 4-Chloropicolinonitrile (7.2 mmol), 50 mg of ZnCl2 (0.36 mmol) and 15 
mL of chlorobenzene were added to a round bottom flask fitted with a reflux condenser under an 
inert atmosphere of N2.  The reaction was heated to 130 C for 24 h at which time the heat was 
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removed and the mixture was allowed to slowly cool to ambient temperature.  The 
chlorobenzene was removed in vacuo and the crude material purified over silica gel (0-3% 
MeOH/CH2Cl2) to yield a gray solid.  This solid was triturated with cold Et2O and filtered to 
provide 1.5 g (76%) of the title compound as a white solid. MP 158-161 C (dec). []19
D
 +140. (c 
1.03, CHCl3); 
1
H NMR (300 MHz, CDCl3):  8.56 (d, J = 5.4 Hz, 1H), 8.06 (d, J = 1.8 Hz, 1H), 
7.57 (dd, J = 5.4, 2.7 Hz, 1H), 7.36 (dd, J = 5.1, 1.8 Hz, 1H), 7.31-7.26 (m, 3H), 5.81 (d, J = 7.8 
Hz, 1H), 5.61-5.56 (m, 1H), 3.53 (dd, J = 18.0, 6.3 Hz, 1H), 3.44 (dd, J = 18.0, 2.1 Hz, 1H); 
13
C 
NMR (75 MHz, CDCl3):  162.1, 150.3, 148.0, 144.6, 141.1, 139.5, 128.6, 127.4, 125.6, 125.5, 
125.2, 124.3, 84.1, 39.5; IR max
neat 
cm
-1
: 3054, 1634, 1573, 1554, 1460, 1413, 1342, 1293, 1240, 
1084, 997, 843, 751, 711, 690; HRMS (EI) m/z calcd for C15H11ClN2O (M)
+
: 270.0555; found: 
270.0549.  
 
 
 
General Procedure for Dimethyl Amine Substituted Ligands (General Procedure C): 
Chloro-oxazoline ligand precursor was added to a medium pressure reaction vessel along with a 
40% dimethylamine solution in H2O.  The vessel was sealed and heated at 110 C for 36 h.  At 
this time the reaction vessel was removed from the oil bath and allowed to slowly cool to 
ambient temperature.  During this time a thick white precipitate formed.  The crude reaction 
mixture was filtered, the solid collected and dried under high vacuum.  Purification over silica 
gel as described in the text. 
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 (S)-4-(Dimethylamino)-N-(1-hydroxy-3-methylbutan-2-yl)picolinamide 
(65a): General procedure C was followed employing (S)-2-(4-Chloropyridin-
2-yl)-4-isopropyl-4,5-dihydrooxazole (0.40 g, 1.8 mmol) and dimethyl amine 
solution (8.0 mL).  The crude material was purified over silica gel (97:3 CH2Cl2/MeOH) to yield 
360 mg (85%) of the title compound as a white foam. []18
D
  -36.2 (c 1.22, CHCl3); 
1
H NMR (300 
MHz, CDCl3):  8.26 (d, J = 8.1 Hz, 1H), 8.11 (d, J = 6.0 Hz, 1H), 7.41 (d, J = 2.7, 1H), 6.51 
(dd, J = 6.0, 2.7 Hz, 1H), 3.91-3.72 (m, 2H), 3.03 (s, 6H), 2.03 (octet,J =  6.6Hz, 1H), 1.0 (app t, 
J = 6.6 Hz, 6H); 
13
C NMR (75 MHz, CDCl3):  166.2, 155.2, 149.8, 148.2, 107.9, 105.2, 64.3, 
57.8, 39.2, 29.1, 19.6, 18.7; IR max
neat 
cm
-1
: 3365, 2959, 2868, 1657, 1613, 1525, 1446, 1377, 
1225, 995; HRMS (EI) m/z calcd for C13H19N3O (M)
+
: 233.1528; found: 233.1526. 
 
 (R)-4-(Dimethylamino)-N-(2-hydroxy-1-phenylethyl)picolinamide 
(65b): General procedure C was followed employing (R)-2-(4-
Chloropyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (0.10 g, 0.39 mmol) and 
dimethyl amine solution (2.0 mL).  The crude material was purified over silica gel (97:3 
CH2Cl2/MeOH) to yield 35 mg (34%) of the title compound as a white waxy solid. []
18
D
  + 2.84 
(c 1.41, CHCl3); 
1
H NMR (300 MHz, CDCl3):  8.71 (d, J = 7.2 Hz, 1H), 8.08 (d, J = 6.0 Hz, 
1H), 7.43-7.35 (m, 5H), 7.30-7.25 (m, 1H), 6.51 (dd, J = 6.0, 2.7 Hz, 1H), 5.28-5.20 (m, 1H), 
4.03-3.93 (m, 2H), 3.02 (s, 6 H);
 13
C NMR (75 MHz, CDCl3):  165.8, 155.1, 149.6, 148.1, 
139.0, 128.7, 127.7, 126.8, 108.0, 105.3, 66.8, 56.4, 39.2; IR max
neat 
cm
-1
: 3371, 3060, 2928, 
1665, 1589, 1522, 1464, 1289, 1072, 998, 750; HRMS (EI) m/z calcd for C16H17N3O (M)
+
: 
267.1371; found: 267.1369. 
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 (S)-4-(Dimethylamino)-N-(1-hydroxy-3-phenylpropan-2-
yl)picolinamide (65c): General procedure C was followed employing 
(S)-4-Benzyl-2-(4-chloropyridin-2-yl)-4,5-dihydrooxazole (0.27 g, 0.99 
mmol) and dimethyl amine solution (4.5 mL).  The crude material was purified over silica gel 
(97:3 CH2Cl2/MeOH) to yield 150 mg (53%) of the title compound as a white foam. []
17
D
  - 67.6 
(c 1.05, CHCl3);  
1
H NMR (300 MHz, CDCl3):  8.37 (d, J = 8.1 Hz, 1H), 8.07 (d, J = 6.0 Hz, 
1H), 7.39 (d, J = 2.7 Hz, 1H), 7.29-7.27 (m, 1H), 7.25-7.16 (m, 1H), 6.47 (dd, J = 6.0, 2.7 Hz, 
1H), 4.40-4.29 (m, 1H), 3.78 (dd, J = 11.4, 3.9 Hz, 1H), 3.69 (dd, J = 11.1, 5.1 Hz, 1H), 3.00 (s, 
6H); 
13
C NMR (75 MHz, CDCl3):  165.5, 155.0, 149.7, 148.0, 137.9, 129.2, 128.4, 126.3, 
107.6, 105.1, 63.7, 53.2, 39.1, 37.1; IR max
neat 
cm
-1
: 3365, 3026, 2927, 1657, 1605, 1523, 1443, 
1377, 996; HRMS (ES+) m/z calcd for C17H22N3O2 (M +H )
+
: 300.1534; found: 300.1540. 
 
(1R,2S)-N-(2,3-Dihydro-2-hydroxy-1H-inden-1-yl)picolinamide (65d): 
General procedure C was followed employing (8R,8aS)-8,8a-Dihydro-2-
(4-chloropyridin-2-yl)-3aH-indeno[1,2-d]oxa-zole (prepared above) 4.5 
mL of a 40% dimethylamine solution in H2O.  The crude material was purified by column 
chromatography (SiO2, 0-3% MeOH/CH2Cl2 gradient) to afford 150 mg (76%) of the title 
compound as a colorless solid.  mp 214-216 C (dec); []19
D
 –52 (c 0.60, CHCl3); 
1
H NMR (300 
MHz, CDCl3):  8.63 (d, J = 8.4 Hz, 1H), 8.11 (d, J = 6.0 Hz, 1H), 7.50 (d, J = 2.7 Hz, 1H), 7.34 
(d, J = 6.6 Hz, 1H), 7.29-7.21 (m, 4H), 6.54 (dd, J = 5.7, 2.7 Hz, 1H), 5.56 (dd, J = 8.7, 5.1 Hz, 
1H), 4.76 (dt, J = 5.1, 2.7 Hz, 1H), 3.22 (dd, J = 16.5, 5.4 Hz, 1H), 3.07 (s, 6H), 3.07-2.99 (m, 
1H); 
13
C NMR (75 MHz, CDCl3):  166.1, 155.1, 149.7, 148.3, 140.5, 140.2, 128.1, 127.1, 
125.2, 124.7, 108.1, 105.3, 74.0, 57.8, 39.5, 39.2 (2C); IR max
neat 
cm
-1
: 2915, 1656, 1605, 1520, 
 88 
1377, 1225, 1057, 996, 911, 820, 733, 584; HRMS (EI) m/z calcd for C17H17N3O2 (M)
+
: 
297.1477; found: 297.1371. 
 
 
 
General Procedure D.  Catalytic Asymmetric Claisen Rearrangements of 39a-k: 
[CpRu(CH3CN)3]PF6 (5 mol %) and picolinamide 65d (5 mol %) were combined in a 2 dram 
vial inside a nitrogen-filled glovebox.  The THF (0.5 M final concentration of the allyl vinyl 
ether substrate) was added and the reaction mixture was periodically shaken over 30 min.  The 
resulting solution was added to another 2 dram vial containing the allyl vinyl ether (1 equiv), 4 Å 
MS (100 wt % relative to the allyl vinyl ether), B(OPh)3 (5 mol %) and a Teflon-coated stir bar.  
The vial was sealed with a threaded cap containing a rubber septum inlet.  Immediately after 
removal from the glovebox, CH3CN (20 mol %) was added to the reaction mixture via syringe.  
The mixture was then stirred at ambient temperature for the indicated time (24-48 h).  After this 
time, the vial was opened and the reaction mixture was concentrated under a stream of N2.  
Pentanes (4x the reaction volume) were added and the resulting heterogeneous mixture was 
filtered through a Florisil
®
 plug eluting with additional pentanes.  The filtrate was concentrated 
and the resulting mixture of the anti/syn [3,3] products (40a-k) and [1,3] regioisomer (50a-k) 
was analyzed by 
1
H NMR and chiral stationary phase GLC.   
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Enantiomer ratio determination: Enantiomer ratios of the [3,3] products (40a-k) were 
determined by chiral stationary phase GLC (Varian Chirasil-Dex CB WCOT Fused Silica CP 
7502 column, 25 m x 0.25 mm) using authentic samples of racemic syn and anti diastereomers of 
the Claisen products for comparison.  The racemic samples were prepared by thermal [3,3] 
rearrangement of the achiral allyl vinyl ethers that provided mixtures of the syn and anti Claisen 
diastereomers (+/–)-40a-k. The relative stereochemistry of the racemic samples was assigned by 
comparison to the know compounds (+/–)-anti-40a67,68 or (+/–)-syn-40a*.68  The relative 
stereochemistry of the remaining racemic samples was assigned by analogy to these 
determinations and the widely precedented preference for thermal [3,3] rearrangements to afford 
the syn Claisen adducts as the major diastereomers. 
 
Compound characterization: Effective separation of the anti & syn [3,3] (40a-k) and [1,3] 
(40a-k) products of the catalyzed Claisen rearrangements could not be achieved using routine 
chromatography.  Accordingly, full compound characterization was obtained for homogeneous 
samples of the primary alcohols obtained by hydride-mediated reduction of the mixture of 
aldehyde products (see General Procedure E). 
 
 
 
General Procedure E.  Reduction of Claisen Rearrangement-derived Aldehydes: The crude 
product mixtures obtained from General Procedure C were dissolved in CH2Cl2  (1 M) and 
cooled to 78 C under an atmosphere of N2.  A 1.0 M heptane solution of 
i
Bu2AlH (1.5 equiv) 
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was added dropwise over 15 min and the reaction mixture was stirred an additional 2 h at 78 
C.  The reaction was quenched by adding a saturated aqueous solution of sodium potassium 
tartrate (100% v/v relative to reaction volume) and the resulting biphasic mixture was warmed to 
ambient temperature.  The mixture was stirred until two homogeneous phases were obtained and 
the phases were separated.  The aqueous phase was extracted with diethyl ether (3x) and the 
combined organic portions were dried (Na2SO4) and concentrated.  The crude product mixture 
was purified by flash chromatography over silica gel (10% ethyl acetate in hexanes eluent). 
 
 (2R,3R)-2-Methyl-3-phenylpent-4-enal (40a): General Procedure D was 
followed employing 100 mg (0.57 mmol) {(E)-3-[(E)-prop-1-enyloxy]prop-1-
enyl}benzene (39a), 8.0 mg (0.028 mmol) ligand 65d, 12.4 mg (0.028 mmol) 
[CpRu(CH3CN)3]PF6, 8.3 mg (0.028 mmol) B(OPh)3, 100 mg 4 Å MS, 6.0 L (0.12 mmol) 
CH3CN and 1.1 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated to yield 
91 mg (91%) of the product mixture containing compounds 40a and 50a as the only detectable 
materials.  Separating the stereoisomers of 40a by GLC {flow rate 1.5 mL/min, method: 90 C 
for 10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 41.2 [(2S,3S)-40aanti], 41.4 
(40asyn1), 42.3 (40asyn2), 42.6 [(2R,3R)-40aanti] (ratio = 11.7:1:19.3:317)} provided the 
enantiomer ratio (2S,3S)-40aanti:(2R,3R)-40aanti = 3.6:96.4 (93% ee). 
 
 (2R,3R)-2-Methyl-3-phenylpent-4-en-1-ol (40a*): General Procedure E was 
followed employing 60 mg (0.34 mmol) of the aldehyde mixture obtained above 
and 0.52 mL of 1 M heptanes solution of 
i
Bu2AlH (0.52 mmol) in 0.4 mL CH2Cl2.  The crude 
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product mixture was purified by column chromatography (SiO2, 10% EtOAc/hexanes) to yield 
38 mg (63%) of 40a* as a colorless oil. []
19
D
 +100 (c 0.880, CHCl3); 
1
H NMR (300 MHz, 
CDCl3):  7.33-7.26 (m, 2H), 7.22-7.18 (m, 3H), 6.02 (ddd, J = 18.0, 15.6, 9.6 Hz, 1H), 5.11 (dd, 
J = 6.0, 1.8 Hz, 1H), 5.06 (s, 1H), 3.49-3.45 (m, 1H), 3.33-3.29 (m, 1H), 3.22 (t, J = 9.0 Hz, 1H), 
2.01 (septet, 6.9 Hz, 1H), 1.00 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  143.5, 139.7, 
128.6, 127.6, 126.2, 115.8, 66.2, 53.0, 40.2, 14.6; IR max
neat 
cm
-1
: 3342, 3027, 2962, 1637, 1452, 
1029, 913, 701; HRMS (EI) m/z calcd for C12H16O (M)
+
: 176.1201; found: 176.1196.   
 
(2R,3R)-2-Ethyl-3-phenylpent-4-enal (40b): General Procedure D was followed 
employing 100 mg (0.53 mmol) {(E)-3-[(E)-but-1-enyloxy]prop-1-enyl}benzene 
(39b), 7.4 mg (0.026 mmol) ligand 65d, 11.5 mg (0.026 mmol) [CpRu(CH3CN)3]PF6, 7.7 mg 
(0.026 mmol) B(OPh)3, 100 mg 4 Å MS, 5.6 L (0.11 mmol) CH3CN and 1.1 mL THF.  The 
reaction mixture was stirred for 48 h at which time it was concentrated under a stream of N2, 
filtered through a plug of Florisil
®
 and concentrated to yield 89 mg (89%) of the product mixture 
containing compounds 40b and 50b as the only detectable materials.  Separating the 
stereoisomers of 40b by GLC {flow rate 0.6 mL/min, method: 105 C for 10 min, ramp @ 0.7 
C/min to 160 C, hold for 5 min; Tr (min) = 42.3 (40bsyn1), 42.9 (40bsyn2), 43.7 [(2R,3R)-40banti] 
(ratio = 1:16.5:94.5)} provided an ee of >99% for (2R,3R)-40banti [(2S,3S)-40banti not detected]. 
 
(2R,3R)-2-Ethyl-3-phenylpent-4-en-1-ol (40b*): General Procedure E was 
followed employing 64 mg (0.34 mmol) of the aldehyde mixture obtained above 
and 0.51 mL of 1 M heptanes solution of 
i
Bu2AlH (0.51 mmol) in 0.40 mL CH2Cl2.  The crude 
product mixture was purified by column chromatography (SiO2, 10% EtOAc/hexanes) to yield 
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50 mg (77%) of the title compound as a colorless oil.  []
22
D
 +76.7 (c 1.03, CHCl3); 
1
H NMR (300 
MHz, CDCl3):  7.34-7.29 (m, 2H), 7.26-7.18 (m, 3H), 6.03 (dt, J = 19.2, 9.9 Hz, 1H), 5.16-5.04 
(m, 2H), 3.53 (dd, J = 11.1, 4.8 Hz, 1H), 3.41 (dd, J = 11.1, 4.5 Hz, 1H), 3.36 (t, J = 9.0 Hz, 1H), 
1.80 (octet, J = 3.9 Hz, 1H), 1.62 (d sextets, J = 7.8, 3.9 Hz, 1H); 1.47-1.32 (m, 1H), 0.94 (t, J = 
7.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  143.4, 140.3, 128.5, 127.7, 126.2, 115.6, 62.0, 51.7, 
46.4, 20.6, 11.3; IR max
neat 
cm
-1
: 3354, 3077, 2961, 1636, 1600, 1454, 1033, 913; HRMS (EI) 
m/z calcd for C13H18O (M)
+
: 190.1357; found: 190.1352.  
 
 (2R,3R)-2-Methyl-3-p-tolylpent-4-enal (40c): General Procedure D was 
followed employing 100 mg (0.53 mmol) 1-methyl-4-{(E)-3-[(E)-prop-1-
enyloxy]prop-1-enyl}benzene (39c), 7.4 mg (0.026 mmol) ligand 65d, 12 mg (0.026 mmol) 
[CpRu(CH3CN)3]PF6, 7.7 mg (0.026 mmol) B(OPh)3, 100 mg 4 Å MS, 5.5 L (0.11 mmol) 
CH3CN and 1.1 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil® and concentrated to yield 
90 mg (90%) of the product mixture containing compounds 40c and 50c as the only detectable 
materials.  Separating the stereoisomers by GLC {flow rate 1.5 mL/min, method: 90 C for 10 
min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 52.8 [(2S,3S)-40canti], 53.1 
(40csyn1), 54.3 (40csyn2), 54.6 [(2R,3R)-40canti] (ratio = 4.8:1:11.7:90.7)} provided the enantiomer 
ratio (2S,3S)-40canti:(2R,3R)-40canti = 5:95 (90% ee).  
(2R,3R)-2-Methyl-3-p-tolylpent-4-en-1-ol (40c*): General Procedure E was 
followed employing 203 mg (1.07 mmol) of the aldehyde mixture obtained 
above and 1.6 mL of 1 M heptanes solution of 
i
Bu2AlH (1.60 mmol) in 1.0 mL CH2Cl2.  The 
crude product mixture was purified by column chromatography (SiO2, 10% EtOAc/hexanes) to 
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yield 130 mg (63%) of the title compound as a colorless oil.  []
21
D
 +76.6 (c 1.07, CHCl3); 
1
H 
NMR (300 MHz, CDCl3):  7.14-7.08 (m, 4H), 6.00 (ddd, J = 18.0, 16.5, 9.3 Hz, 1H), 5.09 (d, J 
= 5.7 Hz, 1H), 5.04 (s, 1H), 3.48 (dd, J = 10.8, 4.8 Hz, 1H), 3.32 (dd, J = 10.8, 6.0 Hz, 1H), 3.17 
(t, J = 9.0 Hz, 1H), 3.12 (s, 3H), 1.99 (septet, 6.9 Hz, 1H), 1.00 (d, J = 6.6 Hz, 3H); 
13
C NMR 
(75 MHz, CDCl3):  140.3, 140.0, 135.8, 129.3, 127.5, 115.2, 66.3, 52.7, 40.1, 20.9, 14.7; IR 
max
neat 
cm
-1
: 3344, 3075, 2923, 1637, 1512, 1456, 1030, 912; HRMS (EI) m/z calcd for 
C13H18OK (M+K)
+
: 229.0095; found: 229.1005.   
 
 (2R,3R)-3-(4-Methoxyphenyl)-2-methylpent-4-enal (40d): General 
Procedure D was followed employing 100 mg (0.49 mmol) 1-methoxy-4-
{(E)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (39d), 6.8 mg (0.024 mmol) ligand 65d, 11 mg 
(0.024 mmol) [CpRu(CH3CN)3]PF6, 7.1 mg (0.024 mmol) B(OPh)3, 100 mg 4 Å MS, 5.1 L 
(0.098 mmol) CH3CN and 0.98 mL THF.  The reaction mixture was stirred for 24 h at which 
time it was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and 
concentrated to yield 86 mg (86%) of the product mixture containing compounds 40d and 50d as 
the only detectable materials.  Separating the stereoisomers of 40d by GLC {flow rate 0.4 
mL/min, method: 105 C for 10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 
80.0 (40dsyn1), 80.2 [(2S,3S)-40danti], 80.6 (40dsyn2), 81.1 [(2R,3R)-40danti] (ratio = 1:2.0:7.2:39)} 
provided the enantiomer ratio (2S,3S)-40danti:(2R,3R)-40danti = 4.9:95.1 
(90% ee). 
(2R,3R)-3-(4-Methoxyphenyl)-2-methylpent-4-en-1-ol (40d*): General 
Procedure E was followed employing 240 mg (1.17 mmol) of the aldehyde mixture obtained 
above and 1.76 mL of 1 M heptanes solution of 
i
Bu2AlH (1.76 mmol) in 1.1 mL CH2Cl2.  The 
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crude product mixture was purified by column chromatography (SiO2, 10% EtOAc/hexanes) to 
yield 168 mg (70%) of the title compound as a colorless oil.  []
23
D
 +90.3 (c 1.03, CHCl3); 
1
H 
NMR (300 MHz, CDCl3):  7.12 (dt, J = 9.6, 3.0 Hz, 2H), 6.85 (dt, J = 9.6, 3.0 Hz, 2H), 5.99 
(ddd, J = 18.9, 13.8, 9.3 Hz, 1H), 5.09-5.03 (m, 2H), 3.77 (s, 3H), 3.45 (dd, J = 10.5, 4.8 Hz, 
1H), 3.27 (dd, J = 10.8, 6.3 Hz, 1H), 3.18 (t, J = 8.7 Hz, 1H), 2.03-1.89 (m, 2H), 0.99 (d, J = 6.6 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  157.7, 139.9, 135.4, 128.4, 115.3, 113.8, 65.9, 55.0, 
51.9, 40.0, 14.5; IR max
neat 
cm
-1
: 3358, 2956, 2932, 1610, 1511, 1463, 1245, 1034, 913, 829; 
HRMS (EI) m/z calcd for C13H18O2 (M): 206.1307; found: 206.1298.  
 
(2R,3R)-3-(4-Bromophenyl)-2-methylpent-4-enal (40e): General Procedure 
D was followed employing 100 mg (0.39 mmol) 1-bromo-4-{(E)-3-[(E)-prop-
1-enyloxy]prop-1-enyl}benzene (39e), 5.5 mg (0.019 mmol) ligand 65d, 8.6 mg (0.019 mmol) 
[CpRu(CH3CN)3]PF6, 5.6 mg (0.019 mmol) B(OPh)3, 100 mg 4 Å MS, 4.1 L (0.079 mmol) 
CH3CN and 0.8 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil® and concentrated to yield 
92 mg (92%) of the product mixture containing compounds 40e and 50e as the only detectable 
materials.  Separating the stereoisomers by GLC {flow rate 0.6 mL/min, method: 105 C for 10 
min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 79.6 (40esyn1), 80.0 [(2S,3S)-
40eanti], 80.9 (40esyn2), 81.1 [(2R,3R)-40eanti] (ratio = 1:3.7:15.4:86.1)} provided the enantiomer 
ratio (2S,3S)-40eanti:(2R,3R)-40eanti = 4:96 (92% ee). 
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(2R,3R)-3-(4-Bromophenyl)-2-methylpent-4-en-1-ol (40e*): General 
Procedure E was followed employing 183 mg (0.72 mmol) of the aldehyde 
mixture obtained above and 1.09 mL of 1 M heptanes solution of 
i
Bu2AlH (1.09 mmol) in 0.7 
mL CH2Cl2.  The crude product mixture was purified by column chromatography (SiO2, 10% 
EtOAc/hexanes) to yield 111 mg (60%) of the title compound as a colorless oil. []
23
D
 +62.5 (c 
1.04, CHCl3); 
1
H NMR (300 MHz, CDCl3):  7.42 (dt, J = 9.0, 3.0 Hz, 2H), 7.08 (dt, J = 9.0, 3.0 
Hz, 2H), 6.01-5.90 (m, 1H), 5.11 (s, 1H), 5.07 (ddd, J = 7.5, 1.8, 1.0 Hz, 1H), 3.45 (dd, J = 10.8, 
5.1 Hz, 1H), 3.30 (dd, J = 10.8, 6.0 Hz, 1H), 3.23 (t, J = 8.7 Hz, 1H), 2.03-1.90 (m, 1H), 0.98 (d, 
J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  142.5, 138.9, 131.5, 129.4, 119.8, 116.3, 65.8, 
52.0, 40.0, 14.3; IR max
neat 
cm
-1
: 3340, 2962, 2926, 2877, 1637, 1487, 1402, 1073, 1030; HRMS 
(EI) m/z calcd for C12H15BrO (M)
+
: 254.0306; found: 254.0301.  
 
(2R,3R)-3-(2-Methoxyphenyl)-2-methylpent-4-enal (40f): General Procedure D 
was followed employing 100 mg (0.49 mmol) 1-methoxy-2-{(E)-3-[(E)-prop-1-
enyloxy]prop-1-enyl}benzene (39f), 6.8 mg (0.024 mmol) ligand 65d, 11 mg (0.024 mmol) 
[CpRu(CH3CN)3]PF6, 7.1 mg (0.024 mmol) B(OPh)3, 100 mg 4 Å MS, 5.1 L (0.098 mmol) 
CH3CN and 0.98 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated to yield 
89 mg (89%) of the product mixture containing compounds 40f and 50f as the only detectable 
materials.  Separating the stereoisomers of 40f by GLC {flow rate 0.6 mL/min, method: 105 C 
for 10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min, Tr (min) = 55.6 [(2R,3R)-40fanti], 56.8 
[(2S,3S)-40fanti+40fsyn1), 57.3 (40fsyn2) (ratio = 35.4:4.0:1)} provided the enantiomer ratio 
(2S,3S)-40fanti:(2R,3R)-40fanti) = 89:11 (78% ee).  The diastereomer ratio 40fanti:40fsyn = 11:1) 
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was determined by integrating the aldehyde proton resonances (–CHO; syn 9.71, anti  9.52) 
in the 
1
H NMR of the crude product mixture.  Using this data, the contribution of the syn 
diastereomer to the unresolved GLC peak at Tr = 56.8 min could be calculated allowing the 
contribution of (2S,3S)-40fanti to be similarly calculated.  This data was used in determining the 
enantiomer ratio [(2S,3S)-40fanti:(2R,3R)-40fanti)]. 
 
(2R,3R)-3-(2-Methoxyphenyl)-2-methylpent-4-en-1-ol (40f*): General 
Procedure E was followed employing 60 mg (0.29 mmol) of the aldehyde 
mixture obtained above and 0.44 mL of 1 M heptanes solution of 
i
Bu2AlH (0.44 mmol) in 0.3 
mL CH2Cl2.  The crude product mixture was purified by column chromatography (SiO2, 10% 
EtOAc/hexanes) to yield 43 mg (71%) of the title compound as a colorless oil.  []
21
D
 +30.4 (c 
1.25, CHCl3); 
1
H NMR (300 MHz, CDCl3):  7.21-7.14 (m, 2H), 6.97-6.86 (m, 2H), 6.09 (ddd, J 
= 17.1, 9.9, 9.3 Hz, 1H), 5.13-5.04 (m, 2H), 3.85 (s, 3H), 3.66 (t, 9.3 Hz, 1H), 3.38 (d, J = 10.8 
Hz, 1H), 3.28 (dd, J = 11.1, 4.5 Hz, 1H), 2.00-1.88 (m, 1H), 1.06 (d, J = 6.9 Hz, 3H); 
13
C NMR 
(75 MHz, CDCl3):  156.3, 139.7, 131.9, 128.2, 127.1, 121.0, 115.7, 110.8, 66.1, 55.5, 45.0, 
39.8, 15.2; IR max
neat 
cm
-1
: 3364, 3073, 2960, 2933, 2876, 1636, 1597, 1491, 1462, 1241, 1029, 
753; HRMS (EI) m/z calcd for C13H18O2 (M)
+
: 206.1306; found: 206.1297.  
 
(2R,3R)-3-(3-Methoxyphenyl)-2-methylpent-4-enal (40g): General Procedure 
D was followed employing 100 mg (0.49 mmol) 1-methoxy-3-{(E)-3-[(E)-prop-
1-enyloxy]prop-1-enyl}benzene (39g), 6.8 mg (0.024 mmol) ligand 65d, 11 mg 
(0.024 mmol) [CpRu(CH3CN)3]PF6, 7.0 mg (0.024 mmol) B(OPh)3, 100 mg 4 Å MS, 5.1 L 
(0.097 mmol) CH3CN and 0.97 mL THF.  The reaction mixture was stirred for 24 h at which 
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time it was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and 
concentrated to yield 93 mg (93%) of the product mixture containing compounds 40g and 50g as 
the only detectable materials.  Separating the stereoisomers of 40g by GLC {flow rate 0.6 
mL/min, method: 105 C for 10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 
63.8 (40gsyn1), 64.1 [(2S,3S)-40ganti], 64.3 (40gsyn2), 64.8 [(2R,3R)-40ganti] (ratio = 
1:6.1:15.6:175)} provided the enantiomer ratio (2S,3S)-40ganti:(2R,3R)-40ganti = 3.4:96.6 (93% 
ee). 
 
(2R,3R)-3-(3-Methoxyphenyl)-2-methylpent-4-en-1-ol (40g*): General 
Procedure E was followed employing 150 mg (0.73 mmol) of the aldehyde 
mixture obtained above and 1.10 mL of 1 M heptanes solution of 
i
Bu2AlH (1.10 
mmol) in 0.8 mL CH2Cl2.  The crude product mixture was purified by column chromatography 
(SiO2, 10% EtOAc/hexanes) to yield 100 mg (66%) of the title compound as a colorless oil.  
[]
22
D
 +68.5 (c 1.08, CHCl3); 
1
H NMR (300 MHz, CDCl3):  7.25-7.19 (m, 1H), 6.81-6.73 (m, 
3H), 5.99 (ddd, J = 16.2, 10.8, 9.3 Hz, 1H), 5.10 (ddd, J = 7.5, 1.8, 0.6 Hz, 1H), 5.06 (s, 1H), 
3.79 (s, 3H), 3.47 (dd, J = 10.8, 5.1 Hz, 1H), 3.32 (dd, J = 10.8, 6.0 Hz, 1H), 3.18 (t, J = 9.0 Hz, 
1H), 2.07-1.94 (m, 1H), 1.00 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  159.7, 145.1, 
139.5, 129.5, 120.0, 115.8, 113.6, 111.2, 66.2, 55.0, 53.0, 40.1, 14.6; IR max
neat 
cm
-1
: 3361, 
3075, 2960, 1600, 1488, 1316, 1157, 1041, 916; HRMS (EI) m/z calcd for C13H18O2Na (M+Na)
+
: 
229.1204; found: 229.1208. 
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(2R,3R)-3-(3-Chlorophenyl)-2-methylpent-4-enal (40h): General Procedure D 
was followed employing 100 mg (0.48 mmol) 1-chloro-3-{(E)-3-[(E)-prop-1-
enyloxy]prop-1-enyl}benzene (39h), 6.7 mg (0.024 mmol) ligand 65d, 11 mg 
(0.024 mmol) [CpRu(CH3CN)3]PF6, 6.9 mg (0.024 mmol) B(OPh)3, 100 mg 4 Å MS, 5.0 L 
(0.098 mmol) CH3CN and 0.96 mL THF.  The reaction mixture was stirred for 24 h at which 
time it was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and 
concentrated to yield 78 mg (78%) of the product mixture containing compounds 40h and 50h as 
the only detectable materials.  Separating the stereoisomers of 40h by GLC {flow rate 0.6 
mL/min, method: 105 C for 10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 
59.1 (40hsyn1), 59.8 [(2S,3S)-40hanti], 59.8 (40hsyn2), 60.6 [(2R,3R)-40hanti] (ratio = 
1:2.6:19.7:146)} provided the enantiomer ratio (2S,3S)-40hanti:(2R,3R)-40hanti = 1.8:98.2 (96% 
ee). 
 
(2R,3R)-3-(3-Chlorophenyl)-2-methylpent-4-en-1-ol (40h*): General 
Procedure E was followed employing 60 mg (0.28 mmol) of the aldehyde 
mixture obtained above and 0.43 mL of 1 M heptanes solution of 
i
Bu2AlH (0.43 
mmol) in 0.3 mL CH2Cl2.  The crude product mixture was purified by column chromatography 
(SiO2, 10% EtOAc/hexanes) to yield 42 mg (69%) of the title compound as a colorless oil.  []
23
D
 
+68.8 (c 1.60, CHCl3); 
1
H NMR (300 MHz, CDCl3):  7.28-7.17 (m, 3H), 7.10 (dt, J = 7.2, 1.8 
Hz, 1H), 5.98 (ddd, J = 16.2, 10.5, 9.3 Hz, 1H), 5.14 (s, 1H), 5.09 (dd, J = 7.8, 1.8 Hz, 1H), 3.48 
(dd, J = 10.8, 4.8 Hz, 1H), 3.33 (dd, J = 10.8, 6.0 Hz, 1H), 3.26 (t, J = 9.0 Hz, 1H), 2.07-1.94 (m, 
1H), 1.00 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  145.6, 138.8, 134.2, 129.7, 127.8, 
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126.3, 125.9, 116.5, 65.9, 52.3, 40.6, 14.3; IR max
neat 
cm
-1
: 3331, 2963, 1594, 1475, 1030, 918; 
HRMS (EI) m/z calcd for C12H15ClO (M)
+
: 210.0811; found: 210.0803. 
 
(2R,3R)-3-(Furan-2-yl)-2-methylpent-4-enal (40i): General Procedure D was 
followed employing 100 mg (0.61 mmol) 2-{(E)-3-[(E)-prop-1-enyloxy]prop-1-
enyl}furan (39i), 8.5 mg (0.031 mmol) ligand 65d, 13 mg (0.031 mmol) [CpRu(CH3CN)3]PF6, 
8.8 mg (0.031 mmol) B(OPh)3, 100 mg 4 Å MS, 6.4 L (0.121 mmol) CH3CN and 1.2 mL THF.  
The reaction mixture was stirred for 48 h at which time it was concentrated under a stream of N2, 
filtered through a plug of Florisil
®
 and concentrated to yield 68 mg (68%) of the product mixture 
containing compounds 40i and 50i as the only detectable materials.  The stereoisomers of 40i 
could not be adequately resolved by GLC so the product mixture was reduced (General 
Procedure D) and the resulting mixture of alcohols used for determining the stereoisomer ratio.   
 
(2R,3R)-3-(Furan-2-yl)-2-methylpent-4-en-1-ol (40i*): General Procedure E 
was followed employing 95 mg (0.58 mmol) of the aldehyde mixture obtained 
above and 0.87 mL of 1 M heptanes solution of 
i
Bu2AlH (0.87 mmol) in 0.6 mL CH2Cl2.  The 
crude product mixture was purified by column chromatography (SiO2, 10% EtOAc/hexanes) to 
yield 62 mg (65%) of the title compound as a colorless oil.  Analyzing the crude product mixture 
by GLC (flow rate 3.5 mL/min, method: 80 C for 10 min, ramp @ 0.5 C/min to 130 C, hold 
for 5 min, Tr (min) = 56.3 [(2S,3S)-40i*], 56.6 (40i*syn1), 57.4 (40i*syn2), 58.2 [(2S,3S)-40i*] 
(ratio = 1:4.7:1:53.8)} provided the diastereomer ratio 40i*anti:40i*syn = 10:1 and the enantiomer 
ratio (2S,3S)-40i*:(2R,3R)-40i* = 1.8:98.2 (96% ee).  []
22
D
 +92.6 (c 1.08, CHCl3); 
1
H NMR (300 
MHz, CDCl3):  7.33 (d, J = 1.2 Hz, 1H), 6.29 (dd, J = 3.0, 1.8 Hz, 1H), 6.04 (d, J = 3.0 Hz, 
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1H), 5.93 (ddd, J = 16.8, 10.2, 9.3 Hz, 1H), 5.17-5.10 (m, 2H) 3.54-3.38 (m, 3H), 2.12 (septet, J 
= 6.6 Hz, 1H), 0.91 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  156.3, 141.0, 136.0, 
117.2, 110.0, 105.4, 65.9, 45.6, 38.8, 13.7; IR max
neat 
cm
-1
: 3342, 3078, 2930, 1639, 1504, 1420, 
1222, 1148, 1032, 922; HRMS (EI) m/z calcd for C12H16O (M+K)
+
: 205.0631; found: 205.0646. 
 
(2R,3R)-2-Methyl-3-(naphthalen-1-yl)pent-4-enal (40j): General Procedure D 
was followed employing 100 mg (0.46 mmol) 1-{(E)-3-[(E)-prop-1-enyloxy]prop-
1-enyl}naphthalene (39j), 6.5 mg (0.023 mmol) ligand 65d, 9.9 mg (0.023 mmol) 
[CpRu(CH3CN)3]PF6, 6.7 mg (0.023 mmol) B(OPh)3, 100 mg 4 Å MS, 4.8 L (0.092 mmol) 
CH3CN and 0.93 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated to yield 
90 mg (90%) of the product mixture containing compounds 40j and 50j as the only detectable 
materials.  Separating the stereoisomers of 40j by GLC {flow rate 1.0 mL/min, method: 105 C 
for 10 min, ramp @ 0.7 C/min to 200 C, hold for 5 min; Tr (min) = 88.2 (40jsyn1), 86.6 
(40jsyn2), 89.5 [(2R,3R)-40janti], 90.0 [(2S,3S)-40janti] (ratio = 11.3:1.4:73:1)} provided the 
enantiomer ratio (2R,3R)-40janti:(2S,3S)-40janti = 98.6:1.4 (97% ee). 
 
(2R,3R)-2-Methyl-3-(naphthalen-1-yl)pent-4-en-1-ol (40j*): General 
Procedure E was followed employing 65 mg (0.29 mmol) of the aldehyde 
mixture obtained above and 0.45 mL of 1 M heptanes solution of 
i
Bu2AlH (0.45 
mmol) in 0.4 mL CH2Cl2.  The crude product mixture was purified by column chromatography 
(SiO2, 10% EtOAc/hexanes) to yield 37 mg (56%) of the title compound as a colorless oil.  []
23
D
 
–14.5 (c 1.45, CHCl3); 
1
H NMR (300 MHz, CDCl3):  8.24 (d, J = 8.4 Hz, 1H), 7.88 (d, J = 9.0 
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Hz, 1H), 7.74 (d, J = 7.8 Hz, 1H), 7.57-7.41 (m, 4H), 6.23 (dt, J = 19.5, 9.9 Hz, 1H), 5.32-5.13 
(m 2H), 4.24 (t, J = 8.4 Hz, 1H), 3.51 (dd, J = 10.8, 5.7 Hz, 1H), 3.38 (dd, J = 10.5, 5.7 Hz, 1H), 
2.25 (septet, J = 6.6 Hz, 1H), 1.04 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  139.7, 
138.7, 134.1, 131.3, 128.9, 126.7, 125.9, 125.4, 125.3, 124.5, 123.2, 116.5, 66.2, 46.4, 39.9, 
14.1; IR max
neat 
cm
-1
: 3346, 3048, 2926, 1635, 1596, 1460, 1029, 779; HRMS (EI) m/z calcd for 
C16H18O (M)
+
: 226.1357; found: 226.1368. 
 
 (2R,3R)-2-Methyl-3-(naphthalen-2-yl)pent-4-enal (40k): General 
Procedure D was followed employing 100 mg (0.46 mmol) 2-{(E)-3-[(E)-
Prop-1-enyloxy]prop-1-enyl}naphthalene (39k), 6.5 mg (0.023 mmol) ligand 65d, 9.9 mg (0.023 
mmol) [CpRu(CH3CN)3]PF6, 6.7 mg (0.023 mmol) B(OPh)3, 100 mg 4 Å MS, 4.8 L (0.092 
mmol) CH3CN and 0.93 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated to yield 
94 mg (94%) of the product mixture.  Separating the stereoisomers of 40k by GLC {flow rate 2.5 
mL/min, method: 105 C for 10 min, ramp @ 0.7 C/min to 200 C, hold for 5 min; Tr (min) = 
80.1 (40ksyn1), 80.7 (40ksyn2 + (2S,3S)-40kanti), 81.5 [(2R,3R)-40kanti], (ratio = 
76.4:10.9:1)}provided the enantiomer ratio (2R,3R)-40kanti:(2S,3S)-40kanti = 92:8 (84% ee). The 
diastereomer ratio 40kanti:40ksyn = 16:1 was determined by integrating the aldehyde proton 
resonances (–CHO; syn 9.74, anti  9.58) in the 1H NMR of the crude product mixture.  Using 
this data, the contribution of the syn diastereomer to the unresolved GLC peak at Tr = 80.7 min 
could be calculated allowing the contribution of (2S,3S)-40kanti to be similarly calculated.  This 
data was used in determining the enantiomer ratio [(2S,3S)-40kanti:(2R,3R)-40kanti)]. 
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 (2R,3R)-2-Methyl-3-(naphthalen-2-yl)pent-4-en-1-ol (40k*): General 
Procedure E was followed employing 92 mg (0.41 mmol) of the aldehyde 
mixture and 0.63 mL 
i
Bu2AlH (0.63 mmol) in 0.5 mL CH2Cl2.  The reaction was purified by 
column chromatography (SiO2, 10% EtOAc/hexanes) to yield 44 mg (48%) of the title 
compound as a colorless oil.  []
21
D
 +89.8 (c 1.27, CHCl3); 
1
H NMR (300 MHz, CDCl3):  7.83-
7.79 (m, 3H), 7.65 (s, 1H), 7.51-7.42 (m, 2H), 7.38 (dd, J = 8.7, 1.8 Hz, 1H), 6.13 (ddd, J = 19.5, 
10.2, 9.3 Hz, 1H), 5.17 (d, J = 6.9 Hz, 1H), 5.13 (app s, 1H), 3.50 (dd, J = 10.8, 4.8 Hz, 1H), 
3.42 (app t, J  = 8.7 Hz, 1H), 3.35 (dd, J = 10.5, 6.0 Hz, 1H), 2.10-2.08 (m, 1H), 1.06 (d, J = 6.6 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  140.9, 139.5, 133.5, 132.1, 128.1, 127.5, 126.0, 126.0, 
125.9, 125.3, 116.1, 66.19, 52.9, 39.9, 14.6; IR max
neat 
cm
-1
: 3347, 3055, 2962, 1633, 1599, 
1507, 1458, 1372, 1029; HRMS (EI) m/z calcd for C16H18O (M)
+
: 249.1255; found: 249.1275. 
 
(E)-5-Cyclohexyl-2-methylpent-4-enal (72): General Procedure D was 
followed using B(O
p
C6H4F)3 in place of B(OPh)3 and using the following 
quantities of reagents: 50 mg (0.27 mmol) {(E)-3-[(E)-Prop-1-enyloxy]prop-1-enyl}cyclohexane 
(70), 8.2 mg (0.027 mmol) ligand 65d, 12.0 mg (0.027 mmol) [CpRu(CH3CN)3]PF6, 9.5 mg 
(0.027 mmol) B(O
p
C6H4F)3, 50 mg 4 Å MS, 3.0 L (0.055 mmol) CH3CN and 0.60 mL THF.  
The reaction mixture was stirred for 24 h at which time it was concentrated under a stream of N2, 
filtered through a plug of Florisil
®
 and concentrated to yield 34 mg (70%) of the product mixture 
containing compound 72 as the only detectable material.    
 
(E)-5-Cyclohexyl-2-methylpent-4-en-1-ol (72*): General Procedure E was 
followed employing 20 mg (0.11 mmol) of the aldehyde mixture obtained 
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above and 0.17 mL of 1 M heptanes solution of 
i
Bu2AlH (0.17 mmol) in 0.4 mL CH2Cl2.  The 
crude product mixture was purified by column chromatography (SiO2, 15% EtOAc/hexanes) to 
yield the title compound as a colorless oil.  []
30
D
 –2.04 (c 1.16, CHCl3); 
1
H NMR (300 MHz, 
CDCl3):  5.37 (m, 2H), 3.47 (dddd, J = 10.5, 6.3 Hz, 2H), 2.06 (m, 1H), 1.89 (m, 2H), 1.67 (m, 
6H), 1.41 (bs, 1H), 1.26 (m, 3H), 1.07 (m, 2H), 0.89 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3):  138.4, 125.4, 68.1, 40.7, 36.7, 36.0, 33.2, 26.2, 26.1, 16.5; IR max
neat 
cm
-1
: 3337, 
2973, 2851, 1448, 1083 ; HRMS (EI) m/z calcd for C12H22O (M)
+
: 182.1671; found: 182.1664.  
The enantiomer ratio was determined by converting 72* to the corresponding (S)-O-
methylmandelate ester and integrating the resonances corresponding to the C2 methyl substituent 
(26% ee).
 69 
 
 
 
Catalyzed rearrangement of {(E)-3-[(Z)-prop-1-enyloxy]prop-1-enyl}benzene (67): General 
Procedure D was followed employing 100 mg (0.57 mmol) {(E)-3-[(Z)-prop-1-enyloxy]prop-1-
enyl}benzene (67), 8.0 mg (0.028 mmol) ligand 65d, 12.4 mg (0.028 mmol) 
[CpRu(CH3CN)3]PF6, 8.3 mg (0.028 mmol) B(OPh)3, 100 mg 4 Å MS, 6.0 L (0.115 mmol) 
CH3CN and 1.1 mL THF.  The reaction mixture was stirred for 24 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated to yield 
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90 mg (90%) of the product mixture containing compounds 40aanti, 40asyn and 50a as the only 
detectable materials; 40a:50a = 1:1 as determined by 
1
H NMR analysis of the crude product 
mixture.  Separating the stereoisomers of 40a by GLC {flow rate 1.5 mL/min, method: 90 C for 
10 min, ramp @ 0.7 C/min to 160 C, hold for 5 min; Tr (min) = 41.2 [(2S,3S)-40aanti], 41.4 
[(2R,3S)-40asyn], 42.3 [(2S,3R)-40asyn], 42.6 [(2R,3R)-40aanti] (ratio = 1:1:27.6:7.1)} provided the 
enantiomer ratio (2R,3S)-40asyn:(2S,3R)-40asyn = 3.5:96.5 (93% ee), (2S,3S)-40aanti:(2R,3R)-
40aanti = 12.5:87.5 (75% ee) and a diastereomer ratio syn:anti = 3.5:1. 
 
 
 
Catalyzed rearrangement of {(Z)-3-[(E)-prop-1-enyloxy]prop-1-enyl}benzene (68): General 
Procedure D was followed employing 100 mg (0.57 mmol) {(Z)-3-[(E)-prop-1-enyloxy]prop-1-
enyl}benzene (68), 8.0 mg (0.028 mmol) ligand 65d, 12.4 mg (0.028 mmol) 
[CpRu(CH3CN)3]PF6, 8.3 mg (0.028 mmol) B(OPh)3, 100 mg 4 Å MS, 6.0 L (0.115 mmol) 
CH3CN and 1.1 mL THF.  The reaction mixture was stirred for 48 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated; 40a:69 = 
4:1 as determined by 
1
H NMR analysis of the crude product mixture.  The crude product mixture 
was purified by column chromatography (SiO2, 3% EtOAc/hexanes) to yield 44 mg (44%) of the 
product mixture containing compounds 40a and 69.  Separating the stereoisomers of 40a by 
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GLC {flow rate 1.5 mL/min, method: 90 C for 10 min, ramp @ 0.7 C/min to 160 C, hold for 
5 min; Tr (min) = 41.2 [(2S,3S)-40aanti], 41.4 [(2R,3S)-40asyn], 42.3 [(2S,3R)-40asyn], 42.6 
[(2R,3R)-40aanti] (ratio = 7.1:26.3:1:2)} provided the enantiomer ratio (2R,3S)-40asyn:(2S,3R)-
40asyn = 96.5:3.5 (93% ee), (2S,3S)-40aanti:(2R,3R)-40aanti = 78:22 (56% ee) and a diastereomer 
ratio syn:anti = 3:1. 
 
Stereochemical Proofs for Claisen Products.  The absolute and relative stereochemistry of 
compounds (2R,3R)-40danti and (2R,3R)-40eanti was unambiguously determined by converting 
these compounds to the corresponding (R)--methylbenzylamides S40d and S40e (General 
Procedure E), respectively, and X-ray diffraction analysis.  The absolute stereochemistry of 
compounds 40a-k was assigned by analogy to these determinations. 
 
 
 
General Procedure F.  Oxidation and amidation of aldehydes 40danti and 40eanti: To a 
magnetically-stirred solution of aldehyde 40danti or 40eanti (1.0 equiv) and 2-methyl-2-butene (15 
equiv) in t-BuOH (0.3 M in 40d,e) was added a solution of NaClO2 (3 equiv) and NaH2PO4 (2.6 
equiv) in H2O (1 M in NaClO2) dropwise via syringe at ambient temperature.  The reaction was 
stirred for 3 h whereupon a saturated aqueous solution of NH4Cl (100% v/v to reaction volume) 
was added and the resulting mixture was extracted with Et2O (3x).  The combined organic 
 106 
extracts were combined, dried (MgSO4) and concentrated to provide the corresponding 
carboxylic acid that was used without purification in the next reaction.   
To a solution of 2-(7-aza-1H-benzotriazide-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU; 2 equiv) and iPr2NEt (2 equiv) in DMF (0.1 M) was added the 
carboxylic acid prepared above as a solution in a small volume of DMF.  The reaction was 
stirred for 1 h at ambient temperature before (R)--methylbenzylamine (1 equiv) was added.  
The reaction was stirred for 24 h whereupon 1 M HCl (100% v/v to reaction volume) and the 
resulting mixture was extracted with Et2O (3x).  The combined organic extracts were dried 
(MgSO4) and concentrated.  The crude product mixture was purified by column chromatography 
(SiO2, 20% EtOAc in hexanes) to yield the amides S40d and S40e as white solids; 
recrystallization provided X-ray-quality crystals (See appendix A and B).  
 
(2R,3R)-3-(4-Methoxyphenyl)-2-methyl-N-{(R)-1-phenyl-ethyl}pent-
4-enamide (S40d): General Procedure F was followed employing 168 
mg (0.823 mmol) (2R,3R)-40d, 1.26 mL (11.9 mmol) 2-methyl-2-butene, 
2.5 mL tBuOH, 223 mg (2.46 mmol) NaClO2, 256 mg (2.14 mmol) NaH2PO4 and 2.5 mL of 
H2O to yield 175 mg (97%) of the crude acid as a colorless oil.  The crude acid (80 mg, 0.363) 
was combined with 226 mg (0.726 mmol) HATU, 100 L (0.726 mmol) iPr2NEt and 46 L 
(0.363 mmol) (R)--methylbenzylamine in 3.63 mL of DMF.  Purifying the crude product 
mixture yielded 100 mg (85% over 2 steps) of the title compound as a colorless solid.  
Recrystallizing S40d from petroleum ether/EtOAc yielded crystals suitable for X-ray diffraction 
analysis (See Appendix A).  mp 123.5-127 C; 1H NMR (300 MHz, CDCl3):  7.16-7.13 (m, 
3H), 7.07 (d, J = 9.0 Hz, 2H), 6.75 (d, J = 9.0 Hz, 2H), 6.70 (d, J = 2.0 Hz, 1H), 6.68 (d, J = 4.0 
 107 
Hz, 1H) 5.89 (dt, J = 15.0, 12.0 Hz, 2H), 5.29 (d, J = 6.0 Hz, 1H), 5.12-5.05 (m, 2H), 4.90 
(quintet, J = 6.0 Hz, 1H), 3.77 (s, 3H), 3.41 (t, J = 9.0 Hz, 1H) 2.40 (dq, J = 12.0, 6.0 Hz, 1H), 
1.34 (d, J = 6.0 Hz, 3H), 1.24 (d, J = 6.0 Hz, 3H) ; 
13
C NMR (75 MHz, CDCl3):  173.8, 158.1, 
142.5, 139.3, 134.9, 128.5, 128.2, 126.8, 125.9, 116.2, 114.0, 55.1, 53.2, 47.7, 47.5, 21.2, 16.6; 
IR max
neat 
cm
-1
: 3300, 3066, 2976, 2929, 1639, 1542, 1452, 1249, 1035, 923, 829, 699; HRMS 
(EI) m/z calcd for C21H25NO2 (M)+: 323.1882; found: 323.1885.  
 
(2R,3R)-3-(4-Bromophenyl)-2-methyl-N-{(R)-1-phenylethyl} pent-4-
enamide (S40e): General Procedure F was followed employing 238 mg 
(0.944 mmol) (2R,3R)-40e, 1.45 mL (13.7 mmol) 2-methyl-2-butene, 3.3 
mL tBuOH, 256 mg (2.83 mmol) NaClO2, 295 mg (2.45 mmol) NaH2PO4 and 3.3 mL of H2O to 
yield 254 mg (100%) of the crude acid as a colorless oil.  The crude acid (100 mg, 0.373) was 
combined with 283 mg (0.746 mmol) HATU, 105 L (0.746 mmol) iPr2NEt and 47 L (0.373 
mmol) (R)--methylbenzylamine in 3.73 mL of DMF.  Purifying the crude product mixture 
yielded 104 mg (75% over 2 steps) of the title compound as a colorless solid.  Recrystallizing 
S40e from petroleum ether/EtOAc yielded crystals suitable for X-ray diffraction analysis (See 
Appendix B).  mp 160-161.5 C; 1H NMR (300 MHz, CDCl3):  7.32 (d, J = 8.4 Hz, 2H), 7.27-
7.22 (m, 3H), 7.02 (d, J = 8.1 Hz, 2H), 6.71 (dd, J = 7.8, 2.4 Hz, 2H), 5.87 (dt, J = 18.9, 9.6 Hz, 
1H), 5.30 (d, J = 7.8 Hz, 1H), 5.14 (d, J = 4.2 Hz, 1H), 5.09 (s, 1H), 4.89 (quintet, J = 7.2 Hz, 
1H), 3.44 (t, J = 9.9 Hz, 1H), 2.37 (dq, J= 10.8, 6.6 Hz, 1H), 1.36 (d, J = 6.9 Hz, 3H), 1.26 (d, J 
= 6.6 Hz, 3H); 
13
C NMR (75 MHz, CDCl3):  173.4, 142.3, 141.8, 138.3, 131.6, 129.4, 128.4, 
127.0, 125.7, 120.3, 117.1, 53.3, 47.9, 47.4, 21.1, 16.7; IR max
neat 
cm
-1
: 3300, 3066, 2976, 1639, 
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1542, 1512, 1452, 1249, 1035, 923, 829, 699; HRMS (EI) m/z calcd for C20H22BrNONa 
(M+Na)+: 394.0799; found: 394.0807. 
4.2 RUTHENIUM CATALYZED ENOLATE ALLYLIC ALKYLATIONS 
General Information: Unless otherwise indicated, all reactions were performed in dry 
glassware under an atmosphere of oxygen-free nitrogen using standard inert atmosphere 
techniques for the manipulation of both solvents and reagents.  Anhydrous solvents were 
obtained by passage through successive alumina- and Q5-packed columns on a solvent 
purification system.  [CpRu(CH3CN)3]PF6 was synthesized according to the published 
procedure
70
 and was stored and weighed out in a nitrogen-filled glove box.  NMR spectra were 
recorded at the indicated magnetic field strengths with chemical shifts reported relative to 
residual CHCl3 (7.26 ppm) for 
1
H and CDCl3 (77.0 ppm) for 
13
C spectra.  Analytical thin layer 
chromatography (TLC) was performed on 0.25 mm silica gel 60-F plates.  Flash chromatography 
was performed over silica gel (230-240 mesh).  Analytical gas chromatography (GC) was 
performed using a flame ionization detector and split mode capillary injection system using 
Varian Chirasil-Dex CB WCOT fused silica 25 m x 0.25 mm column (CP 7502). Analytical 
high-performance liquid chromatography (HPLC) was performed using a variable wavelength 
UV detector (deuterium lamp, 190-600 nm) using a Chiracel OD-H column and HPLC-grade 
isopropanol and hexanes as the eluting solvents. Melting points were obtained on a Laboratory 
Devices Mel-Temp apparatus and are uncorrected. 
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General Procedure A.  Synthesis of pyrrole silyl enol ethers 81a-f: To a 0 
o
C solution of 
diisopropylamine (1.0 equiv) in THF (1.6M relative to diisopropylamine) was added a solution 
of 1.6M n-BuLi in hexanes (1.1 equiv). The reaction was allowed to stir at 0 
o
C for 10 min and 
then cooled to -78 
o
C. Next, a 0.8M solution of acylpyrrole (1.0 equiv) in THF was added 
dropwise to the reaction vessel over 5 min and the resulting solution was allowed to stir at -78 
o
C 
for 30 min.  TMSCl (1.1 equiv) was added dropwise over 5 min, and the reaction was allowed to 
stir an additional 20 min at -78 
o
C. The dry ice/acetone bath was removed and the reaction was 
allowed to stir for an additional 1 h. Next, the reaction was diluted with pentane (4x the reaction 
volume), and the heterogeneous mixture was filtered through a plug of celite and concentrated. 
The final product was purified via kugelrohr distillation. 
 
(Z)-1-{1-[(Trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole (81a): 
Characterization materials match the data provided in the following publication: 
Evans, D. A.; Johnson, D. S.; Org. Lett. 1999, 1, 595-598.   
 
 1-{1-[(trimethylsilyl)oxy]vinyl}-1H-pyrrole (81b): Characterization 
materials match the data provided in the following publication:  Frick, U.; Simchen, 
G. Liebigs Ann. 1987, 10, 839-845. 
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(Z)-1-{3-Methyl-1-[(trimethylsilyl)oxy]but-1-en-1-yl}-1H-pyrrole (81c): 
Characterization materials match the data provided in the following publication 
: Evans, D. A.; Johnson, D. S.; Org. Lett. 1999, 1, 595-598.   
 
(Z)-1-{1-[(Trimethylsilyl)oxy]pent-1-en-1-yl}-1H-pyrrole (81d): General 
procedure A was followed employing 1.87 mL of diisopropylamine (13.2 
mmol), 9.07 mL of 1.6 M n-BuLi  (14.5 mmol), 2.0 g 1-(1H-pyrrol-1-yl)- 1-Pentanone (13.2 
mmol), 1.84 mL TMSCl (1.1 mmol) in 30 mL THF. The reaction was purified via kugelrohr 
distillation at 1 mm Hg. The product distilled between 70 and 80 
o
C (2.14 g, 73%) as a clear 
colorless oil.  
1
H NMR (500 MHz, CDCl3):  6.86 (t, J= 2.0 Hz, 2H), 6.16 (t, J= 2.0 Hz, 2H), 
4.68 (t, J= 7.5 Hz, 1H), 2.09 (q, J= 7.5 Hz, 2H), 1.43 (sextet, J= 7.5 Hz, 2H), 0.96 (t, J= 7.5 Hz, 
3H), 0.15 (s, 9H) ; 
13
C NMR (125 MHz, CDCl3):  143.0, 119.0, 108.8, 97.8, 27.4, 23.1, 13.8, -
0.15; IR max
neat 
cm
-1
: 2959, 2932, 2871, 1682, 1478, 1368, 1254, 1155, 1101, 1078, 1040, 960, 
849, 737, 726; HRMS (EI) m/z calcd for C12H21NOSi (M + H)
+
: 224.1471; found: 224.1480. 
 
(Z)-1-{2-(Benzyloxy)-1-[(trimethylsilyl)oxy]vinyl}-1H-pyrrole (81e): 
Characterization materials match the data provided in the following publication: 
Evans, D. A.; Scheidt, K. A.; Johnson, J. N.; Willis, M. C. J. Am. Chem. Soc. 2001, 123, 4480-
4491. 
 
 (Z)-1-{2-Chloro-1-[(trimethylsilyl)oxy]vinyl}-1H-pyrrole (81f): General 
procedure A was followed employing 1.49 mL of diisopropylamine (10.5 mmol), 
7.19 mL of 1.6 M n-BuLi  (11.5 mmol), 1.5 g  2-Chloro-1-(1H-pyrrol-1-yl)-Ethanone (10.5 
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mmol), 1.46 mL TMSCl in 30 mL THF. The reaction was purified via kugelrohr distillation at 1 
mm Hg. The product distilled between 75 and 80 
o
C (1.85 g, 82%) as a clear colorless oil.  
1
H 
NMR (500 MHz, CDCl3):  6.85 (t, J= 2.0 Hz, 2H), 6.23 (t, J= 2.0 Hz, 2H), 5.53 (s, 1H), 0.27 (s, 
9H); 
13
C NMR (125 MHz, CDCl3):  145.3, 118.9, 110.1, 89.0, 0.06; IR max
neat 
cm
-1
: 3108, 
2961, 2900, 1723, 1655, 1562, 1475, 1353, 1258, 1134, 1078, 961, 887, 789, 728; HRMS (EI) 
m/z calcd for C9H14ClNOSi (M + H)
+
: 216.0611; found: 216.0619. 
 
 
 
General Procedure B.
62
 Synthesis of imidazolylpyridine ligands 91, 97-105:  To a solution of 
picolinaldehyde (1.0 equiv) in CH2Cl2 (0.10 M relative to picolinaldehyde) was added the 
diamine (1.05 equiv).  The reaction was allowed to stir for 30 min before N-bromosuccinimide 
(1.05 equiv) was added as a solid.  The resulting solution was stirred overnight.  The reaction 
was quenched with 10% NaOH/H2O solution of equivalent volume.  Organics were extracted 
with CH2Cl2 (3x the reaction volume), dried with MgSO4, and concentrated in vacuo.  The crude 
product was then subjected to methylation conditions without purification. A solution of the 
crude product in THF (0.10 M) was cooled to -78ºC.  To this was added sodium 
bis(trimethylsilyl)amide (NaHMDS) as a 1.0M solution in THF (1.3 equiv).  After stirring for 30 
min, iodomethane (1.1 equiv) was added.  The reaction flask was then allowed to warm to room 
temperature and stir for 2 h.  Next, the reaction was quenched with an equivalent volume of H2O 
and the organics were extracted with CH2Cl2 (3x the reaction volume).  The extract was dried 
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with MgSO4 and concentrated in vacuo.  The product mixture was purified by column 
chromatography.   
 
2-[(4R,5R)-1-Methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl]pyridine 
(91): Characterization materials match the data provided in the following 
publication : Bastero, A.; Claver, C.; Ruiz, A.; Castillon, S.; Daura, E.; Bo, C.; 
Zangrando, E. Chem. Eur. J. 2004, 10, 3747-3760.  
 
2-[(4R,5R)-1-Benzyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl]pyridine 
(97): Characterization materials match the data provided in the following 
publication : Bastero, A.; Claver, C.; Ruiz, A.; Castillon, S.; Daura, E.; Bo, C.; 
Zangrando, E. Chem. Eur. J. 2004, 10, 3747-3760.  
 
2-[(4R,5R)-4,5-Diphenyl-4,5-dihydro-1H-imidazol-2-yl]pyridine (98): 
Characterization materials match the data provided in the following 
publication : Bastero, A.; Claver, C.; Ruiz, A.; Castillon, S.; Daura, E.; Bo, C.; 
Zangrando, E. Chem. Eur. J. 2004, 10, 3747-3760.  
 
2-Methyl-6-[(4R,5R)-1-methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-
2-yl]pyridine (99): General procedure B was followed employing 163 mg 
of 6-methylpicolinaldehyde (1.34 mmol), 300 mg (1R,2R)-
diphenylethylenediamine (1.41 mmol), 252 mg N-bromosuccinimide (1.41 mmol), in 13.0 mL 
CH2Cl2.  After workup, 429 mg (1.37 mmol) crude product was recovered.  The crude product 
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was then subjected to methylation conditions employing 1.78 mL of NaHMDS (1.0M in THF, 
1.78 mmol) and 94.0 µL iodomethane (1.51 mmol) in 13.0 mL THF.  The reaction mixture was 
purified by column chromatography (SiO2, 5% MeOH/CH2Cl2) to afford 256 mg (57%) of the 
title compound as a pale brown oil: []19
D
 +0.209 (c 4.12, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
7.93 (d, J= 7.5 Hz, 1H), 7.69 (t, J= 8.0 Hz, 1H), 7.42-7.22 (m, 11H), 5.00 (d, J = 10.5 Hz, 1H), 
4.39 (d, J = 10.5 Hz, 1H), 3.00 (s, 3H), 2.64 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 164.3, 
157.5, 149.8, 143.3, 140.8, 136.8, 128.8, 128.4, 127.9, 127.4, 127,1, 126.9, 124.2, 122.0, 34.2, 
24.5; IR max
neat 
cm
-1
:3060, 2922, 1591, 1569, 1453, 1388, 1302, 1277, 1222, 1156, 1080, 913, 
808, 752; HRMS (EI) m/z calcd for C22H21N3 (M + H)
+
: 328.1814; found: 328.1813. 
 
2-[(4R,5R)-1-Methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-
yl]quinoline (100): General procedure B was followed employing 106 mg 
of quinoline-2-carbaldehyde (0.67 mmol), 150 mg (1R,2R)-
diphenylethylenediamine (0.71 mmol), 125 mg N-bromosuccinimide (0.70 mmol), in 7.0 mL 
CH2Cl2.  After workup, 104 mg (0.30 mmol) crude product was recovered.  The crude product 
was then subjected to methylation conditions employing 0.39 mL of NaHMDS (1.0M in THF, 
0.39 mmol) and 24 µL iodomethane (0.33 mmol) in 3.0 mL THF.  The reaction mixture was 
purified by column chromatography (SiO2, 5% MeOH/CH2Cl2) to afford 94 mg (86%) of the 
title compound as a pale brown oil: []19
D
 -1.86 (c 2.01, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
8.27 (dd, J= 14.5, 9.0 Hz, 2H), 8.20 (d, J= 8.5 Hz, 1H), 7.88 (d, J= 8.5 Hz, 1H), 7.77 (ddd, J= 
8.5, 7.0, 1.5 Hz, 1H), 7.61 (ddd, J= 8.0, 1.0 Hz, 1H), 7.44-7.28 (m, 10H), 5.06 (d, J = 10.5 Hz, 
1H), 4.44 (d, J = 10.5 Hz, 1H), 3.20 (s, 3H); 
13
C NMR (125 MHz, CDCl3):  164.0, 150.5, 
147.0, 143.3, 140.9, 136.4, 129.9, 129.7, 128.8, 128.5, 128.2, 127.9, 127.6, 127.4, 127.2, 127.1, 
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122.1, 79.2, 77.4, 34.6; IR max
neat 
cm
-1
: 3059, 3028, 2926, 1600, 1555, 1491, 1392, 1277, 1067, 
839, 755; HRMS (EI) m/z calcd for C25H21N3 (M + H)
+
: 364.1814; found: 364.1808. 
 
4-Methoxy-2-[(4R,5R)-1-methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-
yl]pyridine (101): General procedure B was followed employing 355 mg of 4-
methoxypicolinaldehyde (2.59 mmol), 577 mg (1R,2R)-
diphenylethylenediamine (2.59 mmol), 461 mg N-bromosuccinimide (2.59 mmol), in 26.0 mL 
CH2Cl2.  After workup, 861 mg (2.61 mmol) crude product was recovered.  The crude product 
was then subjected to methylation conditions employing 3.40 mL of NaHMDS (1.0M in THF, 
3.40 mmol) and 42 µL iodomethane (0.67mmol) in 6.0 mL THF.  The reaction mixture was 
purified by column chromatography (SiO2, 0-2% MeOH/CH2Cl2 gradient) to afford 836 mg 
(72%) of the title compound as a pale brown oil: []22
D
 +0.995 (c 2.21, CHCl3); 
1
H NMR (500 
MHz, CDCl3):  8.50 (d, J= 5.5 Hz, 1H), 7.68 (d, J= 2.5 Hz, 1H), 7.40-7.26 (m, 10H), 6.91 (dd, J 
= 6.0, 2.5 Hz, 1H), 4.99 (d, J = 10.5 Hz, 1H), 4.39 (d, J= 10.5 Hz, 1H), 3.93 (s, 3H), 3.01 (s, 
3H); 
13
C NMR (125 MHz, CDCl3):  166.2, 164.3, 151.8, 149.8, 143.0, 140.6, 128.8, 126.9, 
111.9, 110.2, 78.8, 76.9, 55.5, 34.3; IR max
neat 
cm
-1
: 3060, 2939, 1593, 1562, 1474, 1435, 1376, 
1304, 1280, 1190, 1070, 977, 866, 756; HRMS (EI) m/z calcd for C22H21N3O (M + H)
+
: 
344.1763; found: 344.1765. 
 
4-Chloro-2-[(4R,5R)-1-methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-
yl]pyridine: General procedure B was followed employing 223 mg of 4-
chloropicolinaldehyde
71
 (1.57 mmol), 351 mg 1R,2R-diphenylethylenediamine 
(1.65 mmol), 294 mg N-bromosuccinimide (1.65 mmol), in 15.0 mL CH2Cl2.  After workup, 590 
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mg (1.74 mmol) crude product was recovered.  Then the crude product was subjected to 
methylation employing 2.30 mL of NaHMDS (1.0M in THF, 2.26 mmol) and 121 µL 
iodomethane (1.91 mmol) in 18.0 mL THF.  The reaction mixture was purified by column 
chromatography (SiO2, 0-2% MeOH/CH2Cl2 gradient) to afford 440 mg (72%) of the title 
compound as a pale brown oil: []
19
D
 +0.369 (c 2.22, CHCl3); 
1
H NMR (500 MHz, CDCl3):  8.59 
(dd, J= 5.0, 0.5 Hz, 1H), 8.19 (d, J= 1.5 Hz, 1H), 7.41-7.33 (m, 11H), 4.99 (d, J = 10.5 Hz, 1H), 
4.38 (d, J = 10.5 Hz, 1H), 3.01 (s, 3H); 
13
C NMR (125 MHz, CDCl3):  163.2, 152.0, 149.3, 
144.8, 143.1, 140.7, 128.9, 128.5, 127.9, 127.3, 127.2, 126.9, 125.3, 124.9, 79.0, 77.5, 34.3; IR 
max
neat 
cm
-1
:3059, 3028, 2855, 1575, 1550, 1491, 1407, 1343, 1277, 1075, 972, 834; HRMS (EI) 
m/z calcd for C21H18ClN3 (M + H)
+
: 348.1268; found: 348.1250. 
 
2-[(4R,5R)-1-Methyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl]-4-
(pyrrolidin-1-yl)pyridine (102): 4-Chloro-2-[(4R,5R)-1-methyl-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl]pyridine (prepared above), 440 mg (1.27 mmol) 
was added to a medium pressure reaction vessel along with 4.2 mL neat 
pyrrolidine (50.6 mmol). The vessel was sealed and heated to 90°C for 24 h.  At this time the 
reaction vessel was removed from the oil bath and allowed to cool to ambient temperature and 
then concentrated in vacuo.  The crude reaction mixture was purified by column chromatography 
(SiO2, 2-10% MeOH/CH2Cl2 gradient) to afford 256 mg (53%) of the title compound as an off-
white solid: decomposition 62-65C;  []19
D
 -1.57 (c 1.08, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
8.28 (d, J= 5.5 Hz, 1H), 7.38-7.26 (m, 10H), 7.19 (br s, 1H), 6.44 (dd, J= 6.0, 2.5 Hz, 1H), 4.99 
(d, J = 10.0 Hz, 1H), 4.36 (d, J = 10.0 Hz, 1H), 3.40 (d, J= 2.0 Hz, 4H), 2.98 (s, 3H), 2.04 (p, J= 
7.0 Hz, 4.0 Hz, 4H) ; 
13
C NMR (125 MHz, CDCl3):  152.2, 148.7, 128.7, 128.4, 127.9, 127.3, 
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127.2, 126.9, 107.7, 78.7, 47.1, 34.2, 25.3; IR max
neat 
cm
-1
: 3029, 2969, 2855, 1600, 1538, 1495, 
1455, 1346, 1275, 1219, 1157, 1082, 1007, 813, 753; HRMS (EI) m/z calcd for C25H26N4 (M + 
H)
+
: 383.2236; found: 383.2248. 
 
 2-[(4R,5R)-4,5-dicyclohexyl-1-methyl-4,5-dihydro-1H-imidazol-2-
yl]pyridine (104): General procedure B was followed employing 83 µL 
picolinaldehyde (0.87 mmol), 186 mg (1R,2R)-
dicyclohexylethylenediamine
72
 (0.83 mmol), and 155 mg N-bromosuccinimide (0.87 mmol) in 
9.0 mL of CH2Cl2. After workup, 233 mg (0.75 mmol) of the crude product was recovered. Then 
the crude product was subjected to methylation employing 0.97 mL NaHMDS (1.0M in THF, 
0.97 mmol) and 51 µL iodomethane (0.82 mmol) in 7.0 mL of THF.  The reaction mixture was 
purified by column chromatography (SiO2, 5-10% MeOH/CH2Cl2 gradient then 10% MeOH/2% 
Et3N/8% CH2Cl2) to afford 202 mg (83%) the title product, an orange/brown viscous oil; []
18
D
 
+11.3 (c 1.15, CHCl3); 
1
H NMR (500 MHz, CDCl3):  8.64 (dd, J= 4.5, 0.5 Hz, 1H), 7.99 (d, J= 
7.0 Hz, 1H), 7.75 (dt, J= 7.5, 1.5Hz, 1H), 7.32 (ddd, J= 7.5, 5.0, 1.0 Hz, 1H), 3.69 (t, J = 5.0 Hz, 
1H), 3.14 (t, J = 4.0 Hz, 1H), 3.04 (s, 3H), 1.79-1.60 (m, 11H), 1.28-0.99 (m, 11H) ; 
13
C NMR 
(125 MHz, CDCl3):  162.7, 148.7, 136.7, 125.3, 124.6, 71.2, 43.4, 41.2, 34.7, 28.6, 28.5, 27.2, 
26.6, 26.5, 26.4, 26.3, 26.2; IR max
neat 
cm
-1
: 2923, 2851, 1589, 1563, 1448, 1397, 1318, 1259, 
1069, 1044, 799, 748; HRMS (EI) m/z calcd for C21H31N3 (M + H)
+
: 326.2596; found: 326.2588. 
 
4-Chloro-2-[(4R,5R)-4,5-dicyclohexyl-1-methyl-4,5-dihydro-1H-
imidazol-2-yl]pyridine: General procedure B was followed employing 
147 mg 4-chloropicolinaldehyde (1.00 mmol), 213 mg (1R,2R)-
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dicyclohexylethylenediamine (0.95 mmol), and 178 mg N-bromosuccinimide (1.00 mmol) in 
10.0 mL of CH2Cl2. After workup, 319 mg (0.924 mmol) of the crude product was recovered. 
Then the crude product was subjected to methylation employing 1.20 mL NaHMDS (1.0 M in 
THF, 1.20 mmol) and 63.3 µL iodomethane (1.02 mmol) in 10.0 mL of THF. The reaction 
mixture was purified by column chromatography (SiO2, 3-10% MeOH/ CH2Cl2 gradient) to 
afford 203 mg (61%) of the title compound as a viscous, orange oil;  []
19
D
 +10.6 (c 0.870, 
CHCl3); 
1
H NMR (500 MHz, CDCl3):  8.52 (d, J= 5.0 Hz, 1H), 8.17 (br s, 1H), 7.35 (dd, J= 
3.5, 1.5 Hz, 1H), 3.73 (br s, 1H), 3.24 (br s, 1H), 3.09 (s, 3H), 1.79-1.70 (m, 5H), 1.67-1.56 (m, 
6H), 1.28-0.95 (m, 11H) ; 
13
C NMR (125 MHz, CDCl3):  161.2, 149.6, 145.1, 126.1, 125.5, 
71.3, 43.1, 40.7, 34.5, 28.3, 28.2, 28.1, 26.4, 26.3, 26.2, 26.1, 26.0; IR max
neat 
cm
-1
: 2924, 2851, 
1574, 1550, 1447, 1409, 1315, 1262, 1070, 981, 893, 843, 752 ; HRMS (EI) m/z calcd for 
C21H30ClN3 (M + H)
+
: 360.2210; found: 360.2207. 
 
2-[(4R,5R)-4,5-Dicyclohexyl-1-methyl-4,5-dihydro-1H-imidazol-2-yl]-4-
(pyrrolidin-1-yl)pyridine (104): 4-Chloro-2-[(4R,5R)-4,5-dicyclohexyl-1-
methyl-4,5-dihydro-1H-imidazol-2-yl]pyridine (prepared above), 203 mg 
(0.57 mmol) was added to a medium pressure reaction vessel along with 
1.86 mL neat pyrrolidine (22.6 mmol). The vessel was sealed and heated to 
90°C for 24 h.  At this time the reaction vessel was removed from the oil bath and allowed to 
cool to ambient temperature and then concentrated in vacuo.  The crude reaction mixture was 
purified by column chromatography (SiO2, 5-8% MeOH/CH2Cl2 gradient) to afford 229 mg of 
the unmethylated HCl salt.  The HCl salt was reexposed to the methylation procedure employing 
187 mg of the salt (0.45 mmol), 1.12 mL NaHMDS (1.0 M in THF, 1.12 mmol), and 31 µL 
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iodomethane (0.49 mmol) in 6 mL THF.  The crude reaction mixture was purified by column 
chromatography (SiO2, 5-10% MeOH/ CH2Cl2 gradient then 10% MeOH/1% Et3N/9% CH2Cl2 ) 
to afford 157 mg (89%) of the title compound as a pale yellow oil: []
19
D
 +7.07 (c 0.990, CHCl3); 
1
H NMR (500 MHz, CDCl3):  8.18 (d, J= 6.0 Hz, 1H), 6.90 (br s, 1H), 6.31 (d, J= 5.5 Hz, 1H), 
3.61 (t, J= 4.5 Hz, 1H), 3.30 (br s, 4H), 3.01 (br s, 1H), 2.94 (s, 3H), 1.96 (t, J= 6.0 Hz, 4H), 
1.72-1.52 (m, 11H), 1.24-0.98 (m, 11H); 
13
C NMR (125 MHz, CDCl3):  164.0, 151.9, 150.8, 
148.6, 107.5, 107.0, 71.5, 70.5, 46.9, 43.4, 41.2, 34.4, 28.6, 28.4, 28.3, 27.2, 26.7, 26.6, 26.4, 
26.4, 26.3, 26.2, 25.2; IR max
neat 
cm
-1
: 2922, 2850, 1600, 1539, 1484, 1460, 1388, 1349, 1315, 
1262, 1181, 1073, 1006, 811, 750; HRMS (EI) m/z calcd for C25H38N4 (M + H)
+
: 395.3175; 
found: 395.3201. 
 
 
 
General Procedure C.  Catalytic Asymmetric Enolate Allylic Alkylations: 
[CpRu(CH3CN)3]PF6 (5 mol %) and ligand 104 or 102 (5 mol %) were combined in a 2 dram 
vial inside a nitrogen-filled glovebox.  The THF (0.5 M final concentration of the allylic acetate 
substrate) was added and the reaction mixture was periodically shaken over 15 min.  The 
resulting solution was then added to another 2 dram vial containing the allylic acetate (1 equiv), 
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pyrrole silyl enol ether (1.05 equiv), B(O
p
C6H4F)3
73
  (15 mol %) and a Teflon-coated stir bar.  
The vial was sealed with a threaded cap containing a rubber septum inlet.  The vial was removed 
from the glovebox, and the mixture was stirred at ambient temperature for 16h.  After this time, 
the vial was opened and the reaction mixture was concentrated under a stream of N2.  Pentanes 
(4x the reaction volume) were added and the resulting heterogeneous mixture was filtered 
through a Florisil
®
 plug eluting with additional pentanes.  The filtrate was concentrated and the 
resulting mixture of the anti/syn [3,3] products (82a-j, 106) and [1,3] regioisomer (83a-j, 107) 
was analyzed by 
1
H NMR and chiral stationary phase GC.   
 
Enantiomer ratio determination: Enantiomer ratios of the branched products (82a-j) were 
determined by chiral stationary phase GLC (Varian Chirasil-Dex CB WCOT Fused Silica CP 
7502 column, 25 m x 0.25 mm) or analytical high-performance liquid chromatography (HPLC) 
using a variable wavelength UV detector (deuterium lamp, 190-600 nm), a Chiracel OD-H 
column and HPLC-grade isopropanol and hexanes as the eluting solvents. Authentic samples of 
racemic syn and anti diastereomers of the products were used for comparison. 
 
 (2R,3R)-2-Methyl-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82a): General 
Procedure C was followed employing 75 mg (0.43 mmol) cinnamyl acetate, 87 
mg (0.45 mmol) (Z)-1-{1-[(trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole, 6.9 
mg (0.021 mmol) ligand 104, 9.2 mg (0.021 mmol) [CpRu(CH3CN)3]PF6, 22 mg (0.064 mmol) 
B(O
p
C6H4F)3, and 0.80 mL THF.  The reaction mixture was stirred for 16 h at which time it was 
concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated. The 
crude product was purified by column chromatography (SiO2, 3% Et2O/hexanes) to yield 90 mg 
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(89%) as a mixture of diastereomers.  Separating the stereoisomers of 82a by GLC {flow rate 1.5 
mL/min, method: 105 C for 10 min, ramp @ 0.2 C/min to 155 C, hold for 5 min; Tr (min) = 
116.5 [(2S,3S)-82aanti], 117.2 [(2R,3R)-82aanti], 134.3 (82asyn1), 135.4 (82asyn2), (ratio = 
2.1:129.5:1:20.9)} provided the enantiomer ratio (2S,3S)-82aanti:(2R,3R)-82aanti = 1.5:98.4 (97% 
ee), and (82asyn1): (82asyn2) = 4.5:95.4 (91% ee).  
Anti diastereomer (white crystalline solid): mp 49-51 C; []23
D
 +6.67 (c 2.34, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.26-7.20 (m, 6H), 7.16-7.12 (m, 1H), 6.22 (dd, J = 2.0 Hz, 2H), 6.00 (dt, 
J = 16.5, 9.5, Hz, 1H), 5.19 (m, 2H), 3.76 (t, J = 10.0 Hz, 1H), 3.51 (dq, J = 10.0, 7.0 Hz, 1H), 
1.38 (d, J = 6.5 Hz, 3H); 
13
C NMR (125 MHz, CDCl3):  173.1, 142.0, 138.3, 128.6, 127.4, 
126.7, 118.9, 117.3, 113.0, 53.3, 43.2, 16.8; IR max
neat 
cm
-1
: 3150, 3027, 1708, 1637, 1491, 
1301, 1096, 915, 433; HRMS (EI) m/z calcd for C16H17NO (M + H)
+
: 240.1388; found: 
240.1404.  
Syn diastereomer (pale yellow oil): []
23
D
 +7.57 (c 1.06, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
7.37-7.32 (m, 4H), 7.26-7.22 (m, 3H), 6.32 (app t, J = 2.0 Hz, 2H), 5.97 (ddd, J = 18.0, 10.0, 8.0 
Hz, 1H), 5.02 (dt, J = 17.0, 1.0 Hz, 1H), 4.97 (d, J = 10.0 Hz, 1H), 3.72 (t, J = 10.0 Hz, 1H), 
3.46 (dq, J = 10.5, 7.0 Hz, 1H), 1.08 (d, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3):  173.5, 
140.8, 138.9, 128.8, 128.3, 127.0, 119.0, 116.2, 113.3, 53.1, 43.3, 17.0; IR max
neat 
cm
-1
:3027, 
2930, 1711, 1600, 1467, 914, 742; HRMS (EI) m/z calcd for C16H17NO (M + H)
+
: 240.1388; 
found: 240.1373.  
 
 (S)-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82b): General Procedure C 
was followed employing 75 mg (0.43 mmol) cinnamyl acetate, 81 mg (0.45 
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mmol) 1-{1-[(trimethylsilyl)oxy]vinyl}-1H-pyrrole, 6.9 mg (0.021 mmol) ligand 104, 9.2 mg 
(0.021 mmol) [CpRu(CH3CN)3]PF6, 22 mg (0.064 mmol) B(O
p
C6H4F)3, 0.80 mL THF.  The 
reaction mixture was stirred for 16 h at which time it was concentrated under a stream of N2, 
filtered through a plug of Florisil
®
 and concentrated. The crude product was purified via column 
chromatography (SiO2, 3% Et2O/hexanes) to yield 78 mg (82%) of the product as a colorless oil. 
Separating the stereoisomers of 82b by GLC {flow rate 1.5 mL/min, method: 105 C for 10 min, 
ramp @ 0.3 C/min to 175 C, hold for 5 min; Tr (min) = 120.4 [(3S-(82b)], 120.9 [3R-(82b)], 
(ratio = 1:37.4)} provided an ee of 95%. []
23
D
 +0.940 (c 0.830, CHCl3); 
1
H NMR (500 MHz, 
CDCl3):  7.33-7.29 (m, 4H), 7.27-7.21 (m, 3H), 6.28 (app t, J = 2.0 Hz, 2H), 6.06 (ddd, J =  
24.0,10.5, 7.0 Hz, 1H), 5.10 (m, 2H), 4.10 (dd, J = 14.5, 7.0 Hz, 1H), 3.24 (dq, J = 16.0, 7.5 Hz, 
2H); 
13
C NMR (125 MHz, CDCl3): 168.6, 142.3, 139.9, 128.7, 127.6, 126.9, 119.0, 115.3, 
113.2, 44.8, 40.3; IR max
neat 
cm
-1
:3148, 3028, 2921, 1717, 1638, 1600, 1468, 1338, 1275, 1073, 
922, 740; HRMS (EI) m/z calcd for C15H15NO (M + H)
+
 226.1232; found: 226.1224. 
 
(2R,3R)-3-Phenyl-2-propyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82c): General 
Procedure C was followed employing 75 mg (0.43 mmol) cinnamyl acetate, 100 
mg (0.45 mmol) (Z)-1-{1-[(trimethylsilyl)oxy]pent-1-en-1-yl}-1H-pyrrole (81c), 
6.9 mg (0.021 mmol) ligand 104, 9.2 mg (0.021 mmol) [CpRu(CH3CN)3]PF6, 146 mg (0.43 
mmol) B(O
p
C6H4F)3, 0.80 mL THF.  The reaction mixture was stirred for 16 h at which time it 
was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated. The 
crude product was purified via column chromatography (SiO2, 3% Et2O/hexanes) to yield 93 mg 
(82%) of the product (82c) as a mixture of diastereomers.  
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Anti diastereomer (white crystalline solid): mp 81-83 C; []22
D
 +6.40 (c 4.56, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.20-7.15 (m, 5H), 7.10 (m, 1H), 6.16 (app t, J = 2.0 Hz, 2H), 6.02 (ddd, J 
= 17.0, 9.5 Hz, 1H), 5.17 (m, 2H), 3.71 (t, J= 9.5 Hz, 1H), 3.41 (dt, J= 10.0, 4.0 Hz, 1H), 3.14 
(dt, J = 10.0, 4.0 Hz, 1H), 1.83-1.74 (m, 2H), 1.34-1.18 (m, 2H), 0.88 (t, J= 7.0 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3):  173.0, 141.8, 138.5, 128.6, 127.5, 126.7, 119.0, 117.2, 112.9, 53.3, 
49.3, 33.7, 20.4, 14.1; IR max
neat 
cm
-1
: 3148, 3029, 2927, 1694, 1638, 1468, 1345, 1274, 1110, 
1048, 924, 758; HRMS (EI) m/z calcd for C18H21NO (M + H)
+
: 268.1701; found: 268.1720. 
Syn diastereomer (pale yellow oil): []
22
D
 +1.67 (c 1.28, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
7.38 (br s, 2H), 7.34 (t, J= 7.5 Hz, 2H), 7.23 (dd, J = 10.0, 8.5 Hz, 3H), 6.31 (app t, J = 2.0 Hz, 
2H), 5.93 (ddd, J = 19.0, 10.5, 8.3 Hz, 1H), 5.00 (d, J = 17.0 Hz, 1H), 4.92 (d, J = 10.0 Hz, 1H), 
3.68 (t, J = 9.0 Hz, 1H), 3.42 (dt, J= 10.0, 3.5 Hz, 1H), 1.70-1.63 (m, 1H), 1.34-1.28 (m, 1H), 
1.25-1.20 (m, 1H), 1.20-1.17 (m, 1H), 0.74 (t, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 
173.3, 141.2, 138.5, 128.8, 128.0, 126.9, 119.0, 116.4, 113.3, 53.4, 49.3, 33.7, 20.5, 14.0; IR 
max
neat 
cm
-1
: 3150, 3027, 2924, 1709, 1466, 1371, 1114, 1073, 742; HRMS (EI) m/z calcd for 
C18H21NO (M + H)
+
: 268.1701; found: 268.1720.  
 
Methyl (2R,3R)-3-phenyl-2-propylpent-4-enoate (82c*):The above compound 
was derivatized to the methyl ester 82c* for ee determination. General procedure: 
To a solution of acyl pyrrole 82c (1.0 equiv) in MeOH (0.1M) was added 
NaOMe(10.0 equiv). The reaction was allowed to stir at rt for 24 h, and then quenched with 
saturated ammonium chloride.  The reaction was extracted 3 times with Et2O, dried over MgSO4, 
and concentrated to yield 82c* as the methyl ester.  Separating the stereoisomers of 82c* by GLC 
{flow rate 2.0 mL/min, method: 80 C for 10 min, ramp @ 0.4 C/min to 160 C, hold for 5 min; 
 123 
Tr (min) = 60.0 [(2R,3R)-82c*anti], 60.7 [(2S,3S)-82c*anti], 81.2 (82c*syn1), 82.4 (82c*syn2), (ratio 
= 374:7.4:1:65.9)} provided the enantiomer ratio (2R,3R)-82c*anti:(2S,3S)-82c*anti = 98.0:1.9 
(96% ee), and (82c*syn1): (82c*syn2) = 1.5:98.5 (97% ee).   
 
(2R,3S)-2-(Benzyloxy)-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82e): 
General Procedure C was followed employing 100 mg (0.57 mmol) cinnamyl 
acetate, 171 mg (0.59 mmol) (Z)-1-{2-(benzyloxy)-1-[(trimethylsilyl)oxy]vinyl}-
1H-pyrrole, 9.2 mg (0.028 mmol) ligand 104, 12 mg (0.028 mmol) [CpRu(CH3CN)3]PF6, 29 mg 
(0.085 mmol) B(O
p
C6H4F)3, 1.0 mL THF.  The reaction mixture was stirred for 16 h at which 
time it was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and 
concentrated. The crude product was purified via column chromatography (SiO2, 5% 
Et2O/hexanes) to yield 141 mg (75%) of the product 82e as a mixture of diastereomers.  
Anti diastereomer (white solid): mp 77-79 C; []22
D
 +5.00 (c 0.280, CHCl3); 
1
H NMR (500 MHz, 
CDCl3):  7.37 (br s, 2H), 7.32-7.16 (m, 10H), 6.30-6.23 (m, 3H), 5.20 (d, J = 10.5 Hz, 1H), 
5.08 (d, J= 17.0 Hz, 1H), 4.70 (m, 2H), 4.41 (d, J= 11.5Hz, 1H), 3.90 (t, J= 7.0 Hz, 1H); 
13
C 
NMR (125 MHz, CDCl3): 168.7, 139.2, 136.3, 136.1, 128.6, 128.4, 128.3, 128.1, 128.0, 127.3, 
119.5, 117.9, 113.2, 83.3, 72.5, 53.4; IR max
neat 
cm
-1
: 3083, 3029, 2859, 1715, 1688, 1466, 1329, 
1289, 1096, 1019, 926, 739; HRMS (EI) m/z calcd for C22H21NO2 (M + H)
+
: 332.1651; found: 
332.1640.  
Syn diastereomer (yellow oil): []18
D
 +2.5 (c 0.08, CHCl3); 
1
H NMR (500 MHz, CDCl3):  7.48 (t, 
J= 2.5 Hz, 2H), 7.33-7.28 (m, 3H), 7.23-7.20 (m, 5H), 6.97 (m, 2H), 6.28 (t, J = 2.5 Hz, 2H), 
5.95 (ddd, J = 9.0, 10, 17 Hz, 1H), 4.98 (m, 2H), 4.63 (d, J = 9.0 Hz, 1H), 4.57 (d, J= 9.0 Hz, 
1H), 4.23 (d, J= 9.0, 1H), 3.89  (t, J= 9 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): 169.4, 139.6, 
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136.3, 135.6, 128.5, 128.3, 127.9, 127.1, 119.5, 118.0, 113.3, 83.7, 72.4, 54.2; IR max
neat 
cm
-1
: 
2956, 2926, 2867, 1712, 1602, 1505, 1468, 1409, 1344, 1255, 1088, 926, 820.0, 745;  HRMS 
(EI) m/z calcd for C18H21NO (M + Na)
+
: 354.1470; found: 254.1467.  
 
(2R,3S)-2-Hydroxy-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82e*):The 
benzyl ether protecting group of the compound above 82e was removed for ee 
determination.  General Procedure: To a -78 C solution of compound 82e (1.0 
equiv) in CH2Cl2 (0.1M) was added a 1.0M solution of BCl3 in CH2Cl2 dropwise.  The reaction 
was allowed to stir at -78 C for 3 h at which time it was quenched with an equal volume of 
MeOH.  The reaction was allowed to warm to rt and then concentrated in vacuo to yield 82e* as 
the free alcohol. 
Separating the stereoisomers of 82e* by GLC {flow rate 1.0 mL/min, method: 105 C for 10 
min, ramp @ 0.7 C/min to 200 C, hold for 5 min; Tr (min) = 99.3 (82e*syn1), 99.9 (82e*syn2) 
100.9 [(2S,3S)-82e*anti],  101.5 [(2R,3R)-82e*anti], (ratio = 1:17:2:104)} provided the enantiomer 
ratio (2S,3S)-82e*anti:(2R,3R)-82e*anti = 1.9:98.1 (96% ee), and (82e*syn1): (82e*syn2) = 5.6:94.4 
(89% ee). 
 
(2R,3S)-2-Chloro-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82f): General 
Procedure C was followed employing 100 mg (0.57 mmol) cinnamyl acetate, 128 
mg (0.59 mmol) (Z)-1-{2-chloro-1-[(trimethylsilyl)oxy]vinyl}-1H-pyrrole (81f), 
9.2 mg (0.028 mmol) ligand 104, 12 mg (0.028 mmol) [CpRu(CH3CN)3]PF6, 29 mg (0.085 
mmol) B(O
p
C6H4F)3, 1.0 mL THF.  The reaction mixture was stirred for 16 h at which time it 
was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated. The 
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crude product was purified via column chromatography (SiO2, 3% Et2O/hexanes) to yield 56 mg 
(38%) of the product (82f) as an inseparable mixture of diastereomers. In addition, 16 mg (10%) 
of the OAc substituted product (82fʹ)was collected eluting with 10% Et2O/hexanes.  Separating 
the stereoisomers of 82f by GLC {flow rate 1.5 mL/min, method: 105 C for 10 min, ramp @ 0.3 
C/min to 175 C, hold for 5 min; Tr (min) = 140.6 [(2S,3S)-82fanti], 141.2 [(2R,3R)-82fanti], 
(ratio = 66.1:1)} provided an ee of 97%. The syn stereoisomers could not be separated. 
Diastereomer ratio(anti:syn) = 1.0: 0.80 (pale yellow oil); []23
D
 +4.17 (c 5.72, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.43-7.23 (m, 9H), 6.40 (t, J= 2.5 Hz, 2H), 6.29 (t, J= 2.0 Hz, 1.5H), 6.23 
(ddd, J = 18.5, 10.5, 2.0 Hz, 0.8H), 6.01 (ddd, J= 17.5, 11.0, 6.5 Hz, 1H), 5.32 (d, J= 10.0 Hz, 
0.8H), 5.25 (dt, J= 17.0, 10.0 Hz, 0.8H), 5.18 (d, J= 1.0 Hz, 1H), 5.15 (d, J= 6.5 Hz, 1H), 5.12 
(d, J= 10.0 Hz, 0.8H), 5.09 (d, J= 10.5 Hz, 1H), 4.21 (dd, J= 17.5, 7.5 Hz, 1.8H); 
13
C NMR (125 
MHz, CDCl3):  164.5, 165.1, 138.9, 138.6, 136.2, 135.8, 128.9, 128.8, 128.5, 128.1, 127.6, 
127.6, 119.4, 119.3, 119.1, 118.9, 114.2, 113.9, 57.4, 57.1, 53.1, 52.8; IR max
neat 
cm
-1
: 3150, 
3063, 3029, 1638, 1600, 1547, 1411, 1364, 1318, 1265, 1233, 1076, 988, 860, 742; HRMS (EI) 
m/z calcd for C15H14ClNO (M + H)
+
: 260.0842; found: 260.0825. 
 
(3S)-1-Oxo-3-phenyl-1-(1H-pyrrol-1-yl)pent-4-en-2-yl acetate (82fʹ): 
Separating the stereoisomers of 82fʹ by GLC {flow rate 1.5 mL/min, method: 105 
C for 10 min, ramp @ 0.2 C/min to 155 C, hold for 5 min; Tr (min) = 172.7 
[(2R,3S)-82fʹsyn], 174.1 [(2S,3R)-82fʹsyn], 176.3 (82fʹanti1), 178.9 (82fʹanti2), (ratio = 
1.1:112.6:79.9:1)} provided the enantiomer ratio (2R,3S)-82fʹsyn:(2S,3R)-82fʹsyn = 1.0:99.0 (98% 
ee), and (82fʹanti1): (82fʹanti2) = 1.5:98.7 (97% ee). Anti diastereomer: Syn diastereomer = 1.0: 
0.80 (pale yellow oil); []23
D
 +3.31 (c 1.16, CHCl3); 
1
H NMR (500 MHz, CDCl3):  7.38-7.20 (m, 
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13H), 6.33 (app t, J= 2.5 Hz, 1.4H), 6.25 (app t, J= 2.5 Hz, 2H), 6.17 (ddd, J = 17.0, 10.0, 8.5 
Hz, 1.3H), 5.99 (ddd, J= 17.0, 10.0, 8.5 Hz, 0.8H), 5.94 (m, 0.8H), 5.92 (s, 1H), 5.22 (d, J= 10.0 
Hz, 1.1H), 5.12 (m, 2.8H), 4.02 (m, 1.8H), 2.16 (s, 3H), 1.96 (s, 2H); 
13
C NMR (125 MHz, 
CDCl3): 170.2, 170.0, 166.5, 166.1, 138.3, 138.1, 135.0, 134.6, 128.8, 128.6, 128.4, 128.1, 
127.6, 127.5, 119.2, 119.1, 118.7, 118.6, 113.9, 113.7, 74.1, 73.9, 51.9, 51.7, 20.6, 20.3; IR 
max
neat 
cm
-1
: 3150, 3030, 2923, 1722, 1640, 1601, 1470, 1415, 1373, 1323, 1294, 1234, 1123, 
1073, 926, 817, 744; HRMS (EI) m/z calcd for C15H14ClNO (M + Na)
+
: 306.1106; found: 
306.1124. 
 
(2R,3R)-3-(4-Methoxyphenyl)-2-methyl-1-(1H-pyrrol-1-yl)pent-4-en-1-
one (82g): General Procedure C was followed employing 100 mg (0.49 
mmol) (E)-3-(4-methoxyphenyl)allyl acetate, 99 mg (0.51 mmol) (Z)-1-{1-
[(trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole, 7.9 mg (0.024 mmol) 
ligand 104, 11 mg (0.024 mmol) [CpRu(CH3CN)3]PF6, 25 mg (0.073 mmol) B(O
p
C6H4F)3, 1.0 
mL THF.  The reaction mixture was stirred for 16 h at which time it was concentrated under a 
stream of N2, filtered through a plug of Florisil
®
 and concentrated. The crude product was 
purified via column chromatography (SiO2, 5% Et2O/hexanes) to yield 103 mg (79%) of the 
product (82g) as a mixture of diastereomers.  
Anti diastereomer (white crystalline solid): mp 56-59 C; []22
D
 +0.291 (c 1.10, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.22 (br s, 2H), 7.11 (d, J= 9 Hz, 2H), 6.76 (d, J= 8.5 Hz, 2H), 6.22 (app t, 
J = 2.0 Hz, 2H), 5.97 (ddd, J= 18.0, 16.5, 9.0 Hz, 1H), 5.15 (m, 2H), 3.73 (s, 3H), 3.71 (m, 1H), 
3.46 (dq, J= 9.5, 7.0 Hz, 1H), 1.36 (d, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3):  173.1, 
158.2, 138.5, 134.2, 128.4, 118.9, 116.9, 114.0, 113.0, 55.1, 52.4, 43.4, 16.9; IR max
neat 
cm
-1
: 
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3149, 3074, 2935, 2836, 1714, 1636, 1491, 1467, 1366, 1273, 1125, 1072, 995, 896, 742; HRMS 
(EI) m/z calcd for C17H19NO2 (M + H)
+
: 270.1494; found: 270.1501. 
Syn diastereomer (clear colorless oil): []22
D
 +9.74 (c 0.310, CHCl3); 
1
H NMR (500 MHz, 
CDCl3):  7.38 (br s, 2H), 7.14 (d, J= 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 6.32 (app t, J = 2.5 
Hz, 2H), 5.96 (ddd, J = 17.5, 10.5, 8.0 Hz, 1H), 4.98 (m, 2H), 3.81 (s, 3H), 3.68 (t, J = 8.0 Hz, 
1H), 3.41 (dq, J= 10.0, 3.5 Hz, 1H), 1.08 (d, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 
173.6, 158.5, 139.1, 132.8, 129.2, 119.0, 115.8, 114.2, 113.3, 55.3, 52.2, 43.4, 16.9; IR max
neat 
cm
-1
: 2930, 2360, 1709, 1492, 1466, 1371, 1274, 1120, 1073, 914, 743; HRMS (EI) m/z calcd for 
C17H19NO2 (M + H)
+
: 270.1494; found: 270.1479.  
 
Methyl-(2R,3R)-3-(4-methoxyphenyl)-2-methylpent-4-enoate (82g*): The 
above compound 82g was derivatized to the methyl ester 82g* for ee 
determination. General procedure: To a solution of acyl pyrrole 82g (1.0 
equiv) in MeOH (0.1M) was added NaOMe (10.0 equiv). The reaction was allowed to stir at rt 
for 24 h, and then quenched with saturated ammonium chloride.  The reaction was extracted 3 
times with Et2O, dried over MgSO4, and concentrated to yield product 82g* as the methyl ester.  
Separating the stereoisomers of 82g* by GLC {flow rate 2.0 mL/min, method: 80 C for 10 min, 
ramp @ 0.4 C/min to 160 C, hold for 5 min; Tr (min) = 112.9 [(2S,3S)-82g*anti], 113.9 
[(2R,3R)-82g*anti], 123.4 (82g*syn1), 123.7 (82g*syn2), (ratio = 2.2:66.8:1:16.6)} provided the 
enantiomer ratio (2S,3S)-82g*anti:(2R,3R)-82g*anti = 3.2:96.8 (94% ee), and (82g*syn1): (82g*syn2) 
= 5.6:94.3 (89% ee). 
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(2R,3R)-3-(2-Methoxyphenyl)-2-methyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one 
(82h): General Procedure C was followed employing 100 mg (0.49 mmol) (E)-3-
(2-methoxyphenyl)allyl acetate, 99 mg (0.51 mmol) (Z)-1-{1-
[(trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole, 7.9 mg (0.024 mmol) ligand 
104, 11 mg (0.024 mmol) [CpRu(CH3CN)3]PF6, 25 mg (0.073 mmol) B(O
p
C6H4F)3, 1.0 mL 
THF.  The reaction mixture was stirred for 16 h at which time it was concentrated under a stream 
of N2, filtered through a plug of Florisil
®
 and concentrated. The crude product was purified via 
column chromatography (SiO2, 5% Et2O/hexanes) to yield 104 mg (80%) of the product (82h) as 
a mixture of diastereomers. Separating the stereoisomers of 82h by GLC {flow rate 1.5 mL/min, 
method: 105 C for 10 min, ramp @ 0.2 C/min to 155 C, hold for 5 min; Tr (min) = 170.9 
[(2S,3S)-82hanti], 172.4 [(2R,3R)-82hanti], 186.4 (82hsyn1), 187.9 (82hsyn2), (ratio = 
1:84.2:19.0:1.5)} provided the enantiomer ratio (2S,3S)-82hanti:(2R,3R)-82hanti = 1.2:98.8 (98% 
ee), and (82hsyn1): (82hsyn2) = 92.7:7.3 (85% ee).  
Anti diastereomer (white crystalline solid): mp 50-52 C; []22
D
 +7.83 (c 2.84, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.36 (dd, J= 2.0 Hz, 2H), 7.17-7.14 (m, 2H), 6.86 (app t, J= 7.0, 7.0 Hz, 
1H), 6.82 (d, J = 8.0 Hz, 1H), 6.24 (t, J= 2.0 Hz, 2H), 6.21 (m, 1H), 5.10 (m, 2H), 4.03 (t, J= 
9.0Hz, 1H), 3.87 (s, 3H), 3.81 (ddd, J= 7.0 Hz, 1H), 1.25 (d, J= 7.0 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3):  173.3, 156.5, 136.4, 129.9, 129.2, 127.8, 120.7, 119.1, 117.6, 112.6, 110.8, 
55.2, 49.1, 41.1, 15.0; IR max
neat 
cm
-1
: 3151, 3004, 2905, 2835, 1701, 1611, 1513, 1469, 1376, 
1278, 1179, 835, 743 ; HRMS (EI) m/z calcd for C17H19NO2 (M + Na)
+
: 292.1313; found: 
292.1310. 
Syn diastereomer (clear colorless oil): []22
D
 +5.74 (c 0.380, CHCl3); 
1
H NMR (500 MHz, 
CDCl3):  7.38 (br s, 2H), 7.23 (dt, J= 8.0, 1.5 Hz, 1H), 7.16 (dd, J = 7.5, 1.5 Hz, 1H), 6.93 (dt, J 
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= 7.5, 1.0 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 6.30 (app t, J= 2.0 Hz, 2H), 6.10 (ddd, J= 18.5, 
10.0, 8.0 Hz, 1H), 5.04 (dt, J = 17.0, 1.0 Hz, 1H), 4.94 (dd, J= 10.0, 0.5 Hz, 1H), 4.04 (t, J= 9.0 
Hz, 1H), 3.85 (s, 3H), 3.75 (dq, J= 9.5, 7.0 Hz, 1H), 1.08 (d, J= 6.5 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3):  173.9, 157.2, 138.0, 129.7, 129.0, 128.0, 120.8, 119.1, 116.2, 113.0, 111.0, 
55.4, 48.9, 41.5, 16.5; IR max
neat 
cm
-1
: 2930, 2835, 1711, 1637, 1511,1466, 1408, 1320, 1269, 
1178, 1115, 1073, 993, 828, 742; HRMS (EI) m/z calcd for C17H19NO2 (M + H)
+
: 270.1494; 
found: 270.1531.  
 
 (2R,3R)-3-(Furan-2-yl)-2-methyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (82i): 
General Procedure C was followed employing 100 mg (0.60 mmol) (E)-3-(furan-
2-yl)allyl acetate, 123 mg (0.63 mmol) (Z)-1-{1-[(trimethylsilyl)oxy]prop-1-en-1-
yl}-1H-pyrrole, 9.8 mg (0.030 mmol) ligand 104, 13 mg (0.030 mmol) [CpRu(CH3CN)3]PF6, 31 
mg (0.090 mmol) B(O
p
C6H4F)3, 1.2 mL THF.  The reaction mixture was stirred for 16 h at which 
time it was concentrated under a stream of N2, filtered through a plug of Florisil
®
 and 
concentrated. The crude product was purified via column chromatography (SiO2, 3% 
Et2O/hexanes) to yield 136 mg (99%) of the product 82i as a mixture of diastereomers. 
Separating the stereoisomers of 82i by GLC {flow rate 2.0 mL/min, method: 80 C for 10 min, 
ramp @ 0.4 C/min to 160 C, hold for 5 min; Tr (min) = 105.3 [(2S,3S)-82ianti], 106.0 [(2R,3R)-
82ianti], 108.0 (82isyn1), 109.2 (82isyn2), (ratio = 1.1:43.1:1:28.9)} provided the enantiomer ratio 
(2S,3S)-82ianti:(2R,3R)-82ianti = 2.4:97.5 (95% ee), and (82isyn1): (82isyn2) = 3.3:96.7 (93% ee)  
Anti diastereomer (off white, waxy solid): mp 26-28 C; []22
D
 +3.24 (c 4.64, CHCl3); 
1
H NMR 
(500 MHz, CDCl3):  7.31 (br s,  2H), 7.25 (m, 1H), 6.27 (app t, J= 2.5 Hz, 2H), 6.21 (dd, J = 
3.0, 2.0 Hz, 1H), 6.01 (d, J= 3.5 Hz, 1H), 5.92 (ddd, J= 17.0, 10.0, 9.5 Hz, 1H), 5.24 (dd, J= 
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10.0, 1.0 Hz,  1H), 5.18 (d, J= 17.0Hz, 1H), 3.88 (t, J= 9.0 Hz, 1H), 3.57 (dq, J= 8.5, 7.0 Hz, 
1H), 1.29 (d, J= 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  172.9, 154.6, 141.5, 134.7, 119.1, 
118.7, 113.1, 110.2, 106.0, 46.7, 41.5, 15.4; IR max
neat 
cm
-1
: 3149, 2980, 1714, 1503, 1468, 
1364, 1321, 1272, 1096, 994, 734; HRMS (EI) m/z calcd for C14H15NO2 (M + H)
+
: 230.1181; 
found: 230.1183. 
Syn diastereomer (light yellow oil): []22
D
 +3.03 (c 1.79, CHCl3); 
1
H NMR (500 MHz, CDCl3):  
7.37 (dd, J= 2.0, 1.0 Hz, 1H), 7.35 (br s, 2H), 6.32 (m, 3H), 6.15 (d, J = 3.0 Hz, 1H), 5.95 (ddd, 
J = 18.5, 10.5, 8.0 Hz, 1H), 5.08 (dt, J= 17.0, 1.0 Hz, 1H), 5.04 (d, J= 10.0 Hz, 1H), 3.85 (t, J = 
9.0 Hz, 1H), 3.56 (dq, J= 9.5, 6.5 Hz, 1H), 1.16 (t, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3):  172.9, 153.8, 141.8, 135.9, 119.1, 117.4, 113.3, 110.2, 107.3, 46.5, 42.1, 16.8; IR 
max
neat 
cm
-1
: 2978, 2929, 1712, 1639, 1503, 1467, 1409, 1318, 1274, 1148, 1073, 1010, 994, 
909, 806, 737; HRMS (EI) m/z calcd for C14H15NO2 (M + H)
+
: 230.1181; found: 230.1183.  
 
(2R,3R)-2-Methyl-3-(4-nitrophenyl)-1-(1H-pyrrol-1-yl)pent-4-en-1-one 
(82j): General Procedure C was followed employing 100 mg (0.45 mmol) 
(E)-3-(4-nitrophenyl)allyl acetate, 93 mg (0.48 mmol) (Z)-1-{1-
[(trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole, 7.4 mg (0.023 mmol) 
ligand 104, 9.8 mg (0.023 mmol) [CpRu(CH3CN)3]PF6, 23 mg (0.068 mmol) B(O
p
C6H4F)3, 0.90 
mL THF.  The reaction mixture was stirred for 16 h at which time it was concentrated under a 
stream of N2, filtered through a plug of Florisil
®
 and concentrated. The crude product was 
purified via column chromatography (SiO2, 6% Et2O/hexanes) to yield 112 mg (88%) of the 
product as a mixture of diastereomers. Separating the enantiomers by chiral HPLC [Daicel 
Chiralpak OD-H column, flow rate 1.0 ml/min, 1% iPrOH, 99% hexane; Tr (min) = 13.3 
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[(2S,3S)-82janti], 14.3 [(2R,3R)-82janti], 15.9 (82jsyn1), 17.0 (82jsyn2), (ratio = 1:30.4:6.7:220.9)} 
provided the enantiomer ratio (2S,3S)-82janti:(2R,3R)-82janti = 3.2:96.8 (94% ee), and (82jsyn1): 
(82jsyn2) = 2.9:97.1 (94% ee)  
Anti diastereomer (off white solid): mp 93-95 C; []22
D
 +8.71 (c 1.84, CHCl3); 
1
H NMR (500 
MHz, CDCl3):  8.09 (d, J= 8.5 Hz,  2H), 7.36 (d, J= 9.0 Hz, 2H), 7.18 (m, 2H), 6.24 (dd, J = 
2.5 Hz, 2H), 5.94 (m, 1H), 5.23 (m, 2H), 3.86 (t, J= 10.0 Hz,  1H), 3.50 (dq, J= 10.0, 7.0 Hz, 
1H), 1.42 (d, J= 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3):  172.4, 149.8, 146.7, 137.0, 128.4, 
123.9, 118.8, 118.7, 113.6, 53.1, 43.1, 17.3; IR max
neat 
cm
-1
: 3148, 3078, 2927, 1709, 1638, 
1598, 1467, 1408, 1298, 1235, 1094, 994, 919, 893, 822, 743, 704; HRMS (EI) m/z calcd for 
C16H16N2O3 (M + H)
+
: 285.1239; found: 285.1211. 
Syn diastereomer (clear, colorless oil): []22
D
 +2.63 (c 0.950, CHCl3); 
1
H NMR (500 MHz, 
CDCl3):  8.22 (d, J= 9.0 Hz, 2H), 7.41 (d, J= 8.5 Hz, 2H), 7.36 (br s, 2H), 6.35 (app t, J = 2.0 
Hz, 2H), 5.96 (ddd, J = 18.0, 10.5, 7.5 Hz, 1H), 5.07 (m, 2H), 3.90 (t, J= 9.5 Hz, 1H), 3.50 (dq, 
J = 10.0, 7.0 Hz, 1H), 1.10 (t, J= 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3):  172.5, 148.5, 
147.1, 137.3, 129.2, 124.0, 119.0, 117.8, 113.7, 52.7, 43.0, 16.9; IR max
neat 
cm
-1
: 2927, 1711, 
1602, 1519, 1467, 1409, 1346, 1322, 1273, 1113, 1073, 914, 852, 740, 702; HRMS (EI) m/z 
calcd for C16H16N2O3 (M + H)
+
: 285.1239; found: 285.1241.  
 
(2R,3R)-2,3-Dimethyl-1-(1H-pyrrol-1-yl)pent-4-en-1-one (106): General 
Procedure C was followed employing 50 mg (0.44 mmol) (E)-but-2-en-1-yl acetate, 
90 mg (0.46 mmol) (Z)-1-{1-[(trimethylsilyl)oxy]prop-1-en-1-yl}-1H-pyrrole, 8.7 
mg (0.022 mmol) ligand 105, 9.5 mg (0.022 mmol) [CpRu(CH3CN)3]PF6, 23 mg (0.066 mmol) 
B(O
p
C6H4F)3, 0.80 mL THF.  The reaction mixture was stirred for 16 h at which time it was 
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concentrated under a stream of N2, filtered through a plug of Florisil
®
 and concentrated. The 
crude product was purified via column chromatography (SiO2, 1% Et2O/hexanes) to yield 29 mg 
(37%) of the product as an inseparable mixture of diastereomers 106 and regioisomers 107. The 
mixture of products was saponified to the carboxylic acid (to a solution of 11 mg compound 107 
(0.061 mmol) in 0.60 mL THF was added a solution of 0.60 mL of 1.0M NaOH. The solution 
was allowed to stir over night.  The THF was evaporated and the aqueous layer was basified with 
the addition of an equal volume of saturated sodium bicarbonate.  The aqueous layer was 
extracted 3x CH2Cl2 and discarded.  The aqueous layer was then acidified to pH=1 with 1M HCl 
and extracted 3x CH2Cl2, dried over MgSO4 and concentrated) which matched literature data.  
For Anti product see: Metz, P.; Hungerhoff, B. J. Org. Chem. 1997, 62, 4442-4448, for Syn 
product see: Rye, C. E.; Barker, D. J. Org. Chem. 2011, 76, 6636-6648, and for linear product 
see: Deyo, D. T.; Aebi, J. D.; Rich, D. H. Synthesis 1988, 8, 608-610.    
 
 
 
Stereochemical Proof for Products (82a-j): (2R,3R)-3-(4-Methoxyphenyl)-2-methylpent-4-
enal 82d was prepared according to the catalytic asymmetric Claisen rearrangement utilizing 
procedure D, in which the absolute stereochemistry was determined via X-ray crystallography 
(See compound S40d).   
To a magnetically-stirred solution of aldehyde 40d 64 mg (0.32 mmol) and 2-methyl-2-
butene 0.48 mL (4.5 mmol) in 1.0 mL t-BuOH (0.3 M) was added a solution of NaClO2 85 mg 
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(0.94 mmol) and NaH2PO4 113 mg (0.94 mmol) in 1 mL H2O (1 M in NaClO2) dropwise via 
syringe at ambient temperature. The reaction was stirred for 3 h whereupon a saturated aqueous 
solution of NH4Cl (100% v/v to reaction volume) was added and the resulting mixture was 
extracted with Et2O (3x). The combined organic extracts were combined, dried (MgSO4) and 
concentrated to provide 85 mg of the corresponding carboxylic acid that was used without 
purification in the next reaction. 
To a rt solution of carboxylic acid 50 mg (0.23 mmol) in 1 mL CH2Cl2 was added thionyl 
chloride 30 L (0.34 mmol) dropwise followed by 1 drop DMF.  The reaction was allowed to stir 
for 1h until evolution of gas ceased.  The reaction was then concentrated and redissolved in 0.5 
mL of THF.  The THF solution was added dropwise to a -78 °C solution of pyrrole 16 L (0.23 
mmol) and 0.18 mL of 1.4M n-BuLi (0.25 mmol) in 0.5 mL of THF. The reaction was allowed 
to gradually warm to rt and stir overnight. The reaction was quenched with H2O (100% v/v to 
reaction volume), extracted with Et2O (3x), dried over MgSO4 and concentrated to yield 82g. 
The product of this reaction matched the 1H NMR and GLC of compound 82ganti.  The 
absolute stereochemistry of compounds 82a-j was assigned by analogy to this determination. 
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APPENDIX A.  X-RAY CRYSTAL DATA FOR (2R,3R)-3-(4-METHOXYPHENYL)-2-
METHYL-N-[(R)-1-PHENYLETHYL]PENT-4-ENAMIDE S40D 
 
                                 
Figure 15. X-Ray Crystal Structure of S40d 
 
ORTEP and line structure of (2R,3R)-3-(4-Methoxyphenyl)-2-methyl-N-[(R)-1-
phenylethyl]pent-4-enamide.  The molecular structure is drawn with 50% probability 
displacement ellipsoids; hydrogen atoms are drawn with an artificial radius. 
 
Table 20.  CIF information for Compound S40d 
Identification code  dura2s 
Empirical formula  C21 H25 N O2 
Formula weight  323.42 
Temperature  203(2) K 
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Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 5.0151(18) Å a= 90°. 
 b = 16.013(6) Å b= 90°. 
 c = 22.861(8) Å g = 90°. 
Volume 1835.9(11) Å3 
Z 4 
Density (calculated) 1.170 Mg/m3 
Absorption coefficient 0.074 mm-1 
F(000) 696 
Crystal size 0.32 x 0.03 x 0.03 mm3 
Theta range for data collection 1.78 to 24.99°. 
Index ranges -5<=h<=5, -19<=k<=19, -27<=l<=27 
Reflections collected 14062 
Independent reflections 1899 [R(int) = 0.1244] 
Completeness to theta = 24.99° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9978 and 0.9766 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1899 / 16 / 257 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0739, wR2 = 0.1629 
R indices (all data) R1 = 0.1151, wR2 = 0.1812 
Absolute structure parameter ? 
Largest diff. peak and hole 0.220 and -0.223 e.Å-3 
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Table 21.  Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for S40d 
 U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
N 2011(9) 5768(3) 1827(2) 40(1) 
O(1) -2299(6) 5935(2) 1579(2) 48(1) 
O(2) 541(10) 2033(2) 1082(2) 72(1) 
C(3) 2607(14) 3029(4) 2897(3) 65(2) 
C(6) 1900(10) 4710(3) 2594(2) 38(1) 
C(1') 4400(20) 4307(6) 2505(5) 52(3) 
C(2') 4750(20) 3473(6) 2657(4) 68(4) 
C(4') 170(20) 3373(7) 2939(5) 74(4) 
C(5') -150(20) 4202(6) 2798(5) 60(3) 
C(1") 2320(19) 4136(6) 2186(5) 44(3) 
C(2") 2630(19) 3300(6) 2337(4) 49(3) 
C(4") 2040(30) 3634(5) 3325(4) 56(3) 
C(5") 1770(20) 4475(6) 3176(4) 52(3) 
C(7) 1539(10) 5623(3) 2441(2) 41(1) 
C(8) 114(10) 5897(3) 1430(2) 35(1) 
C(9) 941(10) 6027(3) 809(2) 39(1) 
C(10) -677(11) 5437(3) 412(2) 43(1) 
C(11) -1960(14) 4143(4) 970(3) 68(2) 
C(12) -1620(16) 3322(4) 1133(3) 78(2) 
C(13) 414(12) 2850(3) 897(2) 49(2) 
C(14) 2020(13) 3205(4) 505(3) 60(2) 
C(15) 1711(12) 4038(4) 347(3) 59(2) 
C(16) -264(10) 4522(3) 579(2) 37(1) 
C(17) 3246(14) 6200(4) 2809(2) 61(2) 
C(18) 581(14) 6937(3) 643(2) 62(2) 
C(19) -148(14) 5586(3) -222(2) 56(2) 
C(20) -1841(17) 5864(4) -606(3) 80(2) 
C(21) 2474(15) 1512(4) 824(3) 73(2) 
________________________________________________________________________
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Table 22. Bond lengths [Å] and angles [°] for  S40d 
_____________________________________________________  
N-C(8)  1.331(6) 
N-C(7)  1.442(7) 
N-H(1N)  0.78(8) 
O(1)-C(8)  1.259(6) 
O(2)-C(13)  1.378(7) 
O(2)-C(21)  1.408(8) 
C(3)-C(4')  1.346(9) 
C(3)-C(2")  1.352(8) 
C(3)-C(2')  1.402(9) 
C(3)-C(4")  1.406(8) 
C(3)-H(3)  0.9400 
C(6)-C(1")  1.327(11) 
C(6)-C(5")  1.384(8) 
C(6)-C(5')  1.391(8) 
C(6)-C(1')  1.424(11) 
C(6)-C(7)  1.514(7) 
C(1')-C(2')  1.392(9) 
C(1')-H(1')  0.9400 
C(2')-H(2')  0.9400 
C(4')-C(5')  1.374(9) 
C(4')-H(4')  0.9400 
C(5')-H(5')  0.9400 
C(1")-C(2")  1.390(9) 
C(1")-H(1")  0.9400 
C(2")-H(2")  0.9400 
C(4")-C(5")  1.395(9) 
C(4")-H(4")  0.9400 
C(5")-H(5")  0.9400 
C(7)-C(17)  1.515(7) 
C(7)-H(7A)  0.9900 
C(8)-C(9)  1.494(6) 
C(9)-C(18)  1.515(7) 
C(9)-C(10)  1.542(7) 
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C(9)-H(9A)  0.9900 
C(10)-C(19)  1.493(8) 
C(10)-C(16)  1.528(7) 
C(10)-H(10A)  0.9900 
C(11)-C(16)  1.374(8) 
C(11)-C(12)  1.378(8) 
C(11)-H(11A)  0.9400 
C(12)-C(13)  1.379(9) 
C(12)-H(12A)  0.9400 
C(13)-C(14)  1.332(8) 
C(14)-C(15)  1.391(8) 
C(14)-H(14A)  0.9400 
C(15)-C(16)  1.365(7) 
C(15)-H(15A)  0.9400 
C(17)-H(17A)  0.9700 
C(17)-H(17B)  0.9700 
C(17)-H(17C)  0.9700 
C(18)-H(18A)  0.9700 
C(18)-H(18B)  0.9700 
C(18)-H(18C)  0.9700 
C(19)-C(20)  1.298(8) 
C(19)-H(19A)  0.9400 
C(20)-H(20A)  0.9400 
C(20)-H(20B)  0.9400 
C(21)-H(21A)  0.9700 
C(21)-H(21B)  0.9700 
C(21)-H(21C)  0.9700 
C(8)-N-C(7) 124.8(4) 
C(8)-N-H(1N) 114(5) 
C(7)-N-H(1N) 119(5) 
C(13)-O(2)-C(21) 117.8(5) 
C(4')-C(3)-C(2") 86.8(8) 
C(4')-C(3)-C(2') 121.2(8) 
C(2")-C(3)-C(2') 57.3(6) 
C(4')-C(3)-C(4") 58.8(8) 
C(2")-C(3)-C(4") 116.0(7) 
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C(2')-C(3)-C(4") 94.5(8) 
C(4')-C(3)-H(3) 119.4 
C(2")-C(3)-H(3) 127.4 
C(2')-C(3)-H(3) 119.4 
C(4")-C(3)-H(3) 116.6 
C(1")-C(6)-C(5") 119.6(7) 
C(1")-C(6)-C(5') 86.9(7) 
C(5")-C(6)-C(5') 59.0(7) 
C(1")-C(6)-C(1') 56.3(6) 
C(5")-C(6)-C(1') 93.1(7) 
C(5')-C(6)-C(1') 115.6(7) 
C(1")-C(6)-C(7) 121.7(5) 
C(5")-C(6)-C(7) 118.7(6) 
C(5')-C(6)-C(7) 123.7(6) 
C(1')-C(6)-C(7) 120.7(6) 
C(2')-C(1')-C(6) 120.9(10) 
C(2')-C(1')-H(1') 119.6 
C(6)-C(1')-H(1') 119.6 
C(1')-C(2')-C(3) 119.0(10) 
C(1')-C(2')-H(2') 120.5 
C(3)-C(2')-H(2') 120.5 
C(3)-C(4')-C(5') 118.9(10) 
C(3)-C(4')-H(4') 120.5 
C(5')-C(4')-H(4') 120.5 
C(4')-C(5')-C(6) 123.9(10) 
C(4')-C(5')-H(5') 118.0 
C(6)-C(5')-H(5') 118.0 
C(6)-C(1")-C(2") 120.7(9) 
C(6)-C(1")-H(1") 119.6 
C(2")-C(1")-H(1") 119.6 
C(3)-C(2")-C(1") 122.9(9) 
C(3)-C(2")-H(2") 118.5 
C(1")-C(2")-H(2") 118.5 
C(5")-C(4")-C(3) 121.0(8) 
C(5")-C(4")-H(4") 119.5 
C(3)-C(4")-H(4") 119.5 
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C(6)-C(5")-C(4") 119.6(9) 
C(6)-C(5")-H(5") 120.2 
C(4")-C(5")-H(5") 120.2 
N-C(7)-C(6) 111.2(4) 
N-C(7)-C(17) 110.4(4) 
C(6)-C(7)-C(17) 113.1(4) 
N-C(7)-H(7A) 107.3 
C(6)-C(7)-H(7A) 107.3 
C(17)-C(7)-H(7A) 107.3 
O(1)-C(8)-N 120.7(5) 
O(1)-C(8)-C(9) 121.1(5) 
N-C(8)-C(9) 118.1(4) 
C(8)-C(9)-C(18) 109.8(4) 
C(8)-C(9)-C(10) 109.1(4) 
C(18)-C(9)-C(10) 112.3(4) 
C(8)-C(9)-H(9A) 108.5 
C(18)-C(9)-H(9A) 108.5 
C(10)-C(9)-H(9A) 108.5 
C(19)-C(10)-C(16)111.9(4) 
C(19)-C(10)-C(9) 112.3(4) 
C(16)-C(10)-C(9) 111.7(4) 
C(19)-C(10)-H(10A)106.8 
C(16)-C(10)-H(10A)106.8 
C(9)-C(10)-H(10A)106.8 
C(16)-C(11)-C(12)121.4(6) 
C(16)-C(11)-H(11A)119.3 
C(12)-C(11)-H(11A)119.3 
C(11)-C(12)-C(13)120.5(6) 
C(11)-C(12)-H(12A)119.7 
C(13)-C(12)-H(12A)119.7 
C(14)-C(13)-O(2) 125.8(6) 
C(14)-C(13)-C(12)118.5(5) 
O(2)-C(13)-C(12) 115.7(5) 
C(13)-C(14)-C(15)121.1(6) 
C(13)-C(14)-H(14A)119.4 
C(15)-C(14)-H(14A)119.4 
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C(16)-C(15)-C(14)121.6(6) 
C(16)-C(15)-H(15A)119.2 
C(14)-C(15)-H(15A)119.2 
C(15)-C(16)-C(11)116.9(5) 
C(15)-C(16)-C(10)123.0(5) 
C(11)-C(16)-C(10)120.1(5) 
C(7)-C(17)-H(17A)109.5 
C(7)-C(17)-H(17B)109.5 
H(17A)-C(17)-H(17B) 109.5 
C(7)-C(17)-H(17C)109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(9)-C(18)-H(18A)109.5 
C(9)-C(18)-H(18B)109.5 
H(18A)-C(18)-H(18B) 109.5 
C(9)-C(18)-H(18C)109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
C(20)-C(19)-C(10)126.4(6) 
C(20)-C(19)-H(19A)116.8 
C(10)-C(19)-H(19A)116.8 
C(19)-C(20)-H(20A)120.0 
C(19)-C(20)-H(20B)120.0 
H(20A)-C(20)-H(20B) 120.0 
O(2)-C(21)-H(21A)109.5 
O(2)-C(21)-H(21B)109.5 
H(21A)-C(21)-H(21B) 109.5 
O(2)-C(21)-H(21C)109.5 
H(21A)-C(21)-H(21C) 109.5 
H(21B)-C(21)-H(21C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 23. Anisotropic displacement parameters (Å2x 103) for S40d   
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* 
b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
N 20(2)  49(3) 51(3)  6(2) 2(2)  1(2) 
O(1)18(2)  66(3) 59(2)  -6(2) 9(2)  6(2) 
O(2)81(3)  43(2) 92(3)  3(2) 18(3)  8(2) 
C(3)65(5)  60(4) 69(4)  14(4) 3(4)  -2(4) 
C(6)24(3)  51(3) 38(3)  -2(3) 0(2)  0(2) 
C(1') 36(7)  49(7) 70(7)  -4(6) 8(6)  19(5) 
C(2') 69(9)  61(8) 74(9)  22(7) 10(8)  20(8) 
C(4') 65(10)  88(11) 71(9)  17(8) 13(8)  -26(9) 
C(5') 34(6)  61(8) 84(8)  25(7) 16(6)  -11(6) 
C(1") 35(6)  50(7) 47(6)  4(6) -7(5)  -4(6) 
C(2") 34(6)  58(8) 56(7)  -9(6) 1(6)  14(6) 
C(4") 67(9)  56(8) 44(6)  19(6) 14(7)  2(7) 
C(5") 47(7)  46(7) 62(7)  2(6) -3(6)  4(6) 
C(7)22(3)  49(3) 52(3)  -3(3) 3(2)  10(2) 
C(8)27(3)  29(3) 50(3)  -4(2) 4(2)  -1(2) 
C(9)23(3)  42(3) 51(3)  1(2) 1(2)  -5(2) 
C(10) 27(3)  47(3) 55(3)  -3(3) -3(2)  7(2) 
C(11) 61(4)  43(4) 98(5)  0(3) 34(4)  1(3) 
C(12) 86(5)  49(4) 100(5)  6(4) 50(5)  -5(4) 
C(13) 51(4)  38(3) 59(3)  -2(3) -3(3)  0(3) 
C(14) 48(4)  58(4) 74(4)  10(3) 12(3)  14(3) 
C(15) 44(3)  65(4) 67(4)  18(3) 17(3)  17(3) 
C(16) 24(3)  43(3) 45(3)  -5(2) -8(2)  0(2) 
C(17) 60(4)  63(4) 61(3)  -19(3) 4(3)  5(3) 
C(18) 76(5)  50(4) 61(4)  8(3) 3(4)  -10(3) 
C(19) 56(4)  53(4) 59(4)  2(3) -6(3)  1(3) 
C(20) 88(6)  82(5) 70(4)  16(4) -30(4)  -1(5) 
C(21) 72(5)  53(4) 94(5)  -3(4) -16(4)  6(4) 
________________________________________________________________________
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Table 24. Hydrogen coordinates (x 104) and isotropic  displacement parameters (Å2x 10 3) 
for S40d 
 
________________________________________________________________________
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1N) 3410(160) 5910(50) 1730(30) 80(30) 
H(3) 2876 2480 3030 78 
H(1') 5821 4608 2341 62 
H(2') 6413 3211 2601 82 
H(4') -1297 3053 3064 89 
H(5') -1852 4439 2842 71 
H(1") 2408 4295 1791 53 
H(2") 2867 2907 2036 59 
H(4") 1826 3469 3717 67 
H(5") 1513 4878 3469 62 
H(7A) -347 5767 2520 49 
H(9A) 2854 5884 772 46 
H(10A) -2584 5564 479 52 
H(11A) -3382 4451 1129 81 
H(12A) -2784 3081 1407 94 
H(14A) 3385 2887 332 72 
H(15A) 2891 4274 73 70 
H(17A) 2923 6774 2694 92 
H(17B) 5113 6066 2749 92 
H(17C) 2796 6129 3218 92 
H(18A) 1633 7284 903 93 
H(18B) -1286 7087 677 93 
H(18C) 1167 7021 243 93 
H(19A) 1581 5468 -358 67 
H(20A) -3595 5991 -492 96 
H(20B) -1311 5937 -997 96 
H(21A) 2354 957 993 109 
H(21B) 4236 1739 896 109 
H(21C) 2164 1479 406 109 
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APPENDIX B. X-RAY CRYSTAL DATA FOR (2R,3R)-3-(4-BROMOPHENYL)-2-
METHYL-N-[(R)-1-PHENYLETHYL]PENT-4-ENAMIDE S40E 
 
    
Figure 16. X-Ray Crystal Structure of Compound S40e 
 
ORTEP and line structure of (2R,3R)-3-(4-bromophenyl)-2-methyl-N-[(R)-1-phenylethyl]pent-4-
enamide (S40e).  The molecular structure is drawn with 50% probability displacement ellipsoids; 
hydrogen atoms are drawn with an artificial radius. 
 
 
Table 25. CIF information for S40e 
 
Identification code  mgn114s 
Empirical formula  C20 H22 Br N O 
Formula weight  372.30 
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Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 5.0268(12) Å a= 90°. 
 b = 15.831(4) Å b= 90°. 
 c = 22.862(6) Å g = 90°. 
Volume 1819.4(8) Å3 
Z 4 
Density (calculated) 1.359 Mg/m3 
Absorption coefficient 2.264 mm-1 
F(000) 768 
Crystal size 0.26 x 0.05 x 0.01 mm3 
Theta range for data collection 1.56 to 24.99°. 
Index ranges -5<=h<=5, -18<=k<=18, -27<=l<=27 
Reflections collected 14271 
Independent reflections 3185 [R(int) = 0.1035] 
Completeness to theta = 24.99° 100.0 %  
Absorption correction None 
Max. and min. transmission 0.9690 and 0.5906 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3185 / 17 / 253 
Goodness-of-fit on F2 0.920 
Final R indices [I>2sigma(I)] R1 = 0.0616, wR2 = 0.1287 
R indices (all data) R1 = 0.1138, wR2 = 0.1470 
Absolute structure parameter 0.03(2) 
Largest diff. peak and hole 0.705 and -0.268 e.Å-3 
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Table 26. Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for S40e 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
Br 12121(2) 6656(1) 6010(1) 74(1) 
O 7561(8) 10845(3) 6530(2) 52(1) 
N 11845(12) 10742(4) 6777(2) 42(2) 
C(3) 12698(18) 7995(4) 7889(3) 69(2) 
C(6) 11846(11) 9675(4) 7550(2) 41(2) 
C(1') 11600(30) 9471(6) 8133(6) 64(4) 
C(2') 12010(30) 8629(5) 8281(4) 72(5) 
C(4') 12840(30) 8255(6) 7309(3) 53(3) 
C(5') 12640(30) 9091(5) 7131(4) 43(3) 
C(1") 9900(30) 9102(8) 7769(5) 56(4) 
C(2") 10090(20) 8270(8) 7958(6) 84(5) 
C(4") 14750(20) 8418(6) 7604(7) 75(5) 
C(5") 14225(17) 9251(7) 7451(6) 61(5) 
C(7) 11433(12) 10584(4) 7399(3) 45(2) 
C(8) 9912(12) 10855(4) 6399(3) 38(2) 
C(9) 10715(14) 10988(4) 5757(3) 46(2) 
C(10) 9322(13) 10341(4) 5367(3) 47(2) 
C(11) 8586(15) 9005(5) 5925(4) 77(3) 
C(12) 9205(15) 8183(4) 6087(4) 77(2) 
C(13) 11293(14) 7794(4) 5829(3) 50(2) 
C(14) 12708(15) 8202(5) 5429(3) 66(2) 
C(15) 12092(17) 9035(5) 5281(3) 65(2) 
C(16) 10025(12) 9450(4) 5527(3) 41(2) 
C(17) 13137(17) 11166(4) 7763(3) 64(2) 
C(19) 9823(16) 10532(5) 4728(3) 63(2) 
C(20) 8100(20) 10704(5) 4338(4) 99(3) 
C(18) 10100(17) 11899(4) 5612(3) 66(2) 
________________________________________________________________________
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Table 27. Bond lengths [Å] and angles [°] for S40e 
_____________________________________________________  
Br-C(13)  1.895(7) 
O-C(8)  1.220(7) 
N-C(8)  1.313(8) 
N-C(7)  1.460(8) 
N-H(1N)  0.67(5) 
C(3)-C(4')  1.3893(11) 
C(3)-C(2")  1.3895(11) 
C(3)-C(4")  1.3900(11) 
C(3)-C(2')  1.3903(11) 
C(3)-H(3)  0.947(10) 
C(6)-C(1')  1.376(13) 
C(6)-C(5')  1.3895(11) 
C(6)-C(5")  1.3900(11) 
C(6)-C(1")  1.424(14) 
C(6)-C(7)  1.493(9) 
C(1')-C(2')  1.3900(11) 
C(1')-H(1'A)  0.9400 
C(2')-H(2'A)  0.9400 
C(4')-C(5')  1.3896(11) 
C(4')-H(4'A)  0.9400 
C(5')-H(5'A)  0.9400 
C(1")-C(2")  1.3897(11) 
C(1")-H(1"A)  0.9400 
C(2")-H(2"A)  0.9400 
C(4")-C(5")  1.3900(11) 
C(4")-H(4"A)  0.9400 
C(5")-H(5"A)  0.9400 
C(7)-C(17)  1.507(9) 
C(7)-H(7A)  0.9900 
C(8)-C(9)  1.536(8) 
C(9)-C(18)  1.511(9) 
C(9)-C(10)  1.528(9) 
 148 
C(9)-H(9A)  0.9900 
C(10)-C(16)  1.500(9) 
C(10)-C(19)  1.512(9) 
C(10)-H(10A)  0.9900 
C(11)-C(16)  1.359(9) 
C(11)-C(12)  1.388(10) 
C(11)-H(11A)  0.9400 
C(12)-C(13)  1.352(9) 
C(12)-H(12A)  0.9400 
C(13)-C(14)  1.328(9) 
C(14)-C(15)  1.395(10) 
C(14)-H(14A)  0.9400 
C(15)-C(16)  1.352(10) 
C(15)-H(15A)  0.9400 
C(17)-H(17A)  0.9700 
C(17)-H(17B)  0.9700 
C(17)-H(17C)  0.9700 
C(19)-C(20)  1.274(10) 
C(19)-H(19A)  0.9400 
C(20)-H(20A)  0.9400 
C(20)-H(20B)  0.9400 
C(18)-H(18A)  0.9700 
C(18)-H(18B)  0.9700 
C(18)-H(18C)  0.9700 
C(8)-N-C(7) 124.1(6) 
C(8)-N-H(1N) 119(5) 
C(7)-N-H(1N) 117(5) 
C(4')-C(3)-C(2") 93.8(9) 
C(4')-C(3)-C(4") 51.1(8) 
C(2")-C(3)-C(4") 126.9(9) 
C(4')-C(3)-C(2') 114.5(8) 
C(2")-C(3)-C(2') 57.6(8) 
C(4")-C(3)-C(2') 98.0(8) 
C(4')-C(3)-H(3) 118(3) 
C(2")-C(3)-H(3) 103(5) 
C(4")-C(3)-H(3) 128(4) 
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C(2')-C(3)-H(3) 125(3) 
C(1')-C(6)-C(5') 122.5(8) 
C(1')-C(6)-C(5") 97.0(9) 
C(5')-C(6)-C(5") 47.1(7) 
C(1')-C(6)-C(1") 56.6(7) 
C(5')-C(6)-C(1") 90.8(8) 
C(5")-C(6)-C(1") 109.9(8) 
C(1')-C(6)-C(7) 115.9(6) 
C(5')-C(6)-C(7) 121.4(6) 
C(5")-C(6)-C(7) 123.2(6) 
C(1")-C(6)-C(7) 126.8(7) 
C(6)-C(1')-C(2') 116.6(11) 
C(6)-C(1')-H(1'A) 121.7 
C(2')-C(1')-H(1'A) 121.7 
C(1')-C(2')-C(3) 124.9(10) 
C(1')-C(2')-H(2'A) 117.5 
C(3)-C(2')-H(2'A) 117.5 
C(3)-C(4')-C(5') 123.9(8) 
C(3)-C(4')-H(4'A) 118.1 
C(5')-C(4')-H(4'A) 118.1 
C(6)-C(5')-C(4') 117.0(8) 
C(6)-C(5')-H(5'A) 121.5 
C(4')-C(5')-H(5'A) 121.5 
C(2")-C(1")-C(6) 131.8(12) 
C(2")-C(1")-H(1"A)114.1 
C(6)-C(1")-H(1"A)114.1 
C(3)-C(2")-C(1") 109.0(11) 
C(3)-C(2")-H(2"A)125.5 
C(1")-C(2")-H(2"A)125.5 
C(3)-C(4")-C(5") 115.8(10) 
C(3)-C(4")-H(4"A)122.1 
C(5")-C(4")-H(4"A)122.1 
C(4")-C(5")-C(6) 125.4(10) 
C(4")-C(5")-H(5"A)117.3 
C(6)-C(5")-H(5"A)117.3 
N-C(7)-C(6) 111.8(5) 
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N-C(7)-C(17) 110.6(6) 
C(6)-C(7)-C(17) 112.5(5) 
N-C(7)-H(7A) 107.2 
C(6)-C(7)-H(7A) 107.2 
C(17)-C(7)-H(7A) 107.2 
O-C(8)-N 123.6(6) 
O-C(8)-C(9) 119.4(6) 
N-C(8)-C(9) 117.0(6) 
C(18)-C(9)-C(10) 114.7(6) 
C(18)-C(9)-C(8) 106.6(6) 
C(10)-C(9)-C(8) 110.2(5) 
C(18)-C(9)-H(9A) 108.4 
C(10)-C(9)-H(9A) 108.4 
C(8)-C(9)-H(9A) 108.4 
C(16)-C(10)-C(19)112.6(6) 
C(16)-C(10)-C(9) 112.3(5) 
C(19)-C(10)-C(9) 110.7(6) 
C(16)-C(10)-H(10A)106.9 
C(19)-C(10)-H(10A)106.9 
C(9)-C(10)-H(10A)106.9 
C(16)-C(11)-C(12)123.0(7) 
C(16)-C(11)-H(11A)118.5 
C(12)-C(11)-H(11A)118.5 
C(13)-C(12)-C(11)119.1(7) 
C(13)-C(12)-H(12A)120.5 
C(11)-C(12)-H(12A)120.5 
C(14)-C(13)-C(12)119.6(7) 
C(14)-C(13)-Br 119.8(5) 
C(12)-C(13)-Br 120.6(6) 
C(13)-C(14)-C(15)120.5(7) 
C(13)-C(14)-H(14A)119.7 
C(15)-C(14)-H(14A)119.7 
C(16)-C(15)-C(14)122.0(7) 
C(16)-C(15)-H(15A)119.0 
C(14)-C(15)-H(15A)119.0 
C(15)-C(16)-C(11)115.8(6) 
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C(15)-C(16)-C(10)122.4(6) 
C(11)-C(16)-C(10)121.8(6) 
C(7)-C(17)-H(17A)109.5 
C(7)-C(17)-H(17B)109.5 
H(17A)-C(17)-H(17B) 109.5 
C(7)-C(17)-H(17C)109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(20)-C(19)-C(10)127.2(8) 
C(20)-C(19)-H(19A)116.4 
C(10)-C(19)-H(19A)116.4 
C(19)-C(20)-H(20A)120.0 
C(19)-C(20)-H(20B)120.0 
H(20A)-C(20)-H(20B) 120.0 
C(9)-C(18)-H(18A)109.5 
C(9)-C(18)-H(18B)109.5 
H(18A)-C(18)-H(18B) 109.5 
C(9)-C(18)-H(18C)109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:   
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Table 28. Anisotropic displacement parameters(Å2x 103) for S40e  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* 
b* U12 ] 
________________________________________________________________________
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
Br81(1)  56(1) 85(1)  4(1) -12(1)  11(1) 
O 30(3)  75(3) 50(3)  2(2) 2(2)  4(2) 
N 23(3)  64(4) 40(4)  -2(3) 10(3)  3(3) 
C(3)110(7)  43(4) 54(5)  9(4) -2(6)  -13(5) 
C(6)25(3)  58(4) 40(4)  -2(3) 7(3)  -7(3) 
C(1') 101(13)  60(9) 30(8)  1(6) 17(8)  -2(9) 
C(2') 115(14)  51(8) 51(9)  19(7) 46(10)  -13(10) 
C(4') 54(9)  42(8) 61(9)  -24(7) 1(7)  -5(8) 
C(5') 48(8)  48(8) 34(7)  -5(6) -17(7)  -21(7) 
C(1") 42(8)  89(12) 38(9)  7(8) -7(7)  -12(9) 
C(2") 102(15)  70(12) 79(13)  -11(11) 16(11)  -5(13) 
C(4") 84(12)  55(10) 87(13)  -12(10) 27(11)  5(11) 
C(5") 89(14)  36(9) 59(11)  6(8) 27(10)  -12(9) 
C(7)33(4)  64(4) 39(4)  2(3) 4(3)  5(3) 
C(8)24(4)  40(4) 50(4)  -1(3) -1(3)  5(3) 
C(9)39(4)  51(4) 47(4)  11(3) 7(3)  3(3) 
C(10) 48(4)  59(4) 34(4)  10(3) 0(3)  -2(4) 
C(11) 70(5)  67(5) 95(7)  26(5) 39(5)  20(4) 
C(12) 79(5)  53(5) 99(6)  32(5) 35(5)  5(4) 
C(13) 57(5)  51(4) 42(4)  -14(3) -10(3)  1(4) 
C(14) 66(5)  76(5) 56(4)  2(4) 27(4)  21(5) 
C(15) 70(5)  64(5) 62(5)  16(4) 24(5)  7(5) 
C(16) 38(4)  45(4) 39(4)  -6(3) -1(3)  -8(3) 
C(17) 75(5)  62(4) 54(4)  -21(3) -8(4)  14(4) 
C(19) 63(5)  78(5) 49(5)  13(4) -1(4)  9(4) 
C(20) 116(8)  119(7) 63(6)  38(5) -29(6)  -17(7) 
C(18) 89(6)  55(5) 53(5)  12(3) 16(4)  -6(4) 
________________________________________________________________________
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Table 29. Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for 
S40e 
________________________________________________________________________
 x  y  z  U(eq) 
________________________________________________________________________  
H(3) 12570(140) 7409(10) 7970(20) 56(18) 
H(1'A) 11177 9880 8416 76 
H(2'A) 11798 8478 8676 87 
H(4'A) 13097 7840 7020 63 
H(5'A) 13018 9255 6745 52 
H(1"A) 8175 9328 7789 68 
H(2"A) 8685 7946 8109 100 
H(4"A) 16383 8157 7521 91 
H(5"A) 15594 9553 7264 74 
H(7A) 9554 10720 7487 54 
H(9A) 12660 10903 5723 55 
H(10A) 7387 10406 5433 56 
H(11A) 7104 9266 6099 93 
H(12A) 8188 7901 6371 92 
H(14A) 14136 7928 5243 79 
H(15A) 13146 9315 5003 78 
H(17A) 12786 11747 7652 96 
H(17B) 14999 11037 7696 96 
H(17C) 12721 11087 8173 96 
H(19A) 11607 10522 4605 76 
H(20A) 6281 10722 4437 119 
H(20B) 8635 10813 3952 119 
H(18A) 10589 12013 5209 99 
H(18B) 11105 12267 5870 99 
H(18C) 8213 12002 5664 99 
H(1N) 13090(100) 10690(30) 6680(20) 9(16) 
______________________________________________________________________________  
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